0001903596-23-000722.txt : 20230914 0001903596-23-000722.hdr.sgml : 20230914 20230914160535 ACCESSION NUMBER: 0001903596-23-000722 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230914 DATE AS OF CHANGE: 20230914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Netcapital Inc. CENTRAL INDEX KEY: 0001414767 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] IRS NUMBER: 870409951 STATE OF INCORPORATION: UT FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41443 FILM NUMBER: 231255166 BUSINESS ADDRESS: STREET 1: 1 LINCOLN STREET CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: (781) 925-1700 MAIL ADDRESS: STREET 1: 1 LINCOLN STREET CITY: BOSTON STATE: MA ZIP: 02111 FORMER COMPANY: FORMER CONFORMED NAME: ValueSetters Inc. DATE OF NAME CHANGE: 20140924 FORMER COMPANY: FORMER CONFORMED NAME: ValueSetters Corp DATE OF NAME CHANGE: 20071011 10-Q 1 ncpl_10q.htm
0001414767 false --04-30 2024 Q1 0001414767 2023-05-01 2023-07-31 0001414767 2023-09-14 0001414767 2023-07-31 0001414767 2023-04-30 0001414767 2022-05-01 2022-07-31 0001414767 us-gaap:CommonStockMember 2022-04-30 0001414767 ncpl:CommonStockToBeIssuedMember 2022-04-30 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001414767 us-gaap:RetainedEarningsMember 2022-04-30 0001414767 2022-04-30 0001414767 us-gaap:CommonStockMember 2022-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001414767 us-gaap:RetainedEarningsMember 2022-07-31 0001414767 2022-07-31 0001414767 us-gaap:CommonStockMember 2022-10-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-10-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001414767 us-gaap:RetainedEarningsMember 2022-10-31 0001414767 2022-10-31 0001414767 us-gaap:CommonStockMember 2023-01-31 0001414767 ncpl:CommonStockToBeIssuedMember 2023-01-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001414767 us-gaap:RetainedEarningsMember 2023-01-31 0001414767 2023-01-31 0001414767 us-gaap:CommonStockMember 2023-04-30 0001414767 ncpl:CommonStockToBeIssuedMember 2023-04-30 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001414767 us-gaap:RetainedEarningsMember 2023-04-30 0001414767 us-gaap:CommonStockMember 2022-05-01 2022-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-05-01 2022-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-31 0001414767 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-31 0001414767 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-08-01 2022-10-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001414767 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001414767 2022-08-01 2022-10-31 0001414767 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-11-01 2023-01-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001414767 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001414767 2022-11-01 2023-01-31 0001414767 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001414767 ncpl:CommonStockToBeIssuedMember 2023-02-01 2023-04-30 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001414767 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001414767 2023-02-01 2023-04-30 0001414767 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2023-05-01 2023-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001414767 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001414767 us-gaap:CommonStockMember 2023-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2023-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001414767 us-gaap:RetainedEarningsMember 2023-07-31 0001414767 ncpl:ConsultingServicesMember 2023-05-01 2023-07-31 0001414767 ncpl:ConsultingServicesMember 2022-05-01 2022-07-31 0001414767 ncpl:FeesFromOnlineServicesMember 2023-05-01 2023-07-31 0001414767 ncpl:FeesFromOnlineServicesMember 2022-05-01 2022-07-31 0001414767 us-gaap:SecuredDebtMember 2023-07-31 0001414767 us-gaap:SecuredDebtMember 2022-04-30 0001414767 us-gaap:SecuredDebtMember 2023-04-30 0001414767 ncpl:NotesPayableRelatedPartiesMember 2023-07-31 0001414767 ncpl:NotesPayableRelatedPartiesMember 2022-04-30 0001414767 ncpl:NotesPayableRelatedPartiesMember 2023-04-30 0001414767 ncpl:USSBALoanMember 2023-07-31 0001414767 ncpl:USSBALoanMember 2022-04-30 0001414767 ncpl:USSBALoanMember 2023-04-30 0001414767 ncpl:USSBALoanOneMember 2023-07-31 0001414767 ncpl:USSBALoanOneMember 2022-04-30 0001414767 ncpl:USSBALoanOneMember 2023-04-30 0001414767 ncpl:USSBALoanTwoMember 2023-07-31 0001414767 ncpl:USSBALoanTwoMember 2022-04-30 0001414767 ncpl:USSBALoanTwoMember 2023-04-30 0001414767 us-gaap:WarrantMember 2023-07-31 0001414767 us-gaap:WarrantMember 2023-05-01 2023-07-31 0001414767 ncpl:WarrantsExercisableMember 2023-07-31 0001414767 us-gaap:WarrantMember 2022-07-31 0001414767 ncpl:WarrantsExercisableMember 2022-07-31 0001414767 us-gaap:WarrantMember 2022-05-01 2023-04-30 0001414767 ncpl:WarrantsMember srt:MinimumMember 2022-05-01 2023-04-30 0001414767 ncpl:WarrantsMember srt:MaximumMember 2022-05-01 2023-04-30 0001414767 ncpl:WarrantsMember srt:MinimumMember 2023-05-01 2023-07-31 0001414767 ncpl:WarrantsMember srt:MaximumMember 2023-05-01 2023-07-31 0001414767 us-gaap:WarrantMember 2023-04-30 0001414767 srt:ChiefExecutiveOfficerMember 2023-05-01 2023-07-31 0001414767 srt:ChiefExecutiveOfficerMember 2022-05-01 2022-07-31 0001414767 srt:ChiefFinancialOfficerMember 2023-05-01 2023-07-31 0001414767 srt:ChiefFinancialOfficerMember 2022-05-01 2022-07-31 0001414767 ncpl:ChiefExecutiveOfficerOfSubsidiaryMember 2023-05-01 2023-07-31 0001414767 ncpl:ChiefExecutiveOfficerOfSubsidiaryMember 2022-05-01 2022-07-31 0001414767 ncpl:FounderMember 2023-05-01 2023-07-31 0001414767 ncpl:FounderMember 2022-05-01 2022-07-31 0001414767 ncpl:ThirdPartyContractorMember 2023-05-01 2023-07-31 0001414767 ncpl:ThirdPartyContractorMember 2022-05-01 2022-07-31 0001414767 ncpl:BusinessConsultantMember 2023-05-01 2023-07-31 0001414767 ncpl:BusinessConsultantMember 2022-05-01 2022-07-31 0001414767 ncpl:BusinessConsultant1Member 2023-05-01 2023-07-31 0001414767 ncpl:BusinessConsultant1Member 2022-05-01 2022-07-31 0001414767 ncpl:EmployeeStockOptionsMember 2023-05-01 2023-07-31 0001414767 ncpl:EmployeeStockOptionsMember 2022-05-01 2022-07-31 0001414767 ncpl:OptionsOutstandingMember 2023-07-31 0001414767 ncpl:OptionsOutstandingMember 2023-05-01 2023-07-31 0001414767 ncpl:OptionsExercisableMember 2023-07-31 0001414767 ncpl:OptionsOutstandingMember 2022-04-30 0001414767 ncpl:OptionsOutstandingMember 2022-05-01 2023-04-30 0001414767 ncpl:OptionsOutstandingMember 2023-04-30 0001414767 ncpl:OptionsExercisableMember 2023-04-30 0001414767 us-gaap:StockOptionMember 2022-05-01 2023-04-30 0001414767 us-gaap:StockOptionMember 2023-04-30 0001414767 us-gaap:StockOptionMember srt:MinimumMember 2022-05-01 2023-04-30 0001414767 us-gaap:StockOptionMember srt:MaximumMember 2022-05-01 2023-04-30 0001414767 us-gaap:StockOptionMember srt:MinimumMember 2023-04-30 0001414767 us-gaap:StockOptionMember srt:MaximumMember 2023-04-30 0001414767 us-gaap:StockOptionMember 2023-05-01 2023-07-31 0001414767 us-gaap:StockOptionMember 2023-07-31 0001414767 us-gaap:StockOptionMember srt:MinimumMember 2023-07-31 0001414767 us-gaap:StockOptionMember srt:MaximumMember 2023-07-31 0001414767 us-gaap:WarrantMember us-gaap:StockOptionMember 2023-07-31 0001414767 ncpl:AcquiredUsersMember 2023-07-31 0001414767 ncpl:AcquiredUsersMember 2023-04-30 0001414767 ncpl:AcquiredBrandMember 2023-07-31 0001414767 ncpl:AcquiredBrandMember 2023-04-30 0001414767 ncpl:AcquiredIntellectualPropertyAndWebsiteMember 2023-07-31 0001414767 ncpl:AcquiredIntellectualPropertyAndWebsiteMember 2023-04-30 0001414767 ncpl:ProfessionalPracticeMember 2023-07-31 0001414767 ncpl:ProfessionalPracticeMember 2023-04-30 0001414767 ncpl:LiteraryWorksAndContractsMember 2023-07-31 0001414767 ncpl:LiteraryWorksAndContractsMember 2023-04-30 0001414767 ncpl:NetcapitalSystemsLLCMember 2023-07-31 0001414767 ncpl:NetcapitalSystemsLLCMember 2023-04-30 0001414767 ncpl:MustWatchLLCMember 2023-07-31 0001414767 ncpl:MustWatchLLCMember 2023-04-30 0001414767 ncpl:ZelgorIncMember 2023-07-31 0001414767 ncpl:ZelgorIncMember 2023-04-30 0001414767 ncpl:ChipBrainLLCMember 2023-07-31 0001414767 ncpl:ChipBrainLLCMember 2023-04-30 0001414767 ncpl:VymedicIncMember 2023-07-31 0001414767 ncpl:VymedicIncMember 2023-04-30 0001414767 ncpl:CRevealTherapeuticsLLCMember 2023-07-31 0001414767 ncpl:CRevealTherapeuticsLLCMember 2023-04-30 0001414767 ncpl:DeuceDroneLLCMember 2023-07-31 0001414767 ncpl:DeuceDroneLLCMember 2023-04-30 0001414767 ncpl:HiveskillLLCMember 2023-07-31 0001414767 ncpl:HiveskillLLCMember 2023-04-30 0001414767 ncpl:ScanHashLLCMember 2023-07-31 0001414767 ncpl:ScanHashLLCMember 2023-04-30 0001414767 ncpl:CaesarMediaGroupIncMember 2023-07-31 0001414767 ncpl:CaesarMediaGroupIncMember 2023-04-30 0001414767 ncpl:CustCorpMember 2023-07-31 0001414767 ncpl:CustCorpMember 2023-04-30 0001414767 ncpl:KingscrowdIncMember 2023-07-31 0001414767 ncpl:KingscrowdIncMember 2023-04-30 0001414767 ncpl:ReperLLCMember 2023-07-31 0001414767 ncpl:ReperLLCMember 2023-04-30 0001414767 ncpl:DarkLLCMember 2023-07-31 0001414767 ncpl:DarkLLCMember 2023-04-30 0001414767 ncpl:NetwireLLCMember 2023-07-31 0001414767 ncpl:NetwireLLCMember 2023-04-30 0001414767 ncpl:CountSharpLLCMember 2023-07-31 0001414767 ncpl:CountSharpLLCMember 2023-04-30 0001414767 ncpl:CupCrewLLCMember 2023-07-31 0001414767 ncpl:CupCrewLLCMember 2023-04-30 0001414767 ncpl:HeadFarmLLCMember 2023-07-31 0001414767 ncpl:HeadFarmLLCMember 2023-04-30 0001414767 ncpl:RealWorldLLCMember 2023-07-31 0001414767 ncpl:RealWorldLLCMember 2023-04-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: July 31, 2023

 

OR

 

TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number: 001-41443

 

NETCAPITAL INC.
(Exact name of registrant as specified in its charter)

 

Utah   87-0409951
(State or other jurisdiction of incorporation or organization)  

(I.R.S. Employer

Identification No.)

 

1 Lincoln Street

Boston MA 02111

(Address of principal executive offices)

 

(781) 925-1700

 

(Registrant’s telephone number, including area code)

 

Indicate by check whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer  [ ] Accelerated filer  [ ] Non-accelerated filer  [X] Smaller reporting company  [X]
      Emerging growth company  [ ]

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes[ ] No [X]

 

As of September 14, 2023 the Company had 9,434,132 Shares of its common stock, par value $0.001 per share, issued and outstanding.

1 

 

 

 

TABLE OF CONTENTS

 

  Page 
PART I—FINANCIAL INFORMATION
   
Item 1. Financial Statements.  5
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.  23
   
Item 3. Quantitative and Qualitative disclosures about Market Risk.  28
 
Item 4. Controls and Procedures.  28
   
PART II—OTHER INFORMATION
   
Item 1. Legal Proceedings.  29
   
Item1A. Risk Factors.  29
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.  30
   
Item 3. Defaults Upon Senior Securities.  30
   
Item 4. Mine Safety Disclosures.  30
   
Item 5. Other Information.  30
   
Item 6. Exhibits.  30
   
Signatures.  31

 

 

2 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA

 

This Quarterly Report on Form 10-Q contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements may be identified by such forward-looking terminology as “may,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. Our forward-looking statements are based on a series of expectations, assumptions, estimates and projections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty. We may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties, including the risks and uncertainties inherent in our statements regarding:

 

capital requirements and the availability of capital to fund our growth and to service our existing debt;
   
difficulties executing our growth strategy, including attracting new issuers and investors;
   
our anticipated use of the net proceeds from our recent public offering;
   
economic uncertainties and business interruptions resulting from the coronavirus COVID-19 global pandemic and its aftermath;
   
as restrictions related to the coronavirus COVID-19 global pandemic are removed and face-to-face economic activities normalize, it may be difficult for us to maintain the recent sales gains that we have experienced; 
   

 

all the risks of acquiring one or more complementary businesses, including identifying a suitable target, completing comprehensive due diligence uncovering all information relating to the target, the financial stability of the target, the impact on our financial condition of the debt we may incur in acquiring the target, the ability to integrate the target’s operations with our existing operations, our ability to retain management and key employees of the target, among other factors attendant to acquisitions of small, non-public operating companies;
   
difficulties in increasing revenue per issuer;
   
challenges related to hiring and training fintech employees at competitive wage rates;
   
difficulties in increasing the average number of investments made per investor;
   
shortages or interruptions in the supply of quality issuers;
   
our dependence on a small number of large issuers to generate revenue;
   
negative publicity relating to any one of our issuers;
   
competition from other online capital portals with significantly greater resources than we have;
   
changes in investor tastes and purchasing trends;
   
our inability to manage our growth;
   
our inability to maintain an adequate level of cash flow, or access to capital, to meet growth expectations;
   
changes in senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain skilled personnel;

3 

 

 

labor shortages, unionization activities, labor disputes or increased labor costs, including increased labor costs resulting from the demand for qualified employees;
   
our vulnerability to increased costs of running an online portal on Cloud Platform and Amazon Web Services;
   
our vulnerability to increasing labor costs;
   
the impact of governmental laws and regulation;
   
failure to obtain or maintain required licenses;
   
changes in economic or regulatory conditions and other unforeseen conditions that prevent or delay the development of a secondary trading market for shares of equity that are sold on our online portal; and
   
inadequately protecting our intellectual property or breaches of security of confidential user information.
   

You are cautioned that all forward-looking statements involve risks and uncertainties. We undertake no obligation to amend this Form 10-Q or our annual report on Form 10-K or revise publicly these forward-looking statements (other than pursuant to reporting obligations imposed on registrants pursuant to applicable federal securities laws) to reflect subsequent events or circumstances.

 

All of our forward-looking statements are as of the date of this Quarterly Report on Form 10-Q only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties referred to in this Quarterly Report on Form 10-Q or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”) could materially and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this Quarterly Report on Form 10-Q, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this Quarterly Report on Form 10-Q that modify or impact any of the forward-looking statements contained in this Quarterly Report on Form 10-Q will be deemed to modify or supersede such statements in this Quarterly Report on Form 10-Q.

 

This Quarterly Report on Form 10-Q may include market data and certain industry data and forecasts, which we may obtain from internal company surveys, market research, consultant surveys, publicly available information, reports of governmental agencies and industry publications, articles and surveys. Industry surveys, publications, consultant surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy and completeness of such information is not guaranteed. While we believe that such studies and publications are reliable, we have not independently verified market and industry data from third-party sources.

 

 

4 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NETCAPITAL INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

       
       
Assets:  July 31, 2023 (Unaudited)  April 30, 2023 (Audited)
  Cash and cash equivalents  $1,030,618   $569,441 
  Accounts receivable, net   1,355,000    1,388,500 
  Prepaid expenses   444,837    583,030 
Total current assets   2,830,455    2,540,971 
           
  Deposits   6,300    6,300 
 Notes receivable – related parties   202,000    202,000 
 Purchased technology, net   15,846,966    15,875,297 
 Investment in affiliate   240,080    240,080 
 Equity securities at fair value   24,308,633    22,955,445 
Total assets  $43,434,434   $41,820,093 
           
Liabilities and Stockholders' Equity          
Current liabilities:          
  Accounts payable          
   Trade  $586,981   $578,331 
   Related party   75,204    75,204 
  Accrued expenses   242,955    285,065 
  Stock subscription payable   10,000    10,000 
  Deferred revenue   600    661 
  Interest payable   86,185    98,256 
  Deferred tax liability, net   1,532,000    1,657,000 
  Related party debt   15,000    15,000 
  Secured note payable         350,000 
  Current portion of SBA loans   1,885,800    1,885,800 
  Loan payable - bank   34,324    34,324 
  Income taxes notes payable         174,000 
Total current liabilities   4,469,049    5,163,641 
           
Long-term liabilities:          
  Long-term SBA loans, less current portion   500,000    500,000 
Total liabilities   4,969,049    5,663,641 
           
Commitments and contingencies            
           
Stockholders' equity:          
 Common stock, $.001 par value; 900,000,000 shares authorized,    9,434,132 and 6,440,527 shares issued and outstanding   9,434    6,441 
 Shares to be issued   183,187    183,187 
 Capital in excess of par value   33,298,539    30,500,944 
 Retained earnings   4,974,225    5,465,880 
Total stockholders' equity   38,465,385    36,156,452 
Total liabilities and stockholders' equity  $43,434,434   $41,820,093 

 

See Accompanying Notes to the Condensed Consolidated Financial Statements

  

5 

 

 

                   

 NETCAPITAL INC.  

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS  

(UNAUDITED)  

 

       
   Three Months Ended  Three Months Ended
   July 31, 2023  July 31, 2022
       
Revenues  $1,519,809   $1,340,573 
Costs of services   18,053    21,063 
Gross profit   1,501,756    1,319,510 
           
Costs and expenses:          
Consulting expense   163,942    125,611 s
Marketing   241,888    7,780 
Rent   19,610    17,212 
Payroll and payroll related expenses   1,037,042    769,940 
General and administrative costs   788,294    392,297 
               Total costs and expenses   2,250,776    1,312,840 
Operating income (loss)   (749,020)   6,670 
           
Other income (expense):          
Interest expense   (13,304)   (36,312)
Gain on debt conversion         224,260 
Amortization of intangible assets   (28,331)   (21,081)
Realized loss on sale of investment         (406,060)
Total other income (expense)   (41,635)   (239,193)
               Net income (loss) before taxes   (790,655)   (232,523)
Income tax expense (benefit)   (299,000)   (297,000)
Net income (loss)  $(491,655)  $64,477 
           
Basic earnings (loss) per share  $(.07)  $0.02 
Diluted earnings (loss) per share  $(.07)  $0.02 
           
Weighted average number of common shares outstanding:          
Basic   7,471,207    3,168,547 
Diluted   7,471,457    3,171,397 

  

See Accompanying Notes to the Condensed Consolidated Financial Statements

 

6 

 

 

NETCAPITAL INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

 For the Three Months Ended July 31, 2023 and the Year Ended April 30, 2023

 

                   
    Common Stock                     
    Shares    Amount    

Common Stock

To Be Issued

    Capital in Excess of Par Value    Retained Earnings     

Total

Equity

 
Balance, April 30, 2022   2,934,344   $2,934   $244,250   $22,479,769   $2,510,908   $25,237,861 
Shares issued for debt conversion   133,333    134          379,852          379,986 
Sale of common stock   1,205,000    1,205          3,947,912          3,949,117 
Vesting of stock options   —                  32,953          32,953 
Net income for July 31, 2022 quarter   —                        64,477    64,477 
Balance, July 31, 2022   4,272,677    4,273    244,250    26,840,486    2,575,385    29,664,394 
                               
Sale of common stock   2,600    3          23,397          23,400 
Purchase of equity interest   37,500    37          366,338          366,375 
Vesting of stock options   —                  32,953          32,953 
Net income for Oct. 31, 2022 quarter   —                       183,138    183,138 
Balance October 31, 2022   4,312,777    4,313    244,250    27,263,174    2,758,523    30,270,260 
                               
Sale of common stock   1,434,000    1,434          1,620,025          1,621,459 
Purchase of equity interest   18,750    19          171,105          171,124 
Purchase of intellectual property   300,000    300          434,700          435,000 
Reduction in shares to be issued   6,250    6    (61,063)   61,057             
Vesting of stock options   —                  63,057          63,057 
Net income for Jan. 31, 2023 quarter   —                        1,696,499    1,696,499 
Balance January 31, 2023   6,071,777    6,072    183,187    29,613,118    4,455,022    34,257,399 
                               
Purchase of equity interest   18,750    19          195,233          195,252 
Vesting of stock options   —                  132,943          132,943 
Stock-based compensation   350,000    350          559,650          560,000 
Net income April 30, 2023 quarter   —                        1,010,858    1,010,858 
Balance April 30, 2023   6,440,527    6,441    183,187    30,500,944    5,465,880    36,156,452 
                               
Vesting of stock options   —                  139,371          139,371 
Stock-based compensation   100,000    100          143,900          144,000 
Sale of common stock   2,825,000    2,825          2,272,375          2,275,200 
Purchase of equity interest   18,750    18          183,170          183,188 
Stock-based settlement   49,855    50          58,779          58,829 
Net loss July 31, 2023 quarter   —                        (491,655)   (491,655)
Balance July 31, 2023   9,434,132   $9,434   $183,187   $33,298,539   $4,974,225   $38,465,385 

 

See Accompanying Notes to the Condensed Consolidated Financial Statements

7 

 

NETCAPITAL INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

  

Three Months Ended

July 31, 2023

 

Three Months Ended

July 31, 2022

OPERATING ACTIVITIES          
Net income (loss)  $(491,655)  $64,477 
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Stock-based compensation   483,351    32,953 
Receipt of equity in lieu of cash   (1,170,000)   (1,200,000)
Gain on debt conversion         (224,260)
Provision for bad debts   6,000       
Realized loss on investment         406,060 
Changes in deferred taxes   (125,000)   (297,000)
Amortization of intangible assets   28,331    21,081 
Changes in non-cash working capital balances:          
Accounts receivable   27,500    279,200 
Prepaid expenses   (2,958)   (35,842)
Accounts payable and accrued expenses   (33,460)   (135,388)
Deferred revenue   (61)   (1,930)
Accrued interest payable   (12,071)   35,796 
Income taxes payable   (174,000)      
Accounts payable – related party         (8,819)
Net cash used in operating activities   (1,464,023)   (1,063,672)
           
INVESTING ACTIVITIES          
Proceeds from sale of investment         200,000 
Net cash provided by investing activities         200,000 
           
FINANCING ACTIVITIES          
   Payments to secured lender   (350,000)   (1,000,000)
Payment of related party note         (3,200)
Proceeds from sale of common stock   2,275,200    3,949,117 
 Net cash provided by financing activities   1,925,200    2,945,917 
           
Net increase in cash   461,177    2,082,245 
Cash and cash equivalents, beginning of the period   569,441    473,925 
Cash and cash equivalents, end of the period  $1,030,618   $2,556,170 
           
Supplemental disclosure of cash flow information:          
Cash paid for taxes  $     $   
Cash paid for interest  $25,374   $516 
           
Supplemental Non-Cash Investing and Financing Information:          
Common stock issued to pay promissory notes  $     $266,272 
Common stock issued to purchase 10% interest in Caesar Media Group Inc.  $183,188   $   
Common stock issued to pay related party payable  $     $113,714 

  

See Accompanying Notes to the Condensed Consolidated Financial Statements 

8 

 

 

NETCAPITAL INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1– Basis of Presentation

 

The accompanying unaudited condensed financial statements of Netcapital Inc. (the “Company”) have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended July 31, 2023, are not necessarily indicative of the results that may be expected for the fiscal year ended April 30, 2024. For further information, refer to the audited financial statements and footnotes thereto in our Annual Report on Form 10-K for the year ended April 30, 2023.

 

There have been no material changes to our significant accounting policies from our Annual Report on Form 10-K for the fiscal year ended April 30, 2023.


The Company accounts for allowance for credit losses under the current expected credit loss (“CECL”) impairment model for its financial assets, including accounts receivable, and presents the net amount of the financial instrument expected to be collected. The CECL impairment model requires an estimate of expected credit losses, measured over the contractual life of an instrument, which considers forecasts of future economic conditions in addition to information about past events and current conditions. Based on this model, the Company estimates the amount of uncollectible accounts receivable at the end of each reporting period based on the aging of the receivable balance, current and historical customer trends, communications with its customers, and macro-economic conditions. Amounts are written off after considerable collection efforts have been made and the amounts are determined to be uncollectible.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

Note 2 – Concentrations

 

For the three-month period ended July 31, 2023, the Company had one customer that constituted 37% of revenues and a second customer that constituted 37% of revenues. For the three-month period ended July 31, 2022, the Company had one customer that constituted 52% of its revenues and a second customer that constituted 24% of its revenues.

 

Note 3 – Revenue Recognition

 

Revenue Recognition under ASC 606

The Company recognizes service revenue from its consulting contracts, funding portal and game website using the five-step model as prescribed by ASC 606:

 

• Identification of the contract, or contracts, with a customer;

• Identification of the performance obligations in the contract;

• Determination of the transaction price;

• Allocation of the transaction price to the performance obligations in the contract; and

• Recognition of revenue when or as, the Company satisfies a performance obligation.

 

The Company identifies performance obligations in contracts with customers, which primarily are professional services, listing fees on our funding portal, and a portal fee of 4.9% of the money raised on the funding portal. The transaction price is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised services to the customer. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. The Company usually bills its customers before it provides any services and begins performing services after the first payment is received. Contracts are typically one year or less. For larger contracts, in addition to the initial payment, the Company may allow for progress payments throughout the term of the contract.

9 

 

 

Judgments and Estimates

The estimation of variable consideration for each performance obligation requires the Company to make subjective judgments. The Company enters into contracts with customers that regularly include promises to transfer multiple services, such as digital marketing, web-based videos, offering statements, and professional services. For arrangements with multiple services, the Company evaluates whether the individual services qualify as distinct performance obligations. In its assessment of whether a service is a distinct performance obligation, the Company determines whether the customer can benefit from the service on its own or with other readily available resources, and whether the service is separately identifiable from other services in the contract. This evaluation requires the Company to assess the nature of each individual service offering and how the services are provided in the context of the contract, including whether the services are significantly integrated, highly interrelated, or significantly modify each other, which may require judgment based on the facts and circumstances of the contract.

 

When agreements involve multiple distinct performance obligations, the Company allocates arrangement consideration to all performance obligations at the inception of an arrangement based on the relative standalone selling prices (SSP) of each performance obligation. Where the Company has standalone sales data for its performance obligations which are indicative of the price at which the Company sells a promised service separately to a customer, such data is used to establish SSP. In instances where standalone sales data is not available for a particular performance obligation, the Company estimates SSP by the use of observable market and cost-based inputs. The Company continues to review the factors used to establish list price and will adjust standalone selling price methodologies as necessary on a prospective basis.

 

Service Revenue

 

Service revenue from subscriptions to the Company's game website is recognized over time on a ratable basis over the contractual subscription term beginning on the date that the platform is made available to the customer. Payments received in advance of subscription services being rendered are recorded as a deferred revenue. Professional services revenue is recognized over time as the services are rendered.

 

When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company estimates the amount to reserve for uncollectible amounts based on the aging of the contract balance, current and historical customer trends, and communications with its customers. These reserves are recorded as operating expenses against the contract asset (accounts receivable).

 

Contract Assets

 

Contract assets are recorded for those parts of the contract consideration not yet invoiced but for which the performance obligations are completed. The revenue is recognized when the customer receives services. Contract assets are included in other current assets in the consolidated balance sheets and will be recognized during the succeeding twelve-month period.

 

Deferred Revenue

 

Deferred revenues represent billings or payments received in advance of revenue recognition and are recognized upon transfer of control. Balances consist primarily of annual plan subscription services and professional services not yet provided as of the balance sheet date. Deferred revenues that will be recognized during the succeeding twelve-month period are recorded as current deferred revenues in the consolidated balance sheets, with the remainder recorded as other non-current liabilities in the consolidated balance sheets.

 

10 

 

 

Costs to Obtain a Customer Contract

 

Sales commissions and related expenses are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized as other current or non-current assets and amortized on a straight-line basis over the life of the contract, which approximates the benefit period. The benefit period was estimated by taking into consideration the length of customer contracts, technology lifecycle, and other factors. All sales commissions are recorded as consulting fees within the Company's consolidated statement of operations.

 

Remaining Performance Obligations

 

The Company's subscription terms are typically less than one year. All of the Company’s revenues in the three-month periods ended July 31, 2023 and 2022, which amounted to $1,519,809 and $1,340,573, respectively, are considered contract revenues. Contract revenue as of July 31, 2023 and April 30, 2023, which has not yet been recognized, amounted to $600 and $661, respectively, and is recorded on the balance sheet as deferred revenue. The Company expects to recognize revenue on all of its remaining performance obligations over the next 12 months.  

 

Disaggregation of Revenue

 

Revenue is from U.S.-based companies with no notable geographical concentrations in any area. A distinction exists in revenue source; revenues are either generated online or from consulting services.

 

Revenues disaggregated by revenue source consist of the following:

 

       
   Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Consulting services  $1,143,700   $1,161,830 
Fees from online services   376,109    178,743 
Total revenues  $1,519,809   $1,340,573 

 

Note 4 – Earnings Per Common Share

 

Net income (loss) per common and diluted share were calculated as follows for the three-month periods ended July 31, 2023 and 2022:

 

       
   Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Net income (loss) attributable to common stockholders – basic  $(491,655)  $64,477 
Adjustments to net income (loss)            
Net income (loss) attributable to common stockholders – diluted  $(491,655)  $64,477 
           
Weighted average common shares outstanding - basic   7,471,207    3,168,547 
Effect of dilutive securities   250    2,850 
Weighted average common shares outstanding – diluted   7,471,457    3,171,397 
           
Earnings (loss) per common share - basic  $(.07)  $0.02 
Earnings (loss) per common share - diluted  $(.07)  $0.02 

 

11 

 

 

For the three-month period ended July 31, 2023, outstanding vested warrants and stock option grants to purchase 1,541,682 and 344,458 shares of common stock, respectively, and 250 shares of common stock that are issuable pursuant to a stock subscription agreement are not included in the calculation of earnings per share because their effect is anti-dilutive. For the three-month period ended July 31, 2022, 2,850 shares of common stock that are issuable pursuant to stock subscription agreements are included in the calculation of diluted earnings per share. Outstanding warrants to purchase 1,409,732 shares of common stock are not included in the calculation of earnings per share for the three-month period ended July 31, 2022 because their effect is anti-dilutive. Outstanding options to purchase 271,000 shares of common stock are not included in the calculation of earnings per share for the three-month period ended July 31, 2022 because their effect is anti-dilutive.  

Note 5 – Principal Financing Arrangements

 

The following table summarizes components debt as of July 31, 2023 and April 30, 2023:

 

          
   July 31,
2023
  April 30,
2023
  Interest Rate
          
Secured lender  $     $350,000    12.0%
Notes payable – related parties   15,000    15,000    0.0%
U.S. SBA loan   500,000    500,000    3.75%
U.S. SBA loan   1,885,800    1,885,800    1.0%
Loan payable – bank   34,324    34,324    10.0%
        Total Debt   2,435,124    2,785,124      
Less: current portion of long-term debt   1,935,124    2,285,124      
Total long-term debt  $500,000   $500,000      

   

As of July 31, 2023 and April 30, 2023, the Company owed its principal lender (“Lender”) $0 and $350,000, respectively, under an amended loan and security agreement dated July 26, 2014, amended several times thereafter and paid in full in May 2023.

 

As of July 31, 2023 and April 30, 2023, the Company’s related-party unsecured notes payable totaled $15,000.

 

The Company owes $34,324 as of July 31, 2023 and April 30, 2023 to Chase Bank. For the loan from Chase Bank, the Company pays interest only on a monthly basis, which is calculated at a rate of 10.0% per annum as of July 31, 2023.

 

On May 6, 2020, the Company borrowed $1,885,800 (the “May Loan”), on June 17, 2020 the Company borrowed $500,000 (the “June Loan”), and on February 2, 2021, the Company borrowed $1,885,800 (the “February Loan”) from a U.S. Small Business Administration (“SBA”) loan program.

 

12 

 

 

The May loan bore interest at a rate of 1% per annum and was forgiven in its entirety in fiscal 2022.

 

The June Loan required installment payments of $2,437 monthly, beginning on June 17, 2021, over a term of thirty years. However, the SBA postponed the first installment payment for 18 months, and the first payment became due on December 17, 2022. The monthly payments of $2,437 are first applied to accrued interest payable. The monthly payments will not be applied to any of the outstanding principal balance until 2026. Consequently, the entire loan balance of $500,000 is classified as a long term liability. Interest accrues at a rate of 3.75% per annum. The Company agreed to grant a continuing security interest in its assets to secure payment and performance of all debts, liabilities, and obligations to the SBA. The June Loan was personally guaranteed by the Company’s Chief Financial Officer.

 

The February loan bears interest at a rate of 1% per annum and the due date of the first payment has been postponed by the SBA because the Company has applied for forgiveness of the February Loan.

 

Note 6 – Income Taxes

As of July 31, 2023, the Company had net operating loss carryforwards for Federal income tax purposes of approximately $267,000, expiring in the years of 2024 through 2042.

 

For the three-month periods ended July 31, 2023 and 2022, the Company recorded an income tax benefit of $299,000 and $297,000, respectively.

 

As of July 31, 2023 and April 30, 2023, the Company had deferred tax assets calculated at an expected federal rate of 21%, and a state and local rate of 8%, when applicable, or approximately $585,000 and $460,000, respectively. As a result of unrealized book gains on equity securities, the Company also has a deferred tax liability of $1,532,000 and $1,657,000 as of July 31, 2023 and April 30, 2023, respectively. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of July 31, 2023 and April 30, 2023 were as follows:

       
   July 31, 2023  April 30, 2023
       
Deferred tax assets, net:          
Net operating loss carryforwards  $77,000   $   
Bad debt allowance   28,000    27,000 
Stock-based compensation   480,000    433,000 
Deferred tax assets   585,000    460,000 
           
Deferred tax liability          
Unrealized gain   2,117,000    2,117,000 
           
Net deferred tax liability  $(1,532,000)  $(1,657,000)

 

Note 7 – Related Party Transactions

 

The Company’s largest shareholder, Netcapital Systems LLC (“Systems”), owns 1,711,261 shares of common stock, or 18% of the Company’s 9,434,132 outstanding shares as of July 31, 2023. The company paid Systems $0 and $150,000 in the three-month periods ended July 31, 2023 and 2022, respectively, for use of the software that runs the website www.netcapital.com.

 

13 

 

 

The Chief Executive Officer of Netcapital Advisors Inc., (“Advisors”), our wholly owned subsidiary, is a member of the board of directors of KingsCrowd Inc. The Company sold 606,060 shares of KingsCrowd in June 2022 for proceeds of $200,000 and recorded a realized loss on the sale of the investment of $406,060 during the three months ended July 31, 2022. As of July 31, 2023 and April 30, 2023, the Company owned 3,209,685 shares of KingsCrowd Inc., valued at $3,209,685.

 

The Chief Executive Officer of Advisors is a member of the board of directors of Deuce Drone LLC. As of July 31, 2023 and April 30, 2022, the Company owns 2,350,000 membership interest units of Deuce Drone LLC., valued at $2,350,000. The Company has notes receivable aggregating $152,000 from Deuce Drone LLC as of July 31, 2023 and April 30, 2023.

 

Compensation to officers in the three-month periods ended July 31, 2023 and 2022 consisted of stock-based compensation valued at $93,532 and $3,664, respectively, and cash salary of $244,317 and $90,000 respectively.

 

During the three months ended July 31, 2022, we paid $12,019 to a related party to retire a note payable of $3,200 and expenses payable of $8,819.

 

Compensation to a related party consultant in the three-month periods ended July 31, 2023 and 2022 consisted of cash wages of $16,163 and $16,154, respectively. This consultant is also the controlling shareholder of Zelgor Inc. and $16,500 and $11,000 of the Company’s revenues in the three-month periods ended July 31, 2023 and 2022, respectively, were from Zelgor Inc. As of July 31, 2023 and April 30, 2023, the Company owned 1,400,000 shares which are valued at $1,400,000.

 

As of July 31, 2023 and April 30, 2023, the Company has invested $240,080 in an affiliate, 6A Aviation Alaska Consortium, Inc., in conjunction with a land lease in an airport in Alaska. Our Chief Executive Officer is also the Chief Executive Officer of 6A Aviation Alaska Consortium, Inc.

 

We owe Steven Geary, a director, $31,680 as of July 31, 2023 and April 30, 2023. This obligation is not interest bearing. $16,680 is recorded as a related party trade accounts payable and $15,000 as a related party note payable. We have no signed agreements for the indebtedness to Mr. Geary.

Coreen Kraysler, our Chief Financial Officer, has personally guaranteed a $500,000 promissory note from the U.S. Small Business Administration. The note bears interest at an annual rate of 3.75%, has a 30-year term, and monthly payments of $2,437 began on December 17, 2022.

 

Note 8 – Stockholders’ Equity

 

The Company is authorized to issue 900,000,000 shares of its common stock, par value $0.001. 9,434,132 and 6,440,527 shares were outstanding as of July 31, 2023 and April 30, 2023, respectively.

 

During the quarter ended July 31, 2022, the Company issued 39,901 shares of common stock with a value of $113,714 to settle a related party payable of $294,054. The Company also issued 93,432 shares of common stock valued at $266,272 to retire $300,000 of convertible promissory notes plus accrued interest of $10,192. The convertible note holders also received warrants to purchase shares of common stock at a per share exercise price of $5.19, that are exercisable immediately, and expire five years from the date of issuance. These equity issuances resulted in a gain from the conversion of debt totaling $224,260, which is recorded as other income in the income statement.

 

On July 15, 2022, the Company completed an underwritten public offering of 1,205,000 shares of the Company’s common stock and warrants to purchase 1,205,000 shares of the Company’s common stock at a combined public offering price of $4.15 per share and warrant. The gross proceeds from the offering were $5,000,750 prior to deducting underwriting discounts, commissions, and other offering expenses, which resulted in net proceeds of $3,949,117. The warrants have a per share exercise price of $5.19, are exercisable immediately, and expire five years from the date of issuance.

14 

 

 

In addition, the Company granted the underwriter a 45-day option to purchase up to an additional 180,750 shares of common stock and/or up to 180,750 additional warrants to cover over-allotments, if any. In connection with the closing of the offering, the underwriter partially exercised its over-allotment option and purchased an additional 111,300 warrants, and the Company issued an aggregate of 60,250 warrants to 20 individual representatives of the underwriter.

 

On December 16, 2022 the Company completed an underwritten public offering of 1,247,000 shares of the Company’s common stock, at a price to the public of $1.40 per share. Pursuant to the terms of an underwriting agreement, the Company also granted the underwriters a 45-day option to purchase up to an additional 187,000 shares of common stock solely to cover over-allotments, at the same price per share of $1.40, less the underwriting discounts and commissions. In conjunction with this offering, the Company issued the underwriter and its designees warrants to purchase 62,350 shares of our common stock at an exercise price of $1.75. The underwriters exercised their over-allotment option and on January 5, 2023, the Company issued an additional 187,000 shares of its common stock. The Company received net proceeds of $1,621,459 for the issuance of a total of 1,434,000 shares of common stock for both the initial and over-allotment offering. In conjunction with the exercise of the over-allotment, the Company issued the underwriter and its designees warrants to purchase 9,350 shares of our common stock with an exercise price of $1.75.

 

During the year ended April 30, 2023, in addition to the public offerings, the Company issued 75,000 shares of common stock, valued at $732,751, in conjunction with the purchase of a 10% equity stake in Caesar Media Group, Inc., 300,000 shares of common stock, valued at $435,000 to purchase the website and intellectual property of a real-time video conferencing website, 2,600 shares of common stock in conjunction with a stock subscription agreement with accredited investors, valued at $23,400, and 6,250 shares of common stock in conjunction with an acquisition agreement that requires shares to be issued by the Company. As a result of this issuance, the value of the balance sheet account for shares to be issued decreased by $61,063, from $244,250 to $183,187, as of July 31, 2023 and April 30, 2023.

On January 5, 2023, the Company announced the formation of the Netcapital Inc. 2023 Omnibus Equity Incentive Plan (the “Plan”), which was subsequently approved by a vote of the shareholders. In January 2023, the Company granted stock options to four individuals to purchase an aggregate of 1,600,000 of the Company’s common stock at a price of $1.43 per share and on April 25, 2023 also granted 350,000 stock options under the Plan to employees, consultants, and directors at an exercise price of $1.40 per share. All stock options in the Plan vest monthly on a straight-line basis over a 4-year period and expire in 10 years.

In May 2023, the Company issued 100,000 shares of its common stock, valued at $144,000, in conjunction with a consulting agreement with a business advisor.

On May 23, 2023, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell to such investors, in a registered direct offering (the “Offering”), 1,100,000 shares of the Company’s common stock, par value $0.001 per share, at a price of $1.55 per Share, for aggregate gross proceeds of $1,705,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Offering closed on May 25, 2023.

Also in connection with the Offering, on May 23, 2023, the Company entered into a placement agency agreement with ThinkEquity LLC, pursuant to which, the Company issued warrants to purchase up to 55,000 shares of common stock at an exercise price of $1.94, which were issued on May 25, 2023.

15 

 

In July 2023, the Company issued 49,855 shares of its common stock in consideration of a release from an unrelated third party in conjunction with the settlement of an outstanding debt between such third party and Netcapital Systems LLC.

On July 24, 2023 the Company completed an underwritten public offering of 1,725,000 shares of the Company’s common stock, at a price to the public of $0.70 per share for aggregate gross proceeds of $1,207,500, before deducting underwriting discounts and offering expenses payable by the Company. In conjunction with this offering, the Company issued the underwriter, and its designees, warrants to purchase 86,250 shares of the Company’s common stock at an exercise price of $0.875.

On July 31, 2023, the Company issued 18,750 shares of its common stock in conjunction with the purchase of a 10% interest in Caesar Media Group Inc. The Company did not receive any proceeds for the issuance of these shares.

 

The following tables summarize information about warrants outstanding as of July 31, 2023 and April 30, 2023:

 

                                         
    Warrants Outstanding      Warrants Exercisable  
          Weighted-                    
          Average     Weighted-           Weighted-  
Range of         Remaining     Average           Average  
Exercise   Number     Contractual     Exercise     Number     Exercise  
Prices   Outstanding     Life (Years)     Price     Outstanding     Price  
                               
As of July 31, 2023                              
$0.875 - $5.19     1,682,932       4.06     $ 4.72       1,541,682     $ 4.96  
                                         
As of July 31, 2022                                        
$1.75 - $5.19     1,541,682       4.25     $ 5.03       1,469,982     $ 5.19  

 

 

      Number of
Shares
    Exercise Price
Per Share
    Average
Exercise
Price
Outstanding May 1, 2022                 $
                         
Issued during year ended April 30, 2023       1,541,682     1.75-$5.19     $ 5.03
                         
Exercised/canceled during year ended April 30, 2023                 $
                         
Outstanding April 30, 2023       1,541,682     $ 1.75-$5.19     $ 5.53
                         
Issued during quarter ended July 31, 2023       141,250      

$0.875

-$1.94

    $ $1.29
                         
Exercised/canceled during quarter ended July 31, 2023                 $
                         
Warrants outstanding July 31, 2023       1,682,932     $0.875-$5.19     $ 4.72
                         
Warrants exercisable, July 31, 2023       1,541,682       $1.75-$5.19     $ 4.96

 

16 

 

 

Note 9 – Fair Value

 

The Fair Value Measurements Topic of the FASB Accounting Standards Codification establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

 

Level 1: inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the company has the ability to access at the measurement date.

 

Level 2: inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3: inputs are unobservable inputs for the asset or liability.

 

Under the Fair Value Measurements Topic of the FASB Accounting Standards Codification, we base fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. It is our policy to maximize the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements, in accordance with the fair value hierarchy. Fair value measurements for assets and liabilities where there exists limited or no observable market data and, therefore, are based primarily upon management’s own estimates, are often calculated based on current pricing policy, the economic and competitive environment, the characteristics of the asset or liability and other such factors. Therefore, the results cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability. Additionally, there may be inherent weaknesses in any calculation technique, and changes in the underlying assumptions used.

     

 Note 10 – Stock-Based Compensation Plans

In addition to cash payments, the Company enters agreements to issue common stock as payment for services and records the applicable non-cash expense in accordance with the authoritative guidance of the Financial Accounting Standards Board.  

 

For the three months ended July 31, 2023 and 2022, the Company recorded $483,351 and $32,953, respectively, in stock-based compensation expense. As of July 31, 2023 and April 30, 2023, there was $411,178 and $552,329 of prepaid stock-based compensation expense. The prepaid balance is the result of the issuance of 350,000 shares of common stock to a third-party business consultant.

 

 

The table below presents the components of compensation expense for the issuance of shares of common stock and stock options to employees and consultants for the three-month periods ended July 31, 2023 and 2022.

17 

 

 

 

  Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Chief Executive Officer  $62,494   $   
Chief Financial Officer   14,915    2,443 
Chief Executive Officer of subsidiary   1,208    1,221 
Founder   14,915       
Third-party contractor   58,829       
Business consultant   141,151       
Business consultant   144,000       
Employee and consultant options   45,839    29,289 
Total stock-based compensation expense  $483,351   $32,953 

 

The following tables summarize information about stock options outstanding as of July 31, 2023 and April 30, 2023:

 

                                         
    Options Outstanding      Options Exercisable  
          Weighted-                    
          Average     Weighted-           Weighted-  
Range of         Remaining     Average           Average  
Exercise   Number     Contractual     Exercise     Number     Exercise  
Prices   Outstanding     Life (Years)     Price     Outstanding     Price  
                               
As of July 31, 2023                              
$1.40 - $10.50     2,202,000       9.35     $ 2.46       344,458     $ 3.78  
                                         
As of April 30, 2023                                        
$1.40 - $10.50     2,202,000       9.63     $ 2.46       294,333     $ 3.69  

 

 

      Number of
Shares
    Exercise Price
Per Share
    Average
Exercise
Price
Outstanding May 1, 2022       271,000       $10.50     $ 10.50
                         
Issued during year ended April 30, 2023       1,950,000      

$1.40-

$1.43

    $ 1.42
                         
Exercised/canceled during year ended April 30, 2023       (19,000)       $10.50     $ 10.50
                         
Outstanding April 30, 2023       2,202,000       $1.40 - $10.50     $ 2.46
                         
Issued during quarter ended July 31, 2023                 $
                         
Exercised/canceled during quarter ended July 31, 2023                 $
                         
Options outstanding July 31, 2023       2,202,000       $1.40- 10.50     $ 2.46
                         
Options exercisable, July 31, 2023       344,458      

$1.40-

10.50

    $ 3.78

 

 

18 

 

 

Note 11 – Deposits and Commitments

 

We utilize a virtual office at 1 Lincoln Street in Boston, Massachusetts. We pay a membership fee of approximately $5,700 a month, which increases to approximately $6,100 a month in October 2023, under a virtual office agreement that expires in March 2025 and includes a deposit of $6,300.

 

Note 12 – Intangible Assets

 

Intangible assets with defined useful lives are generally measured at cost less straight-line amortization. The useful life is determined using the period of the underlying contract or the period of time over which the intangible asset can be expected to be used. Impairments are recognized if the recoverable amount of the asset is lower than the carrying amount. The recoverable amount is the higher of either the fair value less costs to sell or the value in use. The value in use is determined on the basis of future cash inflows and outflows, and the weighted average cost of capital. Intangible assets with indefinite useful lives, such as trade names and trademarks, that have been acquired as part of acquisitions are measured at cost and tested for impairment annually, or if there is an indication that their value has declined.

 

The following table sets forth the major categories of the intangible assets as of July 31, 2023 and April 30, 2023 

 

 

   July 31, 2023  April 30, 2023
       
Acquired users  $14,288,695   $14,288,695 
Acquired brand   583,429    583,429 
Acquired intellectual property and website   435,000    435,000 
Professional practice   556,830    556,830 
Literary works and contracts   107,750    107,750 
Total intangible assets  $15,971,704   $15,971,704 

 

 

As of July 31, 2023, the weighted average remaining useful life for technology, trade names, professional practice, literary works and domains is 14.09 years. Accumulated amortization amounted to $124,738 as of July 31, 2023, resulting in net intangible assets of $15,846,966.

 

Note 13 – Investments

 

In May 2023, the Company received 2,853,659 units of RealWorld LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

19 

 

 

 

In April 2023, the Company received 2,853,659 units of HeadFarm LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

In April 2023, the Company received 2,853,659 units of CupCrew LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

In April 2023, the Company received 2,853,659 units of CountSharp LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

In January 2023, the Company received 2,100,000 units of Dark LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $1.00 per unit based on a sales price of $1.00 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $2,100,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,100,000 units which are valued at $2,100,000.

 

In August 2022, the Company received 1,911,765 units of NetWire LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.68 per unit based on a sales price of $0.68 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,300,000. As of July 31, 2023 and April 30, 2023, the Company owned 1,911,765 units which are valued at $1,300,000.

 

In May 2022, the Company received 1,764,706 units of Reper LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.68 per unit based on a sales price of $0.68 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,200,000. As of July 31, 2023 and April 30, 2023, the Company owned 1,764,706 units which are valued at $1,200,000.

 

In April 2022, the Company received 3,000,000 units of Cust Corp. as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.40 per unit based on a sales price of $0.40 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,200,000. As of July 31, 2023 and April 30, 2023, the Company owned 3,000,000 units which are valued at $1,200,000.

 

In January 2022, the Company received 1,700,000 units of ScanHash LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.25 per unit based on a sales price of $0.25 per unit on an online funding portal. The receipt of the units satisfied $425,000 of an accounts receivable balance. As of July 31, 2023 and April 30, 2023, the Company owned 1,700,000 units which are valued at $425,000.

 

In January 2022, the Company received 2,850,000 units of Hiveskill LLC as payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.25 per unit based on a sales price of $0.25 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $712,500. As of July 31, 2023 and April 30, 2023, the Company owned 2,850,000 units which are valued at $712,500.

 

20 

 

In fiscal 2022, the Company purchased a 10% interest, or 400 shares of common stock, in Caesar Media Group Inc. (“Caesar”) for an initial purchase price of 50,000 shares of the Company’s common stock, valued at $500,000. Caesar is a marketing and technology solutions provider. The purchase agreement includes additional contractual requirements for the Company and Caesar, including the issuance of an additional 150,000 shares of common stock of the Company over a two-year period. The Company issued 37,500 shares of its common stock in April 2022, 25,000 shares of its common stock in September 2022, 12,500 shares of its common stock in October 2022, 18,750 shares of its common stock in January 2023, 18,750 shares of its common stock in April 2023, and 18,750 shares of its common stock in July 2023, as part of its contractual payment obligations. As of July 31, 2023 and April 30, 2023, there have been no observable price changes in the value of Caesar’s common stock and the Company has valued its ownership in Caesar at cost, which amounted to $1,815,939 and $1,632,751 as of July 31, 2023 and April 30, 2023, respectively.

 

In August 2020 the Company entered a consulting agreement with C-Reveal Therapeutics LLC (“CRT”). for a $120,000 fee over a 12-month period. $50,000 of the fee was payable in CRT units. As of July 31, 2023 and April 30, 2023, the Company owned 5,000 units, at a value of $50,000.

 

In May 2020, the Company entered a consulting contract with MustWatch LLC (“MW”), which allowed the Company to receive 110,000 membership interest units of MW in return for services rendered in conjunction with a crowdfunding offering. The Company earned 97,500 membership interest units in the quarter ended July 31, 2020, valued at $2.14 per unit, or $235,400. As of April 30, 2023, the MW units are valued at $4 per unit based on a sales price of $4 per unit on an online funding portal. As of July 31, 2023 and April 30, 2023, the Company owned 110,000 MW units, which are valued at $440,000.

 

In May 2020, the Company entered into a consulting contract with ChipBrain LLC (“Chip”), which allowed the Company to receive 710,200 membership interest units of Chip in return for services rendered in conjunction with a crowdfunding offering. The Chip units are valued at $4.74 per unit, based on a sales price of $4.74 per unit on an online funding portal. As of July 31, 2023 and April 30, 2023, the units owned by the Company are valued at $3,366,348.

 

In May 2020, the Company entered a consulting contract with a related party, Zelgor Inc. (“Zelgor”), which allowed the Company to receive 1,400,000 shares of common stock of Zelgor in return for services rendered in conjunction with a crowdfunding offering. The Zelgor shares are valued at $1.00 per share based on a sales price of $1.00 per share on an online funding portal. As of July 31, 2023 and April 30, 2023, the Company owned 1,400,000 shares which are valued at $1,400,000.

 

On January 2, 2020, the Company entered a consulting contract with Deuce Drone LLC (“Drone”), which allowed the Company to receive up to 2,350,000 membership interest units of Drone in return for consulting services. The Drone units are valued at $1.00 per share based on a sales price of $1.00 per share on an online funding portal. As of July 31, 2023 and April 30, 2023, the units owned by the Company are valued at $2,350,000.

 

In August 2019, the Company entered a consulting contract with KingsCrowd LLC (“KingsCrowd”), which allowed the Company to receive 300,000 membership interest units of KingsCrowd in return for services rendered in conjunction with a crowdfunding offering. The KingsCrowd units were valued at $1.80 per unit based on a sales price of $1.80 per unit when the units were earned, or $540,000. In December 2020, KingsCrowd converted from a limited liability company to a corporation to facilitate raising capital under Regulation A. KingsCrowd filed a Form 1-A Offering Statement under the Securities Act of 1933 and sold shares at $1.00 per share. In connection with the conversion to a corporation, each membership interest unit converted into 12.71915 shares of common stock, and the Company recorded an unrealized gain of $3,275,745 for the year ended April 30, 2022. The Company sold 606,060 shares of KingsCrowd in June 2022 for proceeds of $200,000 and recorded a realized loss on the sale of the investment of $406,060. KingsCrowd filed a post qualification offering circular amendment on July 21, 2022 and continued to sell shares of stock to the public for $1.00 per share. As of July 31, 2023 and April 30, 2023, the Company owned 3,209,685 shares of KingsCrowd, valued at $3,209,685, respectively.

 

During fiscal 2019, the Company entered into a consulting contract with Netcapital Systems LLC, a related party, and earned membership interest units. As of July 31, 2023 and April 30, 2023, the Company owned 528 units, at a value of $48,128.

 

In July 2020 the Company entered into a consulting agreement with Vymedic, Inc. for a $40,000 fee over a 5-month period. Half the fee was payable in stock and half was payable in cash. As of July 31, 2023 and April 30, 2023 the Company owned 4,000 units, at a value of $11,032.

 

21 

 

 

The following table summarizes the components of investments as of July 31, 2023 and April 30, 2023:

 

 

   July 31, 2023  April 30, 2023
       
Netcapital Systems LLC  $

 48,128

   $48,128 
MustWatch LLC   440,000    440,000 
Zelgor Inc.   1,400,000    1,400,000 
ChipBrain LLC   3,366,348    3,366,348 
Vymedic Inc.   11,032    11,032 
C-Reveal Therapeutics LLC   50,000    50,000 
Deuce Drone LLC   2,350,000    2,350,000 
Hiveskill LLC   712,500    712,500 
ScanHash LLC   425,000    425,000 
Caesar Media Group Inc.   1,815,939    1,632,751 
Cust Corp.   1,200,000    1,200,000 
Kingscrowd Inc.   3,209,685    3,209,685 
Reper LLC   1,200,000    1,200,000 
Dark LLC   2,100,000    2,100,000 
Netwire LLC   1,300,000    1,300,000 
CountSharp LLC   1,170,000    1,170,000 
CupCrew LLC   1,170,000    1,170,000 
HeadFarm LLC   1,170,000    1,170,000 
RealWorld LLC   1,170,000       
Total  $24,308,632   $22,955,444 

 

The above investments in equity securities are within the scope of ASC 321. The Company monitors the investments for any changes in observable prices from orderly transactions. All investments are initially measured at cost and evaluated for changes in estimated fair value.

 

Note 14 – Subsequent Events

 

The Company evaluated subsequent events through the date these financial statements were available to be issued.

 

There were no material subsequent events that required recognition or additional disclosure in these financial statements.

 

22 

 

 

PART I

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

This quarterly report on Form 10-Q and other reports filed by the Company from time to time with the U.S. Securities and Exchange Commission (collectively, the “Filings”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

 

Overview

 

Netcapital Inc. is a fintech company with a scalable technology platform that allows private companies to raise capital online from accredited and non-accredited investors. We give investors the opportunity to access investments in private companies. We believe our model is disruptive to traditional private equity investing and is based on Title III, Reg CF of the JOBS Act. In addition, we have recently expanded our model to include Regulation A (“Reg A”) offerings. We generate fees from listing private companies on our funding portal located at www.netcapital.com. We also generate fees from advising companies with respect to their Reg A offerings posted on www.netcapital.com. Our consulting group, Netcapital Advisors, Inc. (Netcapital Advisors), which is a wholly-owned subsidiary, provides marketing and strategic advice in exchange for equity positions and cash fees. Neither Netcapital Advisors, nor any Netcapital entity, is a broker- dealer, nor do any of such entities operate as a broker-dealer with respect to any Reg A offering listed on the www.netcapital.com website. The Netcapital funding portal is registered with the SEC, is a member of the Financial Industry Regulatory Authority, or FINRA, a registered national securities association, and provides investors with opportunities to invest in private companies.

We provide private company investment access to accredited retail and non-accredited retail investors through our online portal (www.netcapital.com), which is operated by our wholly-owned subsidiary Netcapital Funding Portal, Inc. The Netcapital funding portal charges a $5,000 engagement fee and a 4.9% success fee for capital raised at closing. In addition, the portal generates fees for other ancillary services, such as rolling closes. Netcapital Advisors generates fees and equity stakes from consulting in select portfolio and non-portfolio clients. With respect to its services for Reg A offerings, Netcapital Advisors charges a monthly flat fee for each month the offering is listed on the netcapital.com website as well as a nominal administrative flat fee for each investor that is processed to cover out-of-pocket costs.

23 

 

 

Netcapital.com is an SEC-registered funding portal that enables private companies to raise capital online, while investors are able to invest from almost anywhere in the world, at any time, with just a few clicks. Securities offerings on the portal are accessible through individual offering pages, where companies include product or service details, market size, competitive advantages, and financial documents. Companies can accept investment from virtually anyone, including friends, family, customers, employees, etc.

In addition to access to the funding portal, Netcapital provides the following services:

● a fully automated onboarding process;

● automated filing of required regulatory documents;

● compliance review;

● custom-built offering page on our portal website;

● third party transfer agent and custodial services;

● email marketing to our proprietary list of investors;

● rolling closes, which provide potential access to liquidity before final close date of offering;

● assistance with annual filings; and

● direct access to our team for ongoing support.

 

The company's consulting group, Netcapital Advisors helps companies at all stages to raise capital. Netcapital Advisors provides strategic advice, technology consulting and digital marketing services to assist with fundraising campaigns on the Netcapital platform. The company also acts as an incubator and accelerator, taking equity stakes in select disruptive start-ups. In the instances where we take equity stakes in a company, such interests are of the same class of securities that are offered on the Netcapital platform.

Netcapital Advisors’ services include:

● incubation of technology start-ups;

● investor introductions;

● digital marketing;

● website design, software and software development;

● message crafting, including pitch decks, offering pages, and ad creation;

● strategic advice; and

● technology consulting.

 

 Our valuation group, MSG Development Corp., which is also a wholly-owned subsidiary, prepares valuations.

The valuation services include:

● business valuations;

● fairness and solvency opinions;

● ESOP feasibility and valuation;

● non-cash charitable contributions;

● economic analysis of damages;

● intellectual property appraisals; and

● compensation studies.

 

Recent Developments

On May 23, 2023, we entered into a securities purchase agreement with certain institutional investors, pursuant to which we agreed to issue and sell to such investors, in a registered direct offering (the “Offering”), 1,100,000 shares (the “Shares”) of our common stock at a price of $1.55 per Share, for aggregate gross proceeds of $1,705,000, before deducting the placement agent's fees and other offering expenses payable by the Company. The Offering closed on May 25, 2023 and we received aggregate net proceeds of $1,468,700. In conjunction with this offering, we issued the placement agent and its designees warrants to purchase 55,000 shares of our common stock at an exercise price of $1.94.

24 

 

 

Repayment of Secured Debt

 

On May 25, 2023, we paid $367,167 to our secured lender, Vaxstar LLC, to pay off the remaining $350,000 principal balance and $17,167 in interest, using a portion of the net proceeds of the Offering. Following repayment to Vaxstar LLC the facility was closed and all related agreements were terminated in accordance with their terms.

 

Recent Common Stock Issuances.

 

In April and May 2023, we issued an aggregate of 450,000 shares of common stock to consultants in consideration of services rendered. In addition, in July 2023, we issued 49,855 shares of common stock to an unrelated third party, in consideration of a release from such third party related to settlement of an outstanding debt between such third-party and Netcapital Systems LLC. In July 2023, we issued 18,750 shares of our common stock in connection with our acquisition of a 10% interest in Caesar’s Media Group, Inc. We did not receive any proceeds from these issuances. Such shares were issued as restricted securities and were issued pursuant to the exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

 

July 2023 Public Offering

 

On July 24, 2023 we completed an underwritten public offering of 1,725,000 shares of our common stock, at a price to the public of $0.70 per share for aggregate gross proceeds of $1,207,500, before deducting underwriting discounts and offering expenses payable by us. In conjunction with this offering, we issued the underwriter and its designees warrants to purchase 86,250 shares of our common stock at an exercise price of $0.875.

 

Notice from Nasdaq on Failure to Satisfy a Continued Listing Rule

 

On September 1, 2023, we were notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that we are not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of our common stock between July 20, 2023 and August 31, 2023, we no longer meet the minimum bid price requirement. The Notification Letter has no immediate effect on the listing or trading of our common stock on The Nasdaq Capital Market and, at this time, the common stock will continue to trade on The Nasdaq Capital Market under the symbol “NCPL.”

 

The Notification Letter provides that we have 180 calendar days, or until February 28, 2024, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the bid price of our common stock must have a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. If we do not regain compliance by February 28, 2024, an additional 180 days may be granted to regain compliance, so long as we meet The Nasdaq Capital Market continued listing requirement for market value of publicly-held shares and all other initial listing standards for The Nasdaq Capital Market, other than the minimum closing bid price requirement and notifies Nasdaq in writing of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If we do not qualify for the second compliance period or fails to regain compliance during the second 180-day period, then Nasdaq will notify us of its determination to delist our common stock, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel.

 

We intend to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its outstanding securities, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules. 

Results of Operations

 

Comparison of the Three Months Ended July 31, 2023 and 2022

 

Our revenues for the three months ended July 31, 2023, increased by $179,236, or 13%, to $1,519,809, as compared to $1,340,573 during the three months ended July 31, 2022.  The increase in revenues was primarily attributed to an increase of 335% in the portal fees that we earn from issuers that sell equity securities on our funding portal, which amounted to $221,856 during the three months ended July 31, 2023, as compared to $51,000 during the three months ended July 31, 2022. Additionally, funding portal revenue from new issuers signing engagement letters increased by $26,500, or 21%, to $154,000 for the three months ended July 31, 2023 as compared to $127,500 for the three months ended July 31, 2022. The components of revenue were as follows:

 

   July 31, 2023  July 31, 2022
Consulting services for equity securities  $1,110,000   $1,025,000 
Consulting revenue   33,700    136,830 
Portal fees   221,856    51,000 
Listing fees   154,000    127,500 
Other revenue   253    243 
Total  $1,519,809   $1,340,573 

 

25 

 

Costs of revenues decreased by $3,010, or 14%, to $18,053 for the three months ended July 31, 2023 from $21,063 during the three months ended July 31, 2022.  The decrease was primarily attributed to a decrease in cost of sales for our valuation services during the three months ended July 31, 2023.

 

Payroll and payroll related expenses increased by $267,102, or 35%, to $1,037,042 for the three months ended July 31, 2023, as compared to $769,940 during the three months ended July 31, 2022. The increase was attributed to new hires and salary increases.

 

Marketing expense increased by $234,108, or 3,009%, to $241,888 for the three months ended July 31, 2023, as compared to $7,780 during the three months ended July 31, 2022. The increase was to bring awareness to the funding portal operations and the Company to attract new issuers and investors.

 

Rent expense increased by $2,398, or 14%, to $19,610 for the three months ended July 31, 2023, as compared to $17,212 during the three months ended July 31, 2022. The increase was attributed to additional expenses for renting the virtual office space in the corporate headquarters in Boston.

 

General and administrative expenses increased by $395,997, or 101%, to $788,294 for the three months ended July 31, 2023, from $392,297 during the three months ended July 31, 2022.  The increase was primarily attributed to professional fees, including stock-based compensation.

 

Consulting expense increased by $38,331, or 31%, to $163,942 for the three months ended July 31, 2023 from $125,611 during the three months ended July 31, 2022. The increase was primarily attributed to increased payments of software engineers.

 

Interest expense decreased by $23,008, or 63%, to $13,304 for the three months ended July 31, 2023, as compared to $36,312 during the three months ended July 31, 2022.  The decrease in interest expense was primarily attributed to lower debt amounts that resulted from paying off a secured term loan.  

 

Liquidity and Capital Resources

 

At July 31, 2023, we had cash and cash equivalents of $1,030,618 and negative working capital of $1,638,594 as compared to cash and cash equivalents of $569,441 and negative working capital of $2,622,670 at April 30, 2023.

 

We have been successful in raising capital by completing public offerings of our common stock.

On July 15, 2022, the Company completed an underwritten public offering of 1,205,000 shares of the Company’s common stock and warrants to purchase 1,205,000 shares of the Company’s common stock at a combined public offering price of $4.15 per share and warrant. The gross proceeds from the offering were $5,000,750 prior to deducting underwriting discounts, commissions, and other offering expenses. The warrants have a per share exercise price of $5.19, are exercisable immediately, and expire five years from the date of issuance. With the use of proceeds, we paid $1 million of debt to our secured lender, to reduce the outstanding principal balance to $400,000.

On December 16, 2022 we completed an underwritten public offering of 1,247,000 shares of our common stock, at a price to the public of $1.40 per share. In conjunction with this offering, we issued the underwriter and its designees warrants to purchase 62,350 shares of our common stock at an exercise price of $1.75. The underwriters exercised their over-allotment option and on January 5, 2023, we issued an additional 187,000 shares of its common stock at a price of $1.40 per share. We received net proceeds of $1,621,459 for the issuance of a total of 1,434,000 shares of common stock in both the initial and over-allotment offering. In conjunction with the exercise of the over-allotment, the Company issued the underwriter and its designees warrants to purchase 9,350 shares of our common stock with an exercise price of $1.75.

26 

 

On May 23, 2023, we entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell to such investors, in a registered direct offering (the “Offering”), 1,100,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a price of $1.55 per Share, for aggregate gross proceeds of $1,705,000, before deducting the placement agent's fees and other offering expenses payable by the Company. The Offering closed on May 25, 2023. The Shares were offered and issued and sold pursuant to the Company’s shelf registration statement on Form S-3 (File 333-267921), filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended, on October 18, 2022 and declared effective on October 26, 2022.

With the use of proceeds, we paid our secured lender $350,000 in principal plus accrued interest of $17,167.23 to retire all outstanding obligations to the secured lender.

On July 24, 2023 the Company completed an underwritten public offering of 1,725,000 shares of the Company’s common stock, at a price to the public of $0.70 per share for aggregate gross proceeds of $1,207,500, before deducting underwriting discounts and offering expenses payable by the Company. In conjunction with this offering, the Company issued the underwriter, and its designees, warrants to purchase 86,250 shares of our common stock at an exercise price of $0.875.

 

 We believe that our existing cash investment balances, our anticipated cash flows from operations and liquidity sources including offering of equity and/or debt securities and/or the sale of equity positions in certain portfolio companies for which Netcapital Advisors provides marketing and strategic advice will be sufficient to meet our working capital and expenditure requirements for the next 12 months. Although we believe we have adequate sources of liquidity over the next 12 months, the success of our operations, the global economic outlook, and the pace of sustainable growth in our markets, in each case, in light of the market volatility and uncertainty as a result of the COVID-19 pandemic, among other factors, could impact our business and liquidity. Up to this point in time, we believe the pandemic has helped drive people to online investing, as we see regular monthly increases in users and dollars invested, and an increase in issuers seeking to use online fund-raising services in lieu of face-to-face meetings.

 

Year over Year Changes

 

Net cash used in operating activities amounted to $1,464,023 and $1,063,672 for the three months ended July 31, 2023 and 2022, respectively.  The principal uses of cash from operating activities in the three months ended July 31, 2023 were a net loss of $491,655 and the receipt of equity securities in lieu of cash amounting to $1,170,000. These uses of cash were partially offset by a non-cash item, stock-based compensation of $483,351. The principal sources of cash from operating activities for the three months ended July 31, 2022 was net income of $64,477, a realized loss on investments of $406,060 and stock-based compensation of $32,953. However, these sources of cash were offset by the receipt of equity securities in lieu of cash of $1,200,000, changes in deferred taxes of $297,000 and a decrease in accounts payable and accrued expenses of $135,388.  

 

There were no investing activities during the three months ended July 31, 2023. Net cash provided by investing activities amounted to $200,000 in the three months ended July 31, 2022. The cash provided consisted of proceeds from the sale of 606,060 shares of an investment in KingsCrowd Inc.

 

For the three months ended July 31, 2023, cash provided by financing activities amounted to $1,925,200, which consisted of proceeds of $2,275,200 for the sale of common stock, offset by a $350,000 payment to retire debt from a secured lender. For the three months ended July 31, 2022, cash provided from financing activities amounted to $2,945,917, which included proceeds from the sale of common stock of $3,949,117, a payment of $3,200 for a related party note, and payment of $1,000,000 to a secured lender.

 

In the three months ended July 31, 2023 and 2022, there were no expenditures for capital assets.  We do not anticipate any capital expenditures in fiscal 2024.

 

27 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

The Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

(a) Disclosure Controls and Procedures.

 

The Company’s management, with the participation of the Principal Executive Officer (the “PEO”) and Principal Financial Officer (the “PFO”), has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in SEC Rule 13a-15(e)) as of July 31, 2022. Based on that evaluation, the PEO and the PFO concluded that, as of July 31, 2023, such controls and procedures were effective.

  

(b) Management’s Assessment of Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in the Exchange Act Rules 13a-15(f).  A system of internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

Under the supervision and with the participation of management, including the PEO and the PFO, the Company’s management has evaluated the effectiveness of its internal control over financial reporting as of July 31, 2023, based on the criteria established in a report entitled “2013 Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission” and the interpretive guidance issued by the Commission in Release No. 34-55929.  Based on this evaluation, the Company’s management has evaluated and concluded that the Company’s internal control over financial reporting was effective as of July 31, 2023.

 

The Company’s annual report on Form 10-K for the year ended April 30, 2023 does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting.  The Company’s registered public accounting firm was not required to issue an attestation on its internal controls over financial reporting pursuant to the rules of the SEC.  The Company will continue to evaluate the effectiveness of internal controls and procedures on an ongoing basis.

 

(c) Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal controls over financial reporting (as such term is defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act) during the quarter ended July 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

28 

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

 

ITEM 1A. RISK FACTORS.

 

Risk factors that affect our business and financial results are discussed in Part I, Item 1A “Risk Factors,” in our Annual Report on Form 10-K for the year ended April 30, 2023 as filed with the SEC on July 27, 2023 (“Annual Report”). There have been no material changes in our risk factors from those previously disclosed in our Annual Report, except as discussed below. You should carefully consider the risks described in our Annual Report, which could materially affect our business, financial condition or future results. The risks described in our Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.

 

Our ability to have our securities traded on the Nasdaq Capital Market is subject to us meeting applicable listing criteria.

 

We are currently listed on the Nasdaq Stock Market, LLC (“Nasdaq”), a national securities exchange. The Nasdaq requires companies desiring to list their common stock to meet certain listing criteria including total number of shareholders: minimum stock price, total value of public float, and in some cases total shareholders’ equity and market capitalization. Our failure to meet such applicable listing criteria could prevent us from listing our common stock on the Nasdaq. In the event we are unable to have our shares traded on Nasdaq, our common stock could potentially trade on the OTCQX or the OTCQB, each of which is generally considered less liquid and more volatile than the Nasdaq. Our failure to have our shares traded on the Nasdaq could make it more difficult for you to trade our shares, could prevent our common stock trading on a frequent and liquid basis and could result in the value of our common stock being less than it would be if we were able to list our shares on the Nasdaq.

 

On September 1, 2023, we received written notice from Nasdaq that we were not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of our common stock had been below $1.00 per share for 30 consecutive business days. In accordance with Nasdaq Listing Rule 5810, we have a period of 180-calendar days, or until February 8, 2024, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of our common stock must meet or exceed $1.00 per share for at least 10 consecutive business days during this 180-calendar day period. In the event we do not regain compliance by February 8, 2024, we may be eligible for an additional 180-calendar day grace period so long as we meet The Nasdaq Capital Market continued listing requirement for market value of publicly-held shares and all other initial listing standards for The Nasdaq Capital Market, other than the minimum closing bid price requirement and notifies Nasdaq in writing of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If we do not qualify for or fail to regain compliance during the second compliance period, then Nasdaq will notify us of its determination to delist our common stock, at which point we would have an option to appeal the delisting determination to a Nasdaq hearings panel. We intend to actively monitor the closing bid price of our common stock and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price under the Nasdaq Listing Rules.

29 

 

 

If we are unable to regain compliance with the Nasdaq minimum bid price requirement and Nasdaq delists our common stock and we are unable to obtain listing on another national securities exchange, a reduction in some or all of the following may occur, each of which could have a material adverse effect on our shareholders:

 

  the liquidity of our common stock;

 

  the market price of our common stock;

 

  our ability to obtain financing for the continuation of our operations;

 

  the number of institutional and general investors that will consider investing in our common stock;

 

  the number of investors in general that will consider investing in our common stock;

 

  the number of market makers in our common stock;

 

  the availability of information concerning the trading prices and volume of our common stock; and

 

  the number of broker-dealers willing to execute trades in shares of our common stock.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

On July 31, 2023, the Company issued 18,750 shares of its common stock in conjunction with the purchase of a 10% interest in Caesar Media Group Inc. The Company did not receive any proceeds for the issuance of these shares. The issuance was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None. 

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

ITEM 6. EXHIBITS.

 

Exhibit No.  
   
31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
31.2* Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32.1** Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
32.2** Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
101.INS* Inline XBRL Instance Document
   
101.SCH* Inline XBRL Taxonomy Extension Schema Document
   
101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
104* Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2022 is formatted in Inline XBRL

 

30 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

   
Date: September 14, 2023 NETCAPITAL INC.
   
  By: /s/ Martin Kay
  Martin Kay
 

Chairman of the Board and Chief Executive Officer

(Principal Executive Officer)

   
  By: /s/ Coreen Kraysler  
 

Coreen Kraysler

Chief Financial Officer

  (Principal Financial and Accounting Officer)

 

31 

 

 

 

 

EX-31.1 2 ex31_1.htm

Exhibit 31.1 

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Martin Kay, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Netcapital Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

  

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 14, 2023 By: /s/ Martin Kay    
    Martin Kay    
    Principal Executive Officer
Netcapital Inc.
   

 

EX-31.2 3 ex31_2.htm

Exhibit 31.2 

 

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Coreen Kraysler, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Netcapital Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 14, 2023 By: /s/ Coreen Kraysler  
    Coreen Kraysler  
    Principal Financial and Accounting Officer
Netcapital Inc.
 

 

EX-32.1 4 ex32_1.htm

Exhibit 32.1 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Quarterly Report of Netcapital Inc. (the “Company”), on Form 10-Q for the quarter ended July 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Martin Kay, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) Such Quarterly Report on Form 10-Q for the quarter ended July 31, 2023, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended July 31, 2023, fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

       
Date: September 14, 2023 By: /s/ Martin Kay  
    Martin Kay  
   

Principal Executive Officer,

Netcapital Inc.

 
       

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 ex32_2.htm

Exhibit 32.2 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Quarterly Report of Netcapital Inc. (the “Company”), on Form 10-Q for the quarter ended July 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Coreen Kraysler, Principal Financial and Accounting Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (3) Such Quarterly Report on Form 10-Q for the quarter ended July 31, 2023, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (4) The information contained in such Quarterly Report on Form 10-Q for the quarter ended July 31, 2023, fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

       
Date: September 14, 2023 By: /s/ Coreen Kraysler  
    Coreen Kraysler  
   

Principal Financial and Accounting Officer

Netcapital Inc.

 
       

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.SCH 6 ncpl-20230731.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Basis of Presentatio link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Concentrations link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Earnings Per Common Share link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Principal Financing Arrangements link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stock-Based Compensation Plans link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Deposits and Commitments link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Earnings Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Principal Financing Arrangements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stock-Based Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Revenue Recognition (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Earnings Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Principal Financing Arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Stockholders Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Stockholders Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Stock-Based Compensation Plans (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Stock-Based Compensation Plans (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stock-Based Compensation Plans (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ncpl-20230731_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ncpl-20230731_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ncpl-20230731_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Common Stock To Be Issued [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Product and Service [Axis] Consulting Services [Member] Fees From Online Services [Member] Long-Term Debt, Type [Axis] Secured Debt [Member] Notes Payable Related Parties [Member] U S S B A Loan [Member] U S S B A Loan One [Member] U S S B A Loan Two [Member] Warrant [Member] Warrants Exercisable [Member] Warrants [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Title of Individual [Axis] Chief Executive Officer [Member] Chief Financial Officer [Member] Chief Executive Officer Of Subsidiary [Member] Founder [Member] Third Party Contractor [Member] Business Consultant [Member] Business Consultant 1 [Member] Employee Stock Options [Member] Award Type [Axis] Options Outstanding [Member] Options Exercisable [Member] Equity Option [Member] Finite-Lived Intangible Assets by Major Class [Axis] Acquired Users [Member] Acquired Brand [Member] Acquired Intellectual Property And Website [Member] Professional Practice [Member] Literary Works And Contracts [Member] Counterparty Name [Axis] Netcapital Systems L L C [Member] Must Watch L L C [Member] Zelgor Inc [Member] Chip Brain L L C [Member] Vymedic Inc [Member] C Reveal Therapeutics L L C [Member] Deuce Drone L L C [Member] Hiveskill L L C [Member] Scan Hash L L C [Member] Caesar Media Group Inc [Member] Cust Corp [Member] Kingscrowd Inc [Member] Reper L L C [Member] Dark L L C [Member] Netwire L L C [Member] Count Sharp L L C [Member] Cup Crew L L C [Member] Head Farm L L C [Member] Real World L L C [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets:   Cash and cash equivalents   Accounts receivable, net   Prepaid expenses Total current assets   Deposits  Notes receivable – related parties  Purchased technology, net  Investment in affiliate  Equity securities at fair value Total assets Liabilities and Stockholders' Equity Current liabilities:   Accounts payable    Trade    Related party   Accrued expenses   Stock subscription payable   Deferred revenue   Interest payable   Deferred tax liability, net   Related party debt   Secured note payable   Current portion of SBA loans   Loan payable - bank   Income taxes notes payable Total current liabilities Long-term liabilities:   Long-term SBA loans, less current portion Total liabilities Commitments and contingencies Stockholders' equity:  Common stock, $.001 par value; 900,000,000 shares authorized,    9,434,132 and 6,440,527 shares issued and outstanding  Shares to be issued  Capital in excess of par value  Retained earnings Total stockholders' equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues Costs of services Gross profit Costs and expenses: Consulting expense Marketing Rent Payroll and payroll related expenses General and administrative costs                Total costs and expenses Operating income (loss) Other income (expense): Interest expense Gain on debt conversion Amortization of intangible assets Realized loss on sale of investment Total other income (expense)                Net income (loss) before taxes Income tax expense (benefit) Net income (loss) Basic earnings (loss) per share Diluted earnings (loss) per share Weighted average number of common shares outstanding: Basic Diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance Shares issued for debt conversion Shares issued for debt conversion, Shares Sale of common stock Sale of common stock shares Vesting of stock options Net loss July 31, 2023 quarter Purchase of equity interest Purchase of equity interest shares Purchase of intellectual property Purchase of intellectual property, shares Reduction in shares to be issued Reduction in shares to be issued, Shares Stock-based compensation Stock-based Compensation, shares Stock-based settlement Stock-based settlement, shares Ending balance, value Shares, Outstanding, Ending Balance Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Adjustments to reconcile net income (loss) to net cash used in operating activities: Stock-based compensation Receipt of equity in lieu of cash Gain on debt conversion Provision for bad debts Realized loss on investment Changes in deferred taxes Amortization of intangible assets Changes in non-cash working capital balances: Accounts receivable Prepaid expenses Accounts payable and accrued expenses Deferred revenue Accrued interest payable Income taxes payable Accounts payable – related party Net cash used in operating activities INVESTING ACTIVITIES Proceeds from sale of investment Net cash provided by investing activities FINANCING ACTIVITIES    Payments to secured lender Payment of related party note Proceeds from sale of common stock  Net cash provided by financing activities Net increase in cash Cash and cash equivalents, beginning of the period Cash and cash equivalents, end of the period Supplemental disclosure of cash flow information: Cash paid for taxes Cash paid for interest Supplemental Non-Cash Investing and Financing Information: Common stock issued to pay promissory notes Common stock issued to purchase 10% interest in Caesar Media Group Inc. Common stock issued to pay related party payable Accounting Policies [Abstract] Basis of Presentatio Risks and Uncertainties [Abstract] Concentrations Revenue Recognition Revenue Recognition Earnings Per Share [Abstract] Earnings Per Common Share Principal Financing Arrangements Principal Financing Arrangements Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Equity [Abstract] Stockholders’ Equity Fair Value Disclosures [Abstract] Fair Value Retirement Benefits [Abstract] Stock-Based Compensation Plans Deposits And Commitments Deposits and Commitments Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Equity Method Investments and Joint Ventures [Abstract] Investments Subsequent Events [Abstract] Subsequent Events Schedule of Disaggregation of Revenue Schedule of earnings per share Schedule of Debt Schedule of Income Taxes Schedule of warrants outstanding Schedule of Warrants activity Schedule of stock-based compensation expense Schedule of stock options outstanding Schedule of stock options activity Schedule of intangible assets Schedule of investments Remaining Performance Obligations Contract revenues not recognized Net income (loss) attributable to common stockholders – basic Adjustments to net income (loss) Net income (loss) attributable to common stockholders – diluted Weighted average common shares outstanding - basic Effect of dilutive securities Weighted average common shares outstanding – diluted Earnings (loss) per common share - basic Earnings (loss) per common share - diluted Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Debt, Current Debt Instrument, Interest Rate, Effective Percentage Long-Term Debt, Current Maturities Long-Term Debt Deferred tax assets, net: Net operating loss carryforwards Bad debt allowance Stock-based compensation Deferred tax assets Deferred tax liability Unrealized gain Net deferred tax liability Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number [custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Exercise Price Per Share [custom:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1] [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1] OutstandingExercisedPricePerShare Exercised Price Issued Warrants outstanding Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Warrants exercisable Price [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers-0] Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Employee and consultant options Total stock-based compensation expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne] [custom:StockOptionExercisePrice-0] [custom:StockOptionExercisePriceIssued] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne] [custom:StockOptionExercisePriceExercised] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions-0] [custom:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions-0] [custom:StockOptionExercisePriceOne-0] [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1-0] [custom:ExercisePricePerShareExercisable-0] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Net Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Investment Owned, at Cost Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Costs and Expenses Operating Income (Loss) Interest Expense Shares, Outstanding Debt Conversion, Converted Instrument, Amount ChangesInDeferredAssets Amortization of Intangible Assets Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Net Cash Provided by (Used in) Operating Activities Repayments of Secured Debt Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents RevenueRecognitionTextBlock PrincipalFinancingArrangementsTextBlock Deferred Compensation Share-Based Arrangements, Liability, Current Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period EX-101.PRE 10 ncpl-20230731_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
3 Months Ended
Jul. 31, 2023
Sep. 14, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jul. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --04-30  
Entity File Number 001-41443  
Entity Registrant Name NETCAPITAL INC.  
Entity Central Index Key 0001414767  
Entity Tax Identification Number 87-0409951  
Entity Incorporation, State or Country Code UT  
Entity Address, Address Line One 1 Lincoln Street  
Entity Address, City or Town Boston  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02111  
City Area Code 781  
Local Phone Number 925-1700  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   9,434,132
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jul. 31, 2023
Apr. 30, 2023
Assets:    
  Cash and cash equivalents $ 1,030,618 $ 569,441
  Accounts receivable, net 1,355,000 1,388,500
  Prepaid expenses 444,837 583,030
Total current assets 2,830,455 2,540,971
  Deposits 6,300 6,300
 Notes receivable – related parties 202,000 202,000
 Purchased technology, net 15,846,966 15,875,297
 Investment in affiliate 240,080 240,080
 Equity securities at fair value 24,308,633 22,955,445
Total assets 43,434,434 41,820,093
Current liabilities:    
   Trade 586,981 578,331
   Related party 75,204 75,204
  Accrued expenses 242,955 285,065
  Stock subscription payable 10,000 10,000
  Deferred revenue 600 661
  Interest payable 86,185 98,256
  Deferred tax liability, net 1,532,000 1,657,000
  Related party debt 15,000 15,000
  Secured note payable 350,000
  Current portion of SBA loans 1,885,800 1,885,800
  Loan payable - bank 34,324 34,324
  Income taxes notes payable 174,000
Total current liabilities 4,469,049 5,163,641
Long-term liabilities:    
  Long-term SBA loans, less current portion 500,000 500,000
Total liabilities 4,969,049 5,663,641
Commitments and contingencies
Stockholders' equity:    
 Common stock, $.001 par value; 900,000,000 shares authorized,    9,434,132 and 6,440,527 shares issued and outstanding 9,434 6,441
 Shares to be issued 183,187 183,187
 Capital in excess of par value 33,298,539 30,500,944
 Retained earnings 4,974,225 5,465,880
Total stockholders' equity 38,465,385 36,156,452
Total liabilities and stockholders' equity $ 43,434,434 $ 41,820,093
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jul. 31, 2023
Apr. 30, 2023
Statement of Financial Position [Abstract]    
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 900,000,000 900,000,000
Common Stock, Shares, Issued 9,434,132 6,440,527
Common Stock, Shares, Outstanding 9,434,132 6,440,527
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Income Statement [Abstract]    
Revenues $ 1,519,809 $ 1,340,573
Costs of services 18,053 21,063
Gross profit 1,501,756 1,319,510
Costs and expenses:    
Consulting expense 163,942 125,611
Marketing 241,888 7,780
Rent 19,610 17,212
Payroll and payroll related expenses 1,037,042 769,940
General and administrative costs 788,294 392,297
               Total costs and expenses 2,250,776 1,312,840
Operating income (loss) (749,020) 6,670
Other income (expense):    
Interest expense (13,304) (36,312)
Gain on debt conversion 224,260
Amortization of intangible assets (28,331) (21,081)
Realized loss on sale of investment (406,060)
Total other income (expense) (41,635) (239,193)
               Net income (loss) before taxes (790,655) (232,523)
Income tax expense (benefit) (299,000) (297,000)
Net income (loss) $ (491,655) $ 64,477
Basic earnings (loss) per share $ (0.07) $ 0.02
Diluted earnings (loss) per share $ (0.07) $ 0.02
Weighted average number of common shares outstanding:    
Basic 7,471,207 3,168,547
Diluted 7,471,457 3,171,397
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
Common Stock [Member]
Common Stock To Be Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Apr. 30, 2022 $ 2,934 $ 244,250 $ 22,479,769 $ 2,510,908 $ 25,237,861
Beginning balance at Apr. 30, 2022 2,934,344        
Shares issued for debt conversion $ 134 379,852 379,986
Shares issued for debt conversion, Shares 133,333        
Sale of common stock $ 1,205 3,947,912 3,949,117
Sale of common stock shares 1,205,000        
Vesting of stock options 32,953 32,953
Net loss July 31, 2023 quarter 64,477 64,477
Ending balance, value at Jul. 31, 2022 $ 4,273 244,250 26,840,486 2,575,385 29,664,394
Shares, Outstanding, Ending Balance at Jul. 31, 2022 4,272,677        
Sale of common stock $ 3 23,397 23,400
Sale of common stock shares 2,600        
Vesting of stock options 32,953 32,953
Net loss July 31, 2023 quarter   183,138 183,138
Purchase of equity interest $ 37 366,338 366,375
Purchase of equity interest shares 37,500        
Ending balance, value at Oct. 31, 2022 $ 4,313 244,250 27,263,174 2,758,523 30,270,260
Shares, Outstanding, Ending Balance at Oct. 31, 2022 4,312,777        
Sale of common stock $ 1,434 1,620,025 1,621,459
Sale of common stock shares 1,434,000        
Vesting of stock options 63,057 63,057
Net loss July 31, 2023 quarter 1,696,499 1,696,499
Purchase of equity interest $ 19 171,105 171,124
Purchase of equity interest shares 18,750        
Purchase of intellectual property $ 300 434,700 435,000
Purchase of intellectual property, shares 300,000        
Reduction in shares to be issued $ 6 (61,063) 61,057
Reduction in shares to be issued, Shares 6,250        
Ending balance, value at Jan. 31, 2023 $ 6,072 183,187 29,613,118 4,455,022 34,257,399
Shares, Outstanding, Ending Balance at Jan. 31, 2023 6,071,777        
Vesting of stock options 132,943 132,943
Net loss July 31, 2023 quarter 1,010,858 1,010,858
Purchase of equity interest $ 19 195,233 195,252
Purchase of equity interest shares 18,750        
Stock-based compensation $ 350 559,650 560,000
Stock-based Compensation, shares 350,000        
Ending balance, value at Apr. 30, 2023 $ 6,441 183,187 30,500,944 5,465,880 36,156,452
Shares, Outstanding, Ending Balance at Apr. 30, 2023 6,440,527        
Sale of common stock $ 2,825 2,272,375 2,275,200
Sale of common stock shares 2,825,000        
Vesting of stock options 139,371 139,371
Net loss July 31, 2023 quarter (491,655) (491,655)
Purchase of equity interest $ 18 183,170 183,188
Purchase of equity interest shares 18,750        
Stock-based compensation $ 100 143,900 144,000
Stock-based Compensation, shares 100,000        
Stock-based settlement $ 50 58,779 58,829
Stock-based settlement, shares 49,855        
Ending balance, value at Jul. 31, 2023 $ 9,434 $ 183,187 $ 33,298,539 $ 4,974,225 $ 38,465,385
Shares, Outstanding, Ending Balance at Jul. 31, 2023 9,434,132        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Jul. 31, 2023
Jul. 31, 2022
OPERATING ACTIVITIES    
Net income (loss) $ (491,655) $ 64,477
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Stock-based compensation 483,351 32,953
Receipt of equity in lieu of cash (1,170,000) (1,200,000)
Gain on debt conversion (224,260)
Provision for bad debts 6,000
Realized loss on investment 406,060
Changes in deferred taxes (125,000) (297,000)
Amortization of intangible assets 28,331 21,081
Changes in non-cash working capital balances:    
Accounts receivable 27,500 279,200
Prepaid expenses (2,958) (35,842)
Accounts payable and accrued expenses (33,460) (135,388)
Deferred revenue (61) (1,930)
Accrued interest payable (12,071) 35,796
Income taxes payable (174,000)
Accounts payable – related party (8,819)
Net cash used in operating activities (1,464,023) (1,063,672)
INVESTING ACTIVITIES    
Proceeds from sale of investment 200,000
Net cash provided by investing activities 200,000
FINANCING ACTIVITIES    
   Payments to secured lender (350,000) (1,000,000)
Payment of related party note (3,200)
Proceeds from sale of common stock 2,275,200 3,949,117
 Net cash provided by financing activities 1,925,200 2,945,917
Net increase in cash 461,177 2,082,245
Cash and cash equivalents, beginning of the period 569,441 473,925
Cash and cash equivalents, end of the period 1,030,618 2,556,170
Supplemental disclosure of cash flow information:    
Cash paid for taxes
Cash paid for interest 25,374 516
Supplemental Non-Cash Investing and Financing Information:    
Common stock issued to pay promissory notes 266,272
Common stock issued to purchase 10% interest in Caesar Media Group Inc. 183,188
Common stock issued to pay related party payable $ 113,714
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Presentatio
3 Months Ended
Jul. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentatio

Note 1– Basis of Presentation

 

The accompanying unaudited condensed financial statements of Netcapital Inc. (the “Company”) have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended July 31, 2023, are not necessarily indicative of the results that may be expected for the fiscal year ended April 30, 2024. For further information, refer to the audited financial statements and footnotes thereto in our Annual Report on Form 10-K for the year ended April 30, 2023.

 

There have been no material changes to our significant accounting policies from our Annual Report on Form 10-K for the fiscal year ended April 30, 2023.


The Company accounts for allowance for credit losses under the current expected credit loss (“CECL”) impairment model for its financial assets, including accounts receivable, and presents the net amount of the financial instrument expected to be collected. The CECL impairment model requires an estimate of expected credit losses, measured over the contractual life of an instrument, which considers forecasts of future economic conditions in addition to information about past events and current conditions. Based on this model, the Company estimates the amount of uncollectible accounts receivable at the end of each reporting period based on the aging of the receivable balance, current and historical customer trends, communications with its customers, and macro-economic conditions. Amounts are written off after considerable collection efforts have been made and the amounts are determined to be uncollectible.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Concentrations
3 Months Ended
Jul. 31, 2023
Risks and Uncertainties [Abstract]  
Concentrations

Note 2 – Concentrations

 

For the three-month period ended July 31, 2023, the Company had one customer that constituted 37% of revenues and a second customer that constituted 37% of revenues. For the three-month period ended July 31, 2022, the Company had one customer that constituted 52% of its revenues and a second customer that constituted 24% of its revenues.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition
3 Months Ended
Jul. 31, 2023
Revenue Recognition  
Revenue Recognition

Note 3 – Revenue Recognition

 

Revenue Recognition under ASC 606

The Company recognizes service revenue from its consulting contracts, funding portal and game website using the five-step model as prescribed by ASC 606:

 

• Identification of the contract, or contracts, with a customer;

• Identification of the performance obligations in the contract;

• Determination of the transaction price;

• Allocation of the transaction price to the performance obligations in the contract; and

• Recognition of revenue when or as, the Company satisfies a performance obligation.

 

The Company identifies performance obligations in contracts with customers, which primarily are professional services, listing fees on our funding portal, and a portal fee of 4.9% of the money raised on the funding portal. The transaction price is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised services to the customer. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. The Company usually bills its customers before it provides any services and begins performing services after the first payment is received. Contracts are typically one year or less. For larger contracts, in addition to the initial payment, the Company may allow for progress payments throughout the term of the contract.

Judgments and Estimates

The estimation of variable consideration for each performance obligation requires the Company to make subjective judgments. The Company enters into contracts with customers that regularly include promises to transfer multiple services, such as digital marketing, web-based videos, offering statements, and professional services. For arrangements with multiple services, the Company evaluates whether the individual services qualify as distinct performance obligations. In its assessment of whether a service is a distinct performance obligation, the Company determines whether the customer can benefit from the service on its own or with other readily available resources, and whether the service is separately identifiable from other services in the contract. This evaluation requires the Company to assess the nature of each individual service offering and how the services are provided in the context of the contract, including whether the services are significantly integrated, highly interrelated, or significantly modify each other, which may require judgment based on the facts and circumstances of the contract.

 

When agreements involve multiple distinct performance obligations, the Company allocates arrangement consideration to all performance obligations at the inception of an arrangement based on the relative standalone selling prices (SSP) of each performance obligation. Where the Company has standalone sales data for its performance obligations which are indicative of the price at which the Company sells a promised service separately to a customer, such data is used to establish SSP. In instances where standalone sales data is not available for a particular performance obligation, the Company estimates SSP by the use of observable market and cost-based inputs. The Company continues to review the factors used to establish list price and will adjust standalone selling price methodologies as necessary on a prospective basis.

 

Service Revenue

 

Service revenue from subscriptions to the Company's game website is recognized over time on a ratable basis over the contractual subscription term beginning on the date that the platform is made available to the customer. Payments received in advance of subscription services being rendered are recorded as a deferred revenue. Professional services revenue is recognized over time as the services are rendered.

 

When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company estimates the amount to reserve for uncollectible amounts based on the aging of the contract balance, current and historical customer trends, and communications with its customers. These reserves are recorded as operating expenses against the contract asset (accounts receivable).

 

Contract Assets

 

Contract assets are recorded for those parts of the contract consideration not yet invoiced but for which the performance obligations are completed. The revenue is recognized when the customer receives services. Contract assets are included in other current assets in the consolidated balance sheets and will be recognized during the succeeding twelve-month period.

 

Deferred Revenue

 

Deferred revenues represent billings or payments received in advance of revenue recognition and are recognized upon transfer of control. Balances consist primarily of annual plan subscription services and professional services not yet provided as of the balance sheet date. Deferred revenues that will be recognized during the succeeding twelve-month period are recorded as current deferred revenues in the consolidated balance sheets, with the remainder recorded as other non-current liabilities in the consolidated balance sheets.

 

 

Costs to Obtain a Customer Contract

 

Sales commissions and related expenses are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized as other current or non-current assets and amortized on a straight-line basis over the life of the contract, which approximates the benefit period. The benefit period was estimated by taking into consideration the length of customer contracts, technology lifecycle, and other factors. All sales commissions are recorded as consulting fees within the Company's consolidated statement of operations.

 

Remaining Performance Obligations

 

The Company's subscription terms are typically less than one year. All of the Company’s revenues in the three-month periods ended July 31, 2023 and 2022, which amounted to $1,519,809 and $1,340,573, respectively, are considered contract revenues. Contract revenue as of July 31, 2023 and April 30, 2023, which has not yet been recognized, amounted to $600 and $661, respectively, and is recorded on the balance sheet as deferred revenue. The Company expects to recognize revenue on all of its remaining performance obligations over the next 12 months.  

 

Disaggregation of Revenue

 

Revenue is from U.S.-based companies with no notable geographical concentrations in any area. A distinction exists in revenue source; revenues are either generated online or from consulting services.

 

Revenues disaggregated by revenue source consist of the following:

 

       
   Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Consulting services  $1,143,700   $1,161,830 
Fees from online services   376,109    178,743 
Total revenues  $1,519,809   $1,340,573 

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Common Share
3 Months Ended
Jul. 31, 2023
Earnings Per Share [Abstract]  
Earnings Per Common Share

Note 4 – Earnings Per Common Share

 

Net income (loss) per common and diluted share were calculated as follows for the three-month periods ended July 31, 2023 and 2022:

 

       
   Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Net income (loss) attributable to common stockholders – basic  $(491,655)  $64,477 
Adjustments to net income (loss)            
Net income (loss) attributable to common stockholders – diluted  $(491,655)  $64,477 
           
Weighted average common shares outstanding - basic   7,471,207    3,168,547 
Effect of dilutive securities   250    2,850 
Weighted average common shares outstanding – diluted   7,471,457    3,171,397 
           
Earnings (loss) per common share - basic  $(.07)  $0.02 
Earnings (loss) per common share - diluted  $(.07)  $0.02 

 

 

For the three-month period ended July 31, 2023, outstanding vested warrants and stock option grants to purchase 1,541,682 and 344,458 shares of common stock, respectively, and 250 shares of common stock that are issuable pursuant to a stock subscription agreement are not included in the calculation of earnings per share because their effect is anti-dilutive. For the three-month period ended July 31, 2022, 2,850 shares of common stock that are issuable pursuant to stock subscription agreements are included in the calculation of diluted earnings per share. Outstanding warrants to purchase 1,409,732 shares of common stock are not included in the calculation of earnings per share for the three-month period ended July 31, 2022 because their effect is anti-dilutive. Outstanding options to purchase 271,000 shares of common stock are not included in the calculation of earnings per share for the three-month period ended July 31, 2022 because their effect is anti-dilutive.  

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Financing Arrangements
3 Months Ended
Jul. 31, 2023
Principal Financing Arrangements  
Principal Financing Arrangements

Note 5 – Principal Financing Arrangements

 

The following table summarizes components debt as of July 31, 2023 and April 30, 2023:

 

          
   July 31,
2023
  April 30,
2023
  Interest Rate
          
Secured lender  $     $350,000    12.0%
Notes payable – related parties   15,000    15,000    0.0%
U.S. SBA loan   500,000    500,000    3.75%
U.S. SBA loan   1,885,800    1,885,800    1.0%
Loan payable – bank   34,324    34,324    10.0%
        Total Debt   2,435,124    2,785,124      
Less: current portion of long-term debt   1,935,124    2,285,124      
Total long-term debt  $500,000   $500,000      

   

As of July 31, 2023 and April 30, 2023, the Company owed its principal lender (“Lender”) $0 and $350,000, respectively, under an amended loan and security agreement dated July 26, 2014, amended several times thereafter and paid in full in May 2023.

 

As of July 31, 2023 and April 30, 2023, the Company’s related-party unsecured notes payable totaled $15,000.

 

The Company owes $34,324 as of July 31, 2023 and April 30, 2023 to Chase Bank. For the loan from Chase Bank, the Company pays interest only on a monthly basis, which is calculated at a rate of 10.0% per annum as of July 31, 2023.

 

On May 6, 2020, the Company borrowed $1,885,800 (the “May Loan”), on June 17, 2020 the Company borrowed $500,000 (the “June Loan”), and on February 2, 2021, the Company borrowed $1,885,800 (the “February Loan”) from a U.S. Small Business Administration (“SBA”) loan program.

 

 

The May loan bore interest at a rate of 1% per annum and was forgiven in its entirety in fiscal 2022.

 

The June Loan required installment payments of $2,437 monthly, beginning on June 17, 2021, over a term of thirty years. However, the SBA postponed the first installment payment for 18 months, and the first payment became due on December 17, 2022. The monthly payments of $2,437 are first applied to accrued interest payable. The monthly payments will not be applied to any of the outstanding principal balance until 2026. Consequently, the entire loan balance of $500,000 is classified as a long term liability. Interest accrues at a rate of 3.75% per annum. The Company agreed to grant a continuing security interest in its assets to secure payment and performance of all debts, liabilities, and obligations to the SBA. The June Loan was personally guaranteed by the Company’s Chief Financial Officer.

 

The February loan bears interest at a rate of 1% per annum and the due date of the first payment has been postponed by the SBA because the Company has applied for forgiveness of the February Loan.

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
3 Months Ended
Jul. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 6 – Income Taxes

As of July 31, 2023, the Company had net operating loss carryforwards for Federal income tax purposes of approximately $267,000, expiring in the years of 2024 through 2042.

 

For the three-month periods ended July 31, 2023 and 2022, the Company recorded an income tax benefit of $299,000 and $297,000, respectively.

 

As of July 31, 2023 and April 30, 2023, the Company had deferred tax assets calculated at an expected federal rate of 21%, and a state and local rate of 8%, when applicable, or approximately $585,000 and $460,000, respectively. As a result of unrealized book gains on equity securities, the Company also has a deferred tax liability of $1,532,000 and $1,657,000 as of July 31, 2023 and April 30, 2023, respectively. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of July 31, 2023 and April 30, 2023 were as follows:

       
   July 31, 2023  April 30, 2023
       
Deferred tax assets, net:          
Net operating loss carryforwards  $77,000   $   
Bad debt allowance   28,000    27,000 
Stock-based compensation   480,000    433,000 
Deferred tax assets   585,000    460,000 
           
Deferred tax liability          
Unrealized gain   2,117,000    2,117,000 
           
Net deferred tax liability  $(1,532,000)  $(1,657,000)

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
3 Months Ended
Jul. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 7 – Related Party Transactions

 

The Company’s largest shareholder, Netcapital Systems LLC (“Systems”), owns 1,711,261 shares of common stock, or 18% of the Company’s 9,434,132 outstanding shares as of July 31, 2023. The company paid Systems $0 and $150,000 in the three-month periods ended July 31, 2023 and 2022, respectively, for use of the software that runs the website www.netcapital.com.

 

 

The Chief Executive Officer of Netcapital Advisors Inc., (“Advisors”), our wholly owned subsidiary, is a member of the board of directors of KingsCrowd Inc. The Company sold 606,060 shares of KingsCrowd in June 2022 for proceeds of $200,000 and recorded a realized loss on the sale of the investment of $406,060 during the three months ended July 31, 2022. As of July 31, 2023 and April 30, 2023, the Company owned 3,209,685 shares of KingsCrowd Inc., valued at $3,209,685.

 

The Chief Executive Officer of Advisors is a member of the board of directors of Deuce Drone LLC. As of July 31, 2023 and April 30, 2022, the Company owns 2,350,000 membership interest units of Deuce Drone LLC., valued at $2,350,000. The Company has notes receivable aggregating $152,000 from Deuce Drone LLC as of July 31, 2023 and April 30, 2023.

 

Compensation to officers in the three-month periods ended July 31, 2023 and 2022 consisted of stock-based compensation valued at $93,532 and $3,664, respectively, and cash salary of $244,317 and $90,000 respectively.

 

During the three months ended July 31, 2022, we paid $12,019 to a related party to retire a note payable of $3,200 and expenses payable of $8,819.

 

Compensation to a related party consultant in the three-month periods ended July 31, 2023 and 2022 consisted of cash wages of $16,163 and $16,154, respectively. This consultant is also the controlling shareholder of Zelgor Inc. and $16,500 and $11,000 of the Company’s revenues in the three-month periods ended July 31, 2023 and 2022, respectively, were from Zelgor Inc. As of July 31, 2023 and April 30, 2023, the Company owned 1,400,000 shares which are valued at $1,400,000.

 

As of July 31, 2023 and April 30, 2023, the Company has invested $240,080 in an affiliate, 6A Aviation Alaska Consortium, Inc., in conjunction with a land lease in an airport in Alaska. Our Chief Executive Officer is also the Chief Executive Officer of 6A Aviation Alaska Consortium, Inc.

 

We owe Steven Geary, a director, $31,680 as of July 31, 2023 and April 30, 2023. This obligation is not interest bearing. $16,680 is recorded as a related party trade accounts payable and $15,000 as a related party note payable. We have no signed agreements for the indebtedness to Mr. Geary.

Coreen Kraysler, our Chief Financial Officer, has personally guaranteed a $500,000 promissory note from the U.S. Small Business Administration. The note bears interest at an annual rate of 3.75%, has a 30-year term, and monthly payments of $2,437 began on December 17, 2022.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders’ Equity
3 Months Ended
Jul. 31, 2023
Equity [Abstract]  
Stockholders’ Equity

Note 8 – Stockholders’ Equity

 

The Company is authorized to issue 900,000,000 shares of its common stock, par value $0.001. 9,434,132 and 6,440,527 shares were outstanding as of July 31, 2023 and April 30, 2023, respectively.

 

During the quarter ended July 31, 2022, the Company issued 39,901 shares of common stock with a value of $113,714 to settle a related party payable of $294,054. The Company also issued 93,432 shares of common stock valued at $266,272 to retire $300,000 of convertible promissory notes plus accrued interest of $10,192. The convertible note holders also received warrants to purchase shares of common stock at a per share exercise price of $5.19, that are exercisable immediately, and expire five years from the date of issuance. These equity issuances resulted in a gain from the conversion of debt totaling $224,260, which is recorded as other income in the income statement.

 

On July 15, 2022, the Company completed an underwritten public offering of 1,205,000 shares of the Company’s common stock and warrants to purchase 1,205,000 shares of the Company’s common stock at a combined public offering price of $4.15 per share and warrant. The gross proceeds from the offering were $5,000,750 prior to deducting underwriting discounts, commissions, and other offering expenses, which resulted in net proceeds of $3,949,117. The warrants have a per share exercise price of $5.19, are exercisable immediately, and expire five years from the date of issuance.

 

In addition, the Company granted the underwriter a 45-day option to purchase up to an additional 180,750 shares of common stock and/or up to 180,750 additional warrants to cover over-allotments, if any. In connection with the closing of the offering, the underwriter partially exercised its over-allotment option and purchased an additional 111,300 warrants, and the Company issued an aggregate of 60,250 warrants to 20 individual representatives of the underwriter.

 

On December 16, 2022 the Company completed an underwritten public offering of 1,247,000 shares of the Company’s common stock, at a price to the public of $1.40 per share. Pursuant to the terms of an underwriting agreement, the Company also granted the underwriters a 45-day option to purchase up to an additional 187,000 shares of common stock solely to cover over-allotments, at the same price per share of $1.40, less the underwriting discounts and commissions. In conjunction with this offering, the Company issued the underwriter and its designees warrants to purchase 62,350 shares of our common stock at an exercise price of $1.75. The underwriters exercised their over-allotment option and on January 5, 2023, the Company issued an additional 187,000 shares of its common stock. The Company received net proceeds of $1,621,459 for the issuance of a total of 1,434,000 shares of common stock for both the initial and over-allotment offering. In conjunction with the exercise of the over-allotment, the Company issued the underwriter and its designees warrants to purchase 9,350 shares of our common stock with an exercise price of $1.75.

 

During the year ended April 30, 2023, in addition to the public offerings, the Company issued 75,000 shares of common stock, valued at $732,751, in conjunction with the purchase of a 10% equity stake in Caesar Media Group, Inc., 300,000 shares of common stock, valued at $435,000 to purchase the website and intellectual property of a real-time video conferencing website, 2,600 shares of common stock in conjunction with a stock subscription agreement with accredited investors, valued at $23,400, and 6,250 shares of common stock in conjunction with an acquisition agreement that requires shares to be issued by the Company. As a result of this issuance, the value of the balance sheet account for shares to be issued decreased by $61,063, from $244,250 to $183,187, as of July 31, 2023 and April 30, 2023.

On January 5, 2023, the Company announced the formation of the Netcapital Inc. 2023 Omnibus Equity Incentive Plan (the “Plan”), which was subsequently approved by a vote of the shareholders. In January 2023, the Company granted stock options to four individuals to purchase an aggregate of 1,600,000 of the Company’s common stock at a price of $1.43 per share and on April 25, 2023 also granted 350,000 stock options under the Plan to employees, consultants, and directors at an exercise price of $1.40 per share. All stock options in the Plan vest monthly on a straight-line basis over a 4-year period and expire in 10 years.

In May 2023, the Company issued 100,000 shares of its common stock, valued at $144,000, in conjunction with a consulting agreement with a business advisor.

On May 23, 2023, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell to such investors, in a registered direct offering (the “Offering”), 1,100,000 shares of the Company’s common stock, par value $0.001 per share, at a price of $1.55 per Share, for aggregate gross proceeds of $1,705,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Offering closed on May 25, 2023.

Also in connection with the Offering, on May 23, 2023, the Company entered into a placement agency agreement with ThinkEquity LLC, pursuant to which, the Company issued warrants to purchase up to 55,000 shares of common stock at an exercise price of $1.94, which were issued on May 25, 2023.

In July 2023, the Company issued 49,855 shares of its common stock in consideration of a release from an unrelated third party in conjunction with the settlement of an outstanding debt between such third party and Netcapital Systems LLC.

On July 24, 2023 the Company completed an underwritten public offering of 1,725,000 shares of the Company’s common stock, at a price to the public of $0.70 per share for aggregate gross proceeds of $1,207,500, before deducting underwriting discounts and offering expenses payable by the Company. In conjunction with this offering, the Company issued the underwriter, and its designees, warrants to purchase 86,250 shares of the Company’s common stock at an exercise price of $0.875.

On July 31, 2023, the Company issued 18,750 shares of its common stock in conjunction with the purchase of a 10% interest in Caesar Media Group Inc. The Company did not receive any proceeds for the issuance of these shares.

 

The following tables summarize information about warrants outstanding as of July 31, 2023 and April 30, 2023:

 

                                         
    Warrants Outstanding      Warrants Exercisable  
          Weighted-                    
          Average     Weighted-           Weighted-  
Range of         Remaining     Average           Average  
Exercise   Number     Contractual     Exercise     Number     Exercise  
Prices   Outstanding     Life (Years)     Price     Outstanding     Price  
                               
As of July 31, 2023                              
$0.875 - $5.19     1,682,932       4.06     $ 4.72       1,541,682     $ 4.96  
                                         
As of July 31, 2022                                        
$1.75 - $5.19     1,541,682       4.25     $ 5.03       1,469,982     $ 5.19  

 

 

      Number of
Shares
    Exercise Price
Per Share
    Average
Exercise
Price
Outstanding May 1, 2022                 $
                         
Issued during year ended April 30, 2023       1,541,682     1.75-$5.19     $ 5.03
                         
Exercised/canceled during year ended April 30, 2023                 $
                         
Outstanding April 30, 2023       1,541,682     $ 1.75-$5.19     $ 5.53
                         
Issued during quarter ended July 31, 2023       141,250      

$0.875

-$1.94

    $ $1.29
                         
Exercised/canceled during quarter ended July 31, 2023                 $
                         
Warrants outstanding July 31, 2023       1,682,932     $0.875-$5.19     $ 4.72
                         
Warrants exercisable, July 31, 2023       1,541,682       $1.75-$5.19     $ 4.96

 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value
3 Months Ended
Jul. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value

Note 9 – Fair Value

 

The Fair Value Measurements Topic of the FASB Accounting Standards Codification establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

 

Level 1: inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the company has the ability to access at the measurement date.

 

Level 2: inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3: inputs are unobservable inputs for the asset or liability.

 

Under the Fair Value Measurements Topic of the FASB Accounting Standards Codification, we base fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. It is our policy to maximize the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements, in accordance with the fair value hierarchy. Fair value measurements for assets and liabilities where there exists limited or no observable market data and, therefore, are based primarily upon management’s own estimates, are often calculated based on current pricing policy, the economic and competitive environment, the characteristics of the asset or liability and other such factors. Therefore, the results cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability. Additionally, there may be inherent weaknesses in any calculation technique, and changes in the underlying assumptions used.

     
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Plans
3 Months Ended
Jul. 31, 2023
Retirement Benefits [Abstract]  
Stock-Based Compensation Plans

 Note 10 – Stock-Based Compensation Plans

In addition to cash payments, the Company enters agreements to issue common stock as payment for services and records the applicable non-cash expense in accordance with the authoritative guidance of the Financial Accounting Standards Board.  

 

For the three months ended July 31, 2023 and 2022, the Company recorded $483,351 and $32,953, respectively, in stock-based compensation expense. As of July 31, 2023 and April 30, 2023, there was $411,178 and $552,329 of prepaid stock-based compensation expense. The prepaid balance is the result of the issuance of 350,000 shares of common stock to a third-party business consultant.

 

 

The table below presents the components of compensation expense for the issuance of shares of common stock and stock options to employees and consultants for the three-month periods ended July 31, 2023 and 2022.

 

  Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Chief Executive Officer  $62,494   $   
Chief Financial Officer   14,915    2,443 
Chief Executive Officer of subsidiary   1,208    1,221 
Founder   14,915       
Third-party contractor   58,829       
Business consultant   141,151       
Business consultant   144,000       
Employee and consultant options   45,839    29,289 
Total stock-based compensation expense  $483,351   $32,953 

 

The following tables summarize information about stock options outstanding as of July 31, 2023 and April 30, 2023:

 

                                         
    Options Outstanding      Options Exercisable  
          Weighted-                    
          Average     Weighted-           Weighted-  
Range of         Remaining     Average           Average  
Exercise   Number     Contractual     Exercise     Number     Exercise  
Prices   Outstanding     Life (Years)     Price     Outstanding     Price  
                               
As of July 31, 2023                              
$1.40 - $10.50     2,202,000       9.35     $ 2.46       344,458     $ 3.78  
                                         
As of April 30, 2023                                        
$1.40 - $10.50     2,202,000       9.63     $ 2.46       294,333     $ 3.69  

 

 

      Number of
Shares
    Exercise Price
Per Share
    Average
Exercise
Price
Outstanding May 1, 2022       271,000       $10.50     $ 10.50
                         
Issued during year ended April 30, 2023       1,950,000      

$1.40-

$1.43

    $ 1.42
                         
Exercised/canceled during year ended April 30, 2023       (19,000)       $10.50     $ 10.50
                         
Outstanding April 30, 2023       2,202,000       $1.40 - $10.50     $ 2.46
                         
Issued during quarter ended July 31, 2023                 $
                         
Exercised/canceled during quarter ended July 31, 2023                 $
                         
Options outstanding July 31, 2023       2,202,000       $1.40- 10.50     $ 2.46
                         
Options exercisable, July 31, 2023       344,458      

$1.40-

10.50

    $ 3.78

 

 

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Deposits and Commitments
3 Months Ended
Jul. 31, 2023
Deposits And Commitments  
Deposits and Commitments

Note 11 – Deposits and Commitments

 

We utilize a virtual office at 1 Lincoln Street in Boston, Massachusetts. We pay a membership fee of approximately $5,700 a month, which increases to approximately $6,100 a month in October 2023, under a virtual office agreement that expires in March 2025 and includes a deposit of $6,300.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets
3 Months Ended
Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

Note 12 – Intangible Assets

 

Intangible assets with defined useful lives are generally measured at cost less straight-line amortization. The useful life is determined using the period of the underlying contract or the period of time over which the intangible asset can be expected to be used. Impairments are recognized if the recoverable amount of the asset is lower than the carrying amount. The recoverable amount is the higher of either the fair value less costs to sell or the value in use. The value in use is determined on the basis of future cash inflows and outflows, and the weighted average cost of capital. Intangible assets with indefinite useful lives, such as trade names and trademarks, that have been acquired as part of acquisitions are measured at cost and tested for impairment annually, or if there is an indication that their value has declined.

 

The following table sets forth the major categories of the intangible assets as of July 31, 2023 and April 30, 2023 

 

 

   July 31, 2023  April 30, 2023
       
Acquired users  $14,288,695   $14,288,695 
Acquired brand   583,429    583,429 
Acquired intellectual property and website   435,000    435,000 
Professional practice   556,830    556,830 
Literary works and contracts   107,750    107,750 
Total intangible assets  $15,971,704   $15,971,704 

 

 

As of July 31, 2023, the weighted average remaining useful life for technology, trade names, professional practice, literary works and domains is 14.09 years. Accumulated amortization amounted to $124,738 as of July 31, 2023, resulting in net intangible assets of $15,846,966.

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Investments
3 Months Ended
Jul. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Investments

Note 13 – Investments

 

In May 2023, the Company received 2,853,659 units of RealWorld LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

 

In April 2023, the Company received 2,853,659 units of HeadFarm LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

In April 2023, the Company received 2,853,659 units of CupCrew LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

In April 2023, the Company received 2,853,659 units of CountSharp LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.

 

In January 2023, the Company received 2,100,000 units of Dark LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $1.00 per unit based on a sales price of $1.00 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $2,100,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,100,000 units which are valued at $2,100,000.

 

In August 2022, the Company received 1,911,765 units of NetWire LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.68 per unit based on a sales price of $0.68 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,300,000. As of July 31, 2023 and April 30, 2023, the Company owned 1,911,765 units which are valued at $1,300,000.

 

In May 2022, the Company received 1,764,706 units of Reper LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.68 per unit based on a sales price of $0.68 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,200,000. As of July 31, 2023 and April 30, 2023, the Company owned 1,764,706 units which are valued at $1,200,000.

 

In April 2022, the Company received 3,000,000 units of Cust Corp. as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.40 per unit based on a sales price of $0.40 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,200,000. As of July 31, 2023 and April 30, 2023, the Company owned 3,000,000 units which are valued at $1,200,000.

 

In January 2022, the Company received 1,700,000 units of ScanHash LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.25 per unit based on a sales price of $0.25 per unit on an online funding portal. The receipt of the units satisfied $425,000 of an accounts receivable balance. As of July 31, 2023 and April 30, 2023, the Company owned 1,700,000 units which are valued at $425,000.

 

In January 2022, the Company received 2,850,000 units of Hiveskill LLC as payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.25 per unit based on a sales price of $0.25 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $712,500. As of July 31, 2023 and April 30, 2023, the Company owned 2,850,000 units which are valued at $712,500.

 

In fiscal 2022, the Company purchased a 10% interest, or 400 shares of common stock, in Caesar Media Group Inc. (“Caesar”) for an initial purchase price of 50,000 shares of the Company’s common stock, valued at $500,000. Caesar is a marketing and technology solutions provider. The purchase agreement includes additional contractual requirements for the Company and Caesar, including the issuance of an additional 150,000 shares of common stock of the Company over a two-year period. The Company issued 37,500 shares of its common stock in April 2022, 25,000 shares of its common stock in September 2022, 12,500 shares of its common stock in October 2022, 18,750 shares of its common stock in January 2023, 18,750 shares of its common stock in April 2023, and 18,750 shares of its common stock in July 2023, as part of its contractual payment obligations. As of July 31, 2023 and April 30, 2023, there have been no observable price changes in the value of Caesar’s common stock and the Company has valued its ownership in Caesar at cost, which amounted to $1,815,939 and $1,632,751 as of July 31, 2023 and April 30, 2023, respectively.

 

In August 2020 the Company entered a consulting agreement with C-Reveal Therapeutics LLC (“CRT”). for a $120,000 fee over a 12-month period. $50,000 of the fee was payable in CRT units. As of July 31, 2023 and April 30, 2023, the Company owned 5,000 units, at a value of $50,000.

 

In May 2020, the Company entered a consulting contract with MustWatch LLC (“MW”), which allowed the Company to receive 110,000 membership interest units of MW in return for services rendered in conjunction with a crowdfunding offering. The Company earned 97,500 membership interest units in the quarter ended July 31, 2020, valued at $2.14 per unit, or $235,400. As of April 30, 2023, the MW units are valued at $4 per unit based on a sales price of $4 per unit on an online funding portal. As of July 31, 2023 and April 30, 2023, the Company owned 110,000 MW units, which are valued at $440,000.

 

In May 2020, the Company entered into a consulting contract with ChipBrain LLC (“Chip”), which allowed the Company to receive 710,200 membership interest units of Chip in return for services rendered in conjunction with a crowdfunding offering. The Chip units are valued at $4.74 per unit, based on a sales price of $4.74 per unit on an online funding portal. As of July 31, 2023 and April 30, 2023, the units owned by the Company are valued at $3,366,348.

 

In May 2020, the Company entered a consulting contract with a related party, Zelgor Inc. (“Zelgor”), which allowed the Company to receive 1,400,000 shares of common stock of Zelgor in return for services rendered in conjunction with a crowdfunding offering. The Zelgor shares are valued at $1.00 per share based on a sales price of $1.00 per share on an online funding portal. As of July 31, 2023 and April 30, 2023, the Company owned 1,400,000 shares which are valued at $1,400,000.

 

On January 2, 2020, the Company entered a consulting contract with Deuce Drone LLC (“Drone”), which allowed the Company to receive up to 2,350,000 membership interest units of Drone in return for consulting services. The Drone units are valued at $1.00 per share based on a sales price of $1.00 per share on an online funding portal. As of July 31, 2023 and April 30, 2023, the units owned by the Company are valued at $2,350,000.

 

In August 2019, the Company entered a consulting contract with KingsCrowd LLC (“KingsCrowd”), which allowed the Company to receive 300,000 membership interest units of KingsCrowd in return for services rendered in conjunction with a crowdfunding offering. The KingsCrowd units were valued at $1.80 per unit based on a sales price of $1.80 per unit when the units were earned, or $540,000. In December 2020, KingsCrowd converted from a limited liability company to a corporation to facilitate raising capital under Regulation A. KingsCrowd filed a Form 1-A Offering Statement under the Securities Act of 1933 and sold shares at $1.00 per share. In connection with the conversion to a corporation, each membership interest unit converted into 12.71915 shares of common stock, and the Company recorded an unrealized gain of $3,275,745 for the year ended April 30, 2022. The Company sold 606,060 shares of KingsCrowd in June 2022 for proceeds of $200,000 and recorded a realized loss on the sale of the investment of $406,060. KingsCrowd filed a post qualification offering circular amendment on July 21, 2022 and continued to sell shares of stock to the public for $1.00 per share. As of July 31, 2023 and April 30, 2023, the Company owned 3,209,685 shares of KingsCrowd, valued at $3,209,685, respectively.

 

During fiscal 2019, the Company entered into a consulting contract with Netcapital Systems LLC, a related party, and earned membership interest units. As of July 31, 2023 and April 30, 2023, the Company owned 528 units, at a value of $48,128.

 

In July 2020 the Company entered into a consulting agreement with Vymedic, Inc. for a $40,000 fee over a 5-month period. Half the fee was payable in stock and half was payable in cash. As of July 31, 2023 and April 30, 2023 the Company owned 4,000 units, at a value of $11,032.

 

 

The following table summarizes the components of investments as of July 31, 2023 and April 30, 2023:

 

 

   July 31, 2023  April 30, 2023
       
Netcapital Systems LLC  $

 48,128

   $48,128 
MustWatch LLC   440,000    440,000 
Zelgor Inc.   1,400,000    1,400,000 
ChipBrain LLC   3,366,348    3,366,348 
Vymedic Inc.   11,032    11,032 
C-Reveal Therapeutics LLC   50,000    50,000 
Deuce Drone LLC   2,350,000    2,350,000 
Hiveskill LLC   712,500    712,500 
ScanHash LLC   425,000    425,000 
Caesar Media Group Inc.   1,815,939    1,632,751 
Cust Corp.   1,200,000    1,200,000 
Kingscrowd Inc.   3,209,685    3,209,685 
Reper LLC   1,200,000    1,200,000 
Dark LLC   2,100,000    2,100,000 
Netwire LLC   1,300,000    1,300,000 
CountSharp LLC   1,170,000    1,170,000 
CupCrew LLC   1,170,000    1,170,000 
HeadFarm LLC   1,170,000    1,170,000 
RealWorld LLC   1,170,000       
Total  $24,308,632   $22,955,444 

 

The above investments in equity securities are within the scope of ASC 321. The Company monitors the investments for any changes in observable prices from orderly transactions. All investments are initially measured at cost and evaluated for changes in estimated fair value.

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
3 Months Ended
Jul. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 14 – Subsequent Events

 

The Company evaluated subsequent events through the date these financial statements were available to be issued.

 

There were no material subsequent events that required recognition or additional disclosure in these financial statements.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition (Tables)
3 Months Ended
Jul. 31, 2023
Revenue Recognition  
Schedule of Disaggregation of Revenue

 

       
   Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Consulting services  $1,143,700   $1,161,830 
Fees from online services   376,109    178,743 
Total revenues  $1,519,809   $1,340,573 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Common Share (Tables)
3 Months Ended
Jul. 31, 2023
Earnings Per Share [Abstract]  
Schedule of earnings per share

 

       
   Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Net income (loss) attributable to common stockholders – basic  $(491,655)  $64,477 
Adjustments to net income (loss)            
Net income (loss) attributable to common stockholders – diluted  $(491,655)  $64,477 
           
Weighted average common shares outstanding - basic   7,471,207    3,168,547 
Effect of dilutive securities   250    2,850 
Weighted average common shares outstanding – diluted   7,471,457    3,171,397 
           
Earnings (loss) per common share - basic  $(.07)  $0.02 
Earnings (loss) per common share - diluted  $(.07)  $0.02 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Financing Arrangements (Tables)
3 Months Ended
Jul. 31, 2023
Principal Financing Arrangements  
Schedule of Debt

 

          
   July 31,
2023
  April 30,
2023
  Interest Rate
          
Secured lender  $     $350,000    12.0%
Notes payable – related parties   15,000    15,000    0.0%
U.S. SBA loan   500,000    500,000    3.75%
U.S. SBA loan   1,885,800    1,885,800    1.0%
Loan payable – bank   34,324    34,324    10.0%
        Total Debt   2,435,124    2,785,124      
Less: current portion of long-term debt   1,935,124    2,285,124      
Total long-term debt  $500,000   $500,000      
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Tables)
3 Months Ended
Jul. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Income Taxes

       
   July 31, 2023  April 30, 2023
       
Deferred tax assets, net:          
Net operating loss carryforwards  $77,000   $   
Bad debt allowance   28,000    27,000 
Stock-based compensation   480,000    433,000 
Deferred tax assets   585,000    460,000 
           
Deferred tax liability          
Unrealized gain   2,117,000    2,117,000 
           
Net deferred tax liability  $(1,532,000)  $(1,657,000)
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders’ Equity (Tables)
3 Months Ended
Jul. 31, 2023
Equity [Abstract]  
Schedule of warrants outstanding

 

                                         
    Warrants Outstanding      Warrants Exercisable  
          Weighted-                    
          Average     Weighted-           Weighted-  
Range of         Remaining     Average           Average  
Exercise   Number     Contractual     Exercise     Number     Exercise  
Prices   Outstanding     Life (Years)     Price     Outstanding     Price  
                               
As of July 31, 2023                              
$0.875 - $5.19     1,682,932       4.06     $ 4.72       1,541,682     $ 4.96  
                                         
As of July 31, 2022                                        
$1.75 - $5.19     1,541,682       4.25     $ 5.03       1,469,982     $ 5.19  
Schedule of Warrants activity

 

      Number of
Shares
    Exercise Price
Per Share
    Average
Exercise
Price
Outstanding May 1, 2022                 $
                         
Issued during year ended April 30, 2023       1,541,682     1.75-$5.19     $ 5.03
                         
Exercised/canceled during year ended April 30, 2023                 $
                         
Outstanding April 30, 2023       1,541,682     $ 1.75-$5.19     $ 5.53
                         
Issued during quarter ended July 31, 2023       141,250      

$0.875

-$1.94

    $ $1.29
                         
Exercised/canceled during quarter ended July 31, 2023                 $
                         
Warrants outstanding July 31, 2023       1,682,932     $0.875-$5.19     $ 4.72
                         
Warrants exercisable, July 31, 2023       1,541,682       $1.75-$5.19     $ 4.96
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Plans (Tables)
3 Months Ended
Jul. 31, 2023
Retirement Benefits [Abstract]  
Schedule of stock-based compensation expense

 

  Three Months Ended July 31, 2023  Three Months Ended July 31, 2022
Chief Executive Officer  $62,494   $   
Chief Financial Officer   14,915    2,443 
Chief Executive Officer of subsidiary   1,208    1,221 
Founder   14,915       
Third-party contractor   58,829       
Business consultant   141,151       
Business consultant   144,000       
Employee and consultant options   45,839    29,289 
Total stock-based compensation expense  $483,351   $32,953 
Schedule of stock options outstanding

 

                                         
    Options Outstanding      Options Exercisable  
          Weighted-                    
          Average     Weighted-           Weighted-  
Range of         Remaining     Average           Average  
Exercise   Number     Contractual     Exercise     Number     Exercise  
Prices   Outstanding     Life (Years)     Price     Outstanding     Price  
                               
As of July 31, 2023                              
$1.40 - $10.50     2,202,000       9.35     $ 2.46       344,458     $ 3.78  
                                         
As of April 30, 2023                                        
$1.40 - $10.50     2,202,000       9.63     $ 2.46       294,333     $ 3.69  
Schedule of stock options activity

 

      Number of
Shares
    Exercise Price
Per Share
    Average
Exercise
Price
Outstanding May 1, 2022       271,000       $10.50     $ 10.50
                         
Issued during year ended April 30, 2023       1,950,000      

$1.40-

$1.43

    $ 1.42
                         
Exercised/canceled during year ended April 30, 2023       (19,000)       $10.50     $ 10.50
                         
Outstanding April 30, 2023       2,202,000       $1.40 - $10.50     $ 2.46
                         
Issued during quarter ended July 31, 2023                 $
                         
Exercised/canceled during quarter ended July 31, 2023                 $
                         
Options outstanding July 31, 2023       2,202,000       $1.40- 10.50     $ 2.46
                         
Options exercisable, July 31, 2023       344,458      

$1.40-

10.50

    $ 3.78
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets (Tables)
3 Months Ended
Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets

 

   July 31, 2023  April 30, 2023
       
Acquired users  $14,288,695   $14,288,695 
Acquired brand   583,429    583,429 
Acquired intellectual property and website   435,000    435,000 
Professional practice   556,830    556,830 
Literary works and contracts   107,750    107,750 
Total intangible assets  $15,971,704   $15,971,704 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Investments (Tables)
3 Months Ended
Jul. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of investments

 

   July 31, 2023  April 30, 2023
       
Netcapital Systems LLC  $

 48,128

   $48,128 
MustWatch LLC   440,000    440,000 
Zelgor Inc.   1,400,000    1,400,000 
ChipBrain LLC   3,366,348    3,366,348 
Vymedic Inc.   11,032    11,032 
C-Reveal Therapeutics LLC   50,000    50,000 
Deuce Drone LLC   2,350,000    2,350,000 
Hiveskill LLC   712,500    712,500 
ScanHash LLC   425,000    425,000 
Caesar Media Group Inc.   1,815,939    1,632,751 
Cust Corp.   1,200,000    1,200,000 
Kingscrowd Inc.   3,209,685    3,209,685 
Reper LLC   1,200,000    1,200,000 
Dark LLC   2,100,000    2,100,000 
Netwire LLC   1,300,000    1,300,000 
CountSharp LLC   1,170,000    1,170,000 
CupCrew LLC   1,170,000    1,170,000 
HeadFarm LLC   1,170,000    1,170,000 
RealWorld LLC   1,170,000       
Total  $24,308,632   $22,955,444 

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition (Details) - USD ($)
3 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Revenues $ 1,519,809 $ 1,340,573
Consulting Services [Member]    
Revenues 1,143,700 1,161,830
Fees From Online Services [Member]    
Revenues $ 376,109 $ 178,743
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition (Details Narrative) - USD ($)
Jul. 31, 2023
Apr. 30, 2023
Jul. 31, 2022
Revenue Recognition      
Remaining Performance Obligations $ 1,519,809   $ 1,340,573
Contract revenues not recognized $ 600 $ 661  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Common Share (Details) - USD ($)
3 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Earnings Per Share [Abstract]    
Net income (loss) attributable to common stockholders – basic $ (491,655) $ 64,477
Adjustments to net income (loss)
Net income (loss) attributable to common stockholders – diluted $ (491,655) $ 64,477
Weighted average common shares outstanding - basic 7,471,207 3,168,547
Effect of dilutive securities $ 250 $ 2,850
Weighted average common shares outstanding – diluted 7,471,457 3,171,397
Earnings (loss) per common share - basic $ (0.07) $ 0.02
Earnings (loss) per common share - diluted $ (0.07) $ 0.02
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Principal Financing Arrangements (Details) - USD ($)
Jul. 31, 2023
Apr. 30, 2023
Apr. 30, 2022
Debt Instrument [Line Items]      
Debt, Current $ 2,435,124   $ 2,785,124
Long-Term Debt, Current Maturities 1,935,124   2,285,124
Long-Term Debt 500,000   500,000
Secured Debt [Member]      
Debt Instrument [Line Items]      
Debt, Current   350,000
Debt Instrument, Interest Rate, Effective Percentage   12.00%  
Notes Payable Related Parties [Member]      
Debt Instrument [Line Items]      
Debt, Current 15,000   15,000
Debt Instrument, Interest Rate, Effective Percentage   0.00%  
U S S B A Loan [Member]      
Debt Instrument [Line Items]      
Debt, Current 500,000   500,000
Debt Instrument, Interest Rate, Effective Percentage   3.75%  
U S S B A Loan One [Member]      
Debt Instrument [Line Items]      
Debt, Current 1,885,800   1,885,800
Debt Instrument, Interest Rate, Effective Percentage   1.00%  
U S S B A Loan Two [Member]      
Debt Instrument [Line Items]      
Debt, Current $ 34,324   $ 34,324
Debt Instrument, Interest Rate, Effective Percentage   10.00%  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Details) - USD ($)
Jul. 31, 2023
Apr. 30, 2023
Deferred tax assets, net:    
Net operating loss carryforwards $ 77,000
Bad debt allowance 28,000 27,000
Stock-based compensation 480,000 433,000
Deferred tax assets 585,000 460,000
Deferred tax liability    
Unrealized gain 2,117,000 2,117,000
Net deferred tax liability $ (1,532,000) $ (1,657,000)
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders Equity (Details) - $ / shares
3 Months Ended
Jul. 31, 2023
Apr. 30, 2023
Jul. 31, 2022
Warrant [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 1,682,932 1,682,932 1,541,682
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3] 4 years 21 days    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 4.72 $ 4.72 $ 5.03
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 4 years 3 months    
Warrants Exercisable [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 1,541,682   1,469,982
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 4.96   $ 5.19
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders Equity (Details 1) - $ / shares
3 Months Ended 12 Months Ended
Jul. 31, 2023
Apr. 30, 2023
Jul. 31, 2022
Warrant [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures 141,250 1,541,682  
[custom:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1]   $ 5.03  
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1]   1,541,682  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 1,682,932 1,682,932 1,541,682
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 4.72 $ 4.72 $ 5.03
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number   1,541,682  
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers-0]   $ 4.96  
Warrants [Member] | Minimum [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Exercise Price Per Share   1.75  
OutstandingExercisedPricePerShare   1.75  
Exercised Price Issued 0.875    
Warrants outstanding Price 0.875    
Warrants exercisable Price 1.75    
Warrants [Member] | Maximum [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Exercise Price Per Share   5.19  
OutstandingExercisedPricePerShare   $ 5.19  
Exercised Price Issued 1.94    
Warrants outstanding Price 5.19    
Warrants exercisable Price $ 5.19    
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Plans (Details) - USD ($)
3 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options $ 483,351 $ 32,953
Total stock-based compensation expense 483,351 32,953
Chief Executive Officer [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 62,494
Chief Financial Officer [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 14,915 2,443
Chief Executive Officer Of Subsidiary [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 1,208 1,221
Founder [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 14,915
Third Party Contractor [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 58,829
Business Consultant [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 141,151
Business Consultant 1 [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options 144,000
Employee Stock Options [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Employee and consultant options $ 45,839 $ 29,289
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Plans (Details 1) - $ / shares
3 Months Ended 12 Months Ended
Jul. 31, 2023
Apr. 30, 2023
Apr. 30, 2022
Options Outstanding [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 2,202,000   2,202,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 9 years 4 months 6 days 9 years 7 months 17 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 2.46 $ 2.46  
Options Exercisable [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 344,458 294,333  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 3.78 $ 3.69  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Plans (Details 2) - $ / shares
3 Months Ended 12 Months Ended
Jul. 31, 2023
Apr. 30, 2023
Jul. 31, 2022
Warrant [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 4.72 $ 4.72 $ 5.03
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1]   1,541,682  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 1,682,932 1,682,932 1,541,682
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures 141,250 1,541,682  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number   1,541,682  
Equity Option [Member]      
Defined Benefit Plan Disclosure [Line Items]      
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne]   271,000  
[custom:StockOptionExercisePrice-0]   $ 10.50  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price   $ 10.50  
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1]   1,950,000  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   $ 1.42  
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne]   (19,000)  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price $ 10.50  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   2,202,000  
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions-0]   $ 2.46  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures    
[custom:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period    
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions-0] 2,202,000    
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1-0] $ 2.46    
Equity Option [Member] | Warrant [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number 344,458    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 3.78    
Equity Option [Member] | Minimum [Member]      
Defined Benefit Plan Disclosure [Line Items]      
[custom:StockOptionExercisePrice-0]   1.40  
[custom:StockOptionExercisePriceIssued]   1.40  
[custom:StockOptionExercisePriceExercised]   10.50  
[custom:StockOptionExercisePriceOne-0] $ 1.40    
[custom:ExercisePricePerShareExercisable-0] 1.40    
Equity Option [Member] | Maximum [Member]      
Defined Benefit Plan Disclosure [Line Items]      
[custom:StockOptionExercisePrice-0]   10.50  
[custom:StockOptionExercisePriceIssued]   $ 1.43  
[custom:StockOptionExercisePriceOne-0] $ 10.50    
[custom:ExercisePricePerShareExercisable-0] 10.50    
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets (Details) - USD ($)
Jul. 31, 2023
Apr. 30, 2023
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net $ 15,971,704 $ 15,971,704
Acquired Users [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net 14,288,695 14,288,695
Acquired Brand [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net 583,429 583,429
Acquired Intellectual Property And Website [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net 435,000 435,000
Professional Practice [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net 556,830 556,830
Literary Works And Contracts [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net $ 107,750 $ 107,750
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Investments (Details) - USD ($)
Jul. 31, 2023
Apr. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost $ 24,308,632 $ 22,955,444
Netcapital Systems L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 48,128 48,128
Must Watch L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 440,000 440,000
Zelgor Inc [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,400,000 1,400,000
Chip Brain L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 3,366,348 3,366,348
Vymedic Inc [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 11,032 11,032
C Reveal Therapeutics L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 50,000 50,000
Deuce Drone L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 2,350,000 2,350,000
Hiveskill L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 712,500 712,500
Scan Hash L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 425,000 425,000
Caesar Media Group Inc [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,815,939 1,632,751
Cust Corp [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,200,000 1,200,000
Kingscrowd Inc [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 3,209,685 3,209,685
Reper L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,200,000 1,200,000
Dark L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 2,100,000 2,100,000
Netwire L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,300,000 1,300,000
Count Sharp L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,170,000 1,170,000
Cup Crew L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,170,000 1,170,000
Head Farm L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost 1,170,000 1,170,000
Real World L L C [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Investment Owned, at Cost $ 1,170,000
XML 51 ncpl_10q_htm.xml IDEA: XBRL DOCUMENT 0001414767 2023-05-01 2023-07-31 0001414767 2023-09-14 0001414767 2023-07-31 0001414767 2023-04-30 0001414767 2022-05-01 2022-07-31 0001414767 us-gaap:CommonStockMember 2022-04-30 0001414767 ncpl:CommonStockToBeIssuedMember 2022-04-30 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001414767 us-gaap:RetainedEarningsMember 2022-04-30 0001414767 2022-04-30 0001414767 us-gaap:CommonStockMember 2022-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001414767 us-gaap:RetainedEarningsMember 2022-07-31 0001414767 2022-07-31 0001414767 us-gaap:CommonStockMember 2022-10-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-10-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001414767 us-gaap:RetainedEarningsMember 2022-10-31 0001414767 2022-10-31 0001414767 us-gaap:CommonStockMember 2023-01-31 0001414767 ncpl:CommonStockToBeIssuedMember 2023-01-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001414767 us-gaap:RetainedEarningsMember 2023-01-31 0001414767 2023-01-31 0001414767 us-gaap:CommonStockMember 2023-04-30 0001414767 ncpl:CommonStockToBeIssuedMember 2023-04-30 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001414767 us-gaap:RetainedEarningsMember 2023-04-30 0001414767 us-gaap:CommonStockMember 2022-05-01 2022-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-05-01 2022-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-31 0001414767 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-31 0001414767 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-08-01 2022-10-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001414767 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001414767 2022-08-01 2022-10-31 0001414767 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001414767 ncpl:CommonStockToBeIssuedMember 2022-11-01 2023-01-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001414767 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001414767 2022-11-01 2023-01-31 0001414767 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001414767 ncpl:CommonStockToBeIssuedMember 2023-02-01 2023-04-30 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001414767 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001414767 2023-02-01 2023-04-30 0001414767 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2023-05-01 2023-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001414767 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001414767 us-gaap:CommonStockMember 2023-07-31 0001414767 ncpl:CommonStockToBeIssuedMember 2023-07-31 0001414767 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001414767 us-gaap:RetainedEarningsMember 2023-07-31 0001414767 ncpl:ConsultingServicesMember 2023-05-01 2023-07-31 0001414767 ncpl:ConsultingServicesMember 2022-05-01 2022-07-31 0001414767 ncpl:FeesFromOnlineServicesMember 2023-05-01 2023-07-31 0001414767 ncpl:FeesFromOnlineServicesMember 2022-05-01 2022-07-31 0001414767 us-gaap:SecuredDebtMember 2023-07-31 0001414767 us-gaap:SecuredDebtMember 2022-04-30 0001414767 us-gaap:SecuredDebtMember 2023-04-30 0001414767 ncpl:NotesPayableRelatedPartiesMember 2023-07-31 0001414767 ncpl:NotesPayableRelatedPartiesMember 2022-04-30 0001414767 ncpl:NotesPayableRelatedPartiesMember 2023-04-30 0001414767 ncpl:USSBALoanMember 2023-07-31 0001414767 ncpl:USSBALoanMember 2022-04-30 0001414767 ncpl:USSBALoanMember 2023-04-30 0001414767 ncpl:USSBALoanOneMember 2023-07-31 0001414767 ncpl:USSBALoanOneMember 2022-04-30 0001414767 ncpl:USSBALoanOneMember 2023-04-30 0001414767 ncpl:USSBALoanTwoMember 2023-07-31 0001414767 ncpl:USSBALoanTwoMember 2022-04-30 0001414767 ncpl:USSBALoanTwoMember 2023-04-30 0001414767 us-gaap:WarrantMember 2023-07-31 0001414767 us-gaap:WarrantMember 2023-05-01 2023-07-31 0001414767 ncpl:WarrantsExercisableMember 2023-07-31 0001414767 us-gaap:WarrantMember 2022-07-31 0001414767 ncpl:WarrantsExercisableMember 2022-07-31 0001414767 us-gaap:WarrantMember 2022-05-01 2023-04-30 0001414767 srt:MinimumMember ncpl:WarrantsMember 2022-05-01 2023-04-30 0001414767 srt:MaximumMember ncpl:WarrantsMember 2022-05-01 2023-04-30 0001414767 srt:MinimumMember ncpl:WarrantsMember 2023-05-01 2023-07-31 0001414767 srt:MaximumMember ncpl:WarrantsMember 2023-05-01 2023-07-31 0001414767 us-gaap:WarrantMember 2023-04-30 0001414767 srt:ChiefExecutiveOfficerMember 2023-05-01 2023-07-31 0001414767 srt:ChiefExecutiveOfficerMember 2022-05-01 2022-07-31 0001414767 srt:ChiefFinancialOfficerMember 2023-05-01 2023-07-31 0001414767 srt:ChiefFinancialOfficerMember 2022-05-01 2022-07-31 0001414767 ncpl:ChiefExecutiveOfficerOfSubsidiaryMember 2023-05-01 2023-07-31 0001414767 ncpl:ChiefExecutiveOfficerOfSubsidiaryMember 2022-05-01 2022-07-31 0001414767 ncpl:FounderMember 2023-05-01 2023-07-31 0001414767 ncpl:FounderMember 2022-05-01 2022-07-31 0001414767 ncpl:ThirdPartyContractorMember 2023-05-01 2023-07-31 0001414767 ncpl:ThirdPartyContractorMember 2022-05-01 2022-07-31 0001414767 ncpl:BusinessConsultantMember 2023-05-01 2023-07-31 0001414767 ncpl:BusinessConsultantMember 2022-05-01 2022-07-31 0001414767 ncpl:BusinessConsultant1Member 2023-05-01 2023-07-31 0001414767 ncpl:BusinessConsultant1Member 2022-05-01 2022-07-31 0001414767 ncpl:EmployeeStockOptionsMember 2023-05-01 2023-07-31 0001414767 ncpl:EmployeeStockOptionsMember 2022-05-01 2022-07-31 0001414767 ncpl:OptionsOutstandingMember 2023-07-31 0001414767 ncpl:OptionsOutstandingMember 2023-05-01 2023-07-31 0001414767 ncpl:OptionsExercisableMember 2023-07-31 0001414767 ncpl:OptionsOutstandingMember 2022-04-30 0001414767 ncpl:OptionsOutstandingMember 2022-05-01 2023-04-30 0001414767 ncpl:OptionsOutstandingMember 2023-04-30 0001414767 ncpl:OptionsExercisableMember 2023-04-30 0001414767 us-gaap:StockOptionMember 2022-05-01 2023-04-30 0001414767 us-gaap:StockOptionMember 2023-04-30 0001414767 srt:MinimumMember us-gaap:StockOptionMember 2022-05-01 2023-04-30 0001414767 srt:MaximumMember us-gaap:StockOptionMember 2022-05-01 2023-04-30 0001414767 srt:MinimumMember us-gaap:StockOptionMember 2023-04-30 0001414767 srt:MaximumMember us-gaap:StockOptionMember 2023-04-30 0001414767 us-gaap:StockOptionMember 2023-05-01 2023-07-31 0001414767 us-gaap:StockOptionMember 2023-07-31 0001414767 srt:MinimumMember us-gaap:StockOptionMember 2023-07-31 0001414767 srt:MaximumMember us-gaap:StockOptionMember 2023-07-31 0001414767 us-gaap:StockOptionMember us-gaap:WarrantMember 2023-07-31 0001414767 ncpl:AcquiredUsersMember 2023-07-31 0001414767 ncpl:AcquiredUsersMember 2023-04-30 0001414767 ncpl:AcquiredBrandMember 2023-07-31 0001414767 ncpl:AcquiredBrandMember 2023-04-30 0001414767 ncpl:AcquiredIntellectualPropertyAndWebsiteMember 2023-07-31 0001414767 ncpl:AcquiredIntellectualPropertyAndWebsiteMember 2023-04-30 0001414767 ncpl:ProfessionalPracticeMember 2023-07-31 0001414767 ncpl:ProfessionalPracticeMember 2023-04-30 0001414767 ncpl:LiteraryWorksAndContractsMember 2023-07-31 0001414767 ncpl:LiteraryWorksAndContractsMember 2023-04-30 0001414767 ncpl:NetcapitalSystemsLLCMember 2023-07-31 0001414767 ncpl:NetcapitalSystemsLLCMember 2023-04-30 0001414767 ncpl:MustWatchLLCMember 2023-07-31 0001414767 ncpl:MustWatchLLCMember 2023-04-30 0001414767 ncpl:ZelgorIncMember 2023-07-31 0001414767 ncpl:ZelgorIncMember 2023-04-30 0001414767 ncpl:ChipBrainLLCMember 2023-07-31 0001414767 ncpl:ChipBrainLLCMember 2023-04-30 0001414767 ncpl:VymedicIncMember 2023-07-31 0001414767 ncpl:VymedicIncMember 2023-04-30 0001414767 ncpl:CRevealTherapeuticsLLCMember 2023-07-31 0001414767 ncpl:CRevealTherapeuticsLLCMember 2023-04-30 0001414767 ncpl:DeuceDroneLLCMember 2023-07-31 0001414767 ncpl:DeuceDroneLLCMember 2023-04-30 0001414767 ncpl:HiveskillLLCMember 2023-07-31 0001414767 ncpl:HiveskillLLCMember 2023-04-30 0001414767 ncpl:ScanHashLLCMember 2023-07-31 0001414767 ncpl:ScanHashLLCMember 2023-04-30 0001414767 ncpl:CaesarMediaGroupIncMember 2023-07-31 0001414767 ncpl:CaesarMediaGroupIncMember 2023-04-30 0001414767 ncpl:CustCorpMember 2023-07-31 0001414767 ncpl:CustCorpMember 2023-04-30 0001414767 ncpl:KingscrowdIncMember 2023-07-31 0001414767 ncpl:KingscrowdIncMember 2023-04-30 0001414767 ncpl:ReperLLCMember 2023-07-31 0001414767 ncpl:ReperLLCMember 2023-04-30 0001414767 ncpl:DarkLLCMember 2023-07-31 0001414767 ncpl:DarkLLCMember 2023-04-30 0001414767 ncpl:NetwireLLCMember 2023-07-31 0001414767 ncpl:NetwireLLCMember 2023-04-30 0001414767 ncpl:CountSharpLLCMember 2023-07-31 0001414767 ncpl:CountSharpLLCMember 2023-04-30 0001414767 ncpl:CupCrewLLCMember 2023-07-31 0001414767 ncpl:CupCrewLLCMember 2023-04-30 0001414767 ncpl:HeadFarmLLCMember 2023-07-31 0001414767 ncpl:HeadFarmLLCMember 2023-04-30 0001414767 ncpl:RealWorldLLCMember 2023-07-31 0001414767 ncpl:RealWorldLLCMember 2023-04-30 iso4217:USD shares iso4217:USD shares pure 0001414767 false --04-30 2024 Q1 10-Q true 2023-07-31 false 001-41443 NETCAPITAL INC. UT 87-0409951 1 Lincoln Street Boston MA 02111 781 925-1700 Yes Yes Non-accelerated Filer true false false 9434132 1030618 569441 1355000 1388500 444837 583030 2830455 2540971 6300 6300 202000 202000 15846966 15875297 240080 240080 24308633 22955445 43434434 41820093 586981 578331 75204 75204 242955 285065 10000 10000 600 661 86185 98256 1532000 1657000 15000 15000 350000 1885800 1885800 34324 34324 174000 4469049 5163641 500000 500000 4969049 5663641 0.001 0.001 900000000 900000000 9434132 9434132 6440527 6440527 9434 6441 183187 183187 33298539 30500944 4974225 5465880 38465385 36156452 43434434 41820093 1519809 1340573 18053 21063 1501756 1319510 163942 125611 241888 7780 19610 17212 1037042 769940 788294 392297 2250776 1312840 -749020 6670 13304 36312 224260 -28331 -21081 -406060 -41635 -239193 -790655 -232523 -299000 -297000 -491655 64477 -0.07 0.02 -0.07 0.02 7471207 3168547 7471457 3171397 2934344 2934 244250 22479769 2510908 25237861 133333 134 379852 379986 1205000 1205 3947912 3949117 32953 32953 64477 64477 4272677 4273 244250 26840486 2575385 29664394 2600 3 23397 23400 37500 37 366338 366375 32953 32953 183138 183138 4312777 4313 244250 27263174 2758523 30270260 1434000 1434 1620025 1621459 18750 19 171105 171124 300000 300 434700 435000 6250 6 -61063 61057 63057 63057 1696499 1696499 6071777 6072 183187 29613118 4455022 34257399 18750 19 195233 195252 132943 132943 350000 350 559650 560000 1010858 1010858 6440527 6441 183187 30500944 5465880 36156452 139371 139371 100000 100 143900 144000 2825000 2825 2272375 2275200 18750 18 183170 183188 49855 50 58779 58829 -491655 -491655 9434132 9434 183187 33298539 4974225 38465385 -491655 64477 483351 32953 -1170000 -1200000 224260 6000 406060 125000 297000 28331 21081 -27500 -279200 2958 35842 -33460 -135388 -61 -1930 -12071 35796 -174000 -8819 -1464023 -1063672 200000 200000 350000 1000000 -3200 2275200 3949117 1925200 2945917 461177 2082245 569441 473925 1030618 2556170 25374 516 266272 183188 113714 <p id="xdx_805_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zf86ZutCkdkg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1– <span id="xdx_820_zD262DraqGr7">Basis of Presentatio</span>n</b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed financial statements of Netcapital Inc. (the “Company”) have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended July 31, 2023, are not necessarily indicative of the results that may be expected for the fiscal year ended April 30, 2024. For further information, refer to the audited financial statements and footnotes thereto in our Annual Report on Form 10-K for the year ended April 30, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There have been no material changes to our significant accounting policies from our Annual Report on Form 10-K for the fiscal year ended April 30, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><br/> The Company accounts for allowance for credit losses under the current expected credit loss (“CECL”) impairment model for its financial assets, including accounts receivable, and presents the net amount of the financial instrument expected to be collected. The CECL impairment model requires an estimate of expected credit losses, measured over the contractual life of an instrument, which considers forecasts of future economic conditions in addition to information about past events and current conditions. Based on this model, the Company estimates the amount of uncollectible accounts receivable at the end of each reporting period based on the aging of the receivable balance, current and historical customer trends, communications with its customers, and macro-economic conditions. Amounts are written off after considerable collection efforts have been made and the amounts are determined to be uncollectible.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--ConcentrationRiskDisclosureTextBlock_zJxeuwrbzrh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_827_zFWvdaFlTiD4">Concentrations</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three-month period ended July 31, 2023, the Company had one customer that constituted 37% of revenues and a second customer that constituted 37% of revenues. For the three-month period ended July 31, 2022, the Company had one customer that constituted 52% of its revenues and a second customer that constituted 24% of its revenues.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_804_ecustom--RevenueRecognitionTextBlock_zs9MdzUgGLab" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3 – <span id="xdx_82A_zdDcZJ1NzqTh">Revenue Recognition</span></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue Recognition under ASC 606</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes service revenue from its consulting contracts, funding portal and game website using the five-step model as prescribed by ASC 606:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">• Identification of the contract, or contracts, with a customer;</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">• Identification of the performance obligations in the contract;</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">• Determination of the transaction price;</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">• Allocation of the transaction price to the performance obligations in the contract; and</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">• Recognition of revenue when or as, the Company satisfies a performance obligation.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies performance obligations in contracts with customers, which primarily are professional services, listing fees on our funding portal, and a portal fee of 4.9% of the money raised on the funding portal. The transaction price is determined based on the amount the Company expects to be entitled to receive in exchange for transferring the promised services to the customer. The transaction price in the contract is allocated to each distinct performance obligation in an amount that represents the relative amount of consideration expected to be received in exchange for satisfying each performance obligation. Revenue is recognized when performance obligations are satisfied. The Company usually bills its customers before it provides any services and begins performing services after the first payment is received. Contracts are typically one year or less. For larger contracts, in addition to the initial payment, the Company may allow for progress payments throughout the term of the contract.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Judgments and Estimates</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimation of variable consideration for each performance obligation requires the Company to make subjective judgments. The Company enters into contracts with customers that regularly include promises to transfer multiple services, such as digital marketing, web-based videos, offering statements, and professional services. For arrangements with multiple services, the Company evaluates whether the individual services qualify as distinct performance obligations. In its assessment of whether a service is a distinct performance obligation, the Company determines whether the customer can benefit from the service on its own or with other readily available resources, and whether the service is separately identifiable from other services in the contract. This evaluation requires the Company to assess the nature of each individual service offering and how the services are provided in the context of the contract, including whether the services are significantly integrated, highly interrelated, or significantly modify each other, which may require judgment based on the facts and circumstances of the contract.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When agreements involve multiple distinct performance obligations, the Company allocates arrangement consideration to all performance obligations at the inception of an arrangement based on the relative standalone selling prices (SSP) of each performance obligation. Where the Company has standalone sales data for its performance obligations which are indicative of the price at which the Company sells a promised service separately to a customer, such data is used to establish SSP. In instances where standalone sales data is not available for a particular performance obligation, the Company estimates SSP by the use of observable market and cost-based inputs. The Company continues to review the factors used to establish list price and will adjust standalone selling price methodologies as necessary on a prospective basis.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Service Revenue</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service revenue from subscriptions to the Company's game website is recognized over time on a ratable basis over the contractual subscription term beginning on the date that the platform is made available to the customer. Payments received in advance of subscription services being rendered are recorded as a deferred revenue. Professional services revenue is recognized over time as the services are rendered.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company estimates the amount to reserve for uncollectible amounts based on the aging of the contract balance, current and historical customer trends, and communications with its customers. These reserves are recorded as operating expenses against the contract asset (accounts receivable).</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contract Assets</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets are recorded for those parts of the contract consideration not yet invoiced but for which the performance obligations are completed. The revenue is recognized when the customer receives services. Contract assets are included in other current assets in the consolidated balance sheets and will be recognized during the succeeding twelve-month period.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Deferred Revenue</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenues represent billings or payments received in advance of revenue recognition and are recognized upon transfer of control. Balances consist primarily of annual plan subscription services and professional services not yet provided as of the balance sheet date. Deferred revenues that will be recognized during the succeeding twelve-month period are recorded as current deferred revenues in the consolidated balance sheets, with the remainder recorded as other non-current liabilities in the consolidated balance sheets.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Costs to Obtain a Customer Contract</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales commissions and related expenses are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized as other current or non-current assets and amortized on a straight-line basis over the life of the contract, which approximates the benefit period. The benefit period was estimated by taking into consideration the length of customer contracts, technology lifecycle, and other factors. All sales commissions are recorded as consulting fees within the Company's consolidated statement of operations.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remaining Performance Obligations</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company's subscription terms are typically less than one year. All of the Company’s revenues in the three-month periods ended July 31, 2023 and 2022, which amounted to $<span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230731_z4H2dMfHu4Q9" title="Remaining Performance Obligations">1,519,809</span> and $<span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20220731_zDErb3noQ2ml">1,340,573</span>, respectively, are considered contract revenues. Contract revenue as of July 31, 2023 and April 30, 2023, which has not yet been recognized, amounted to $<span id="xdx_906_ecustom--ContractRevenues_iI_c20230731_zzFNtMOuVUDd" title="Contract revenues not recognized">600</span> and $<span id="xdx_90B_ecustom--ContractRevenues_iI_c20230430_zw61Bl7uApd2">661</span>, respectively, and is recorded on the balance sheet as deferred revenue. The Company expects to recognize revenue on all of its remaining performance obligations over the next 12 months.  </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disaggregation of Revenue</i></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is from U.S.-based companies with no notable geographical concentrations in any area. A distinction exists in revenue source; revenues are either generated online or from consulting services.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues disaggregated by revenue source consist of the following:</span></p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zx3vq6ahUFdc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z0xQhjOiZBha" style="display: none">Schedule of Disaggregation of Revenue</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_134_zIaq4ZXhriC2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Revenue Recognition (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" id="xdx_49A_20230501__20230731_z3adgsCRNDhb" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49A_20220501__20220731_zdFQUaMrrif6" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Consulting services</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230501__20230731__srt--ProductOrServiceAxis__custom--ConsultingServicesMember_zT7ZWmBLTJgg" style="width: 12%; text-align: right">1,143,700</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20220501__20220731__srt--ProductOrServiceAxis__custom--ConsultingServicesMember_zECTBD1R2if9" style="width: 12%; text-align: right">1,161,830</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Fees from online services</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20230501__20230731__srt--ProductOrServiceAxis__custom--FeesFromOnlineServicesMember_zlOIRIvGlXne" style="border-bottom: Black 1pt solid; text-align: right">376,109</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20220501__20220731__srt--ProductOrServiceAxis__custom--FeesFromOnlineServicesMember_zo0DeiX8tcpg" style="border-bottom: Black 1pt solid; text-align: right">178,743</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230501__20230731_zT5LPPTdb5se" style="border-bottom: Black 2.5pt double; text-align: right">1,519,809</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220501__20220731_ztFFXgGYtD8j" style="border-bottom: Black 2.5pt double; text-align: right">1,340,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zhSJmGvPKOS6" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1519809 1340573 600 661 <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zx3vq6ahUFdc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z0xQhjOiZBha" style="display: none">Schedule of Disaggregation of Revenue</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_134_zIaq4ZXhriC2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Revenue Recognition (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" id="xdx_49A_20230501__20230731_z3adgsCRNDhb" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49A_20220501__20220731_zdFQUaMrrif6" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Consulting services</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230501__20230731__srt--ProductOrServiceAxis__custom--ConsultingServicesMember_zT7ZWmBLTJgg" style="width: 12%; text-align: right">1,143,700</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20220501__20220731__srt--ProductOrServiceAxis__custom--ConsultingServicesMember_zECTBD1R2if9" style="width: 12%; text-align: right">1,161,830</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Fees from online services</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20230501__20230731__srt--ProductOrServiceAxis__custom--FeesFromOnlineServicesMember_zlOIRIvGlXne" style="border-bottom: Black 1pt solid; text-align: right">376,109</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20220501__20220731__srt--ProductOrServiceAxis__custom--FeesFromOnlineServicesMember_zo0DeiX8tcpg" style="border-bottom: Black 1pt solid; text-align: right">178,743</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20230501__20230731_zT5LPPTdb5se" style="border-bottom: Black 2.5pt double; text-align: right">1,519,809</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220501__20220731_ztFFXgGYtD8j" style="border-bottom: Black 2.5pt double; text-align: right">1,340,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1143700 1161830 376109 178743 1519809 1340573 <p id="xdx_801_eus-gaap--EarningsPerShareTextBlock_ziURUdUP9jAh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_821_zb5LrgwvhUf1">Earnings Per Common Share</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0.2in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss) per common and diluted share were calculated as follows for the three-month periods ended July 31, 2023 and 2022:</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zj67x4oViHte" style="margin: 0 0.2in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z8lxZp80X6me" style="display: none">Schedule of earnings per share</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zfPVthIG3uK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Earnings Per Common Share (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" id="xdx_492_20230501__20230731_zvTaYHGPAEWi" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49D_20220501__20220731_zQxrkKlmeV72" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2022</td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zbVN0ba7oGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Net income (loss) attributable to common stockholders – basic</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(491,655</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">64,477</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--AdjustmentsToNetIncomeLoss_zMc6kcOLN6Mg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Adjustments to net income (loss)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_z2wmSpZd6q8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net income (loss) attributable to common stockholders – diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(491,655</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">64,477</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zh6vpjkv9eU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Weighted average common shares outstanding - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,471,207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,168,547</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DilutiveSecurities_zBzupvCFdYNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Effect of dilutive securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">250</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,850</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_zOR4ukJT67mg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Weighted average common shares outstanding – diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,471,457</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,171,397</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_zHC4mlItSDok" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Earnings (loss) per common share - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_zeASWmzdP8fl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Earnings (loss) per common share - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zfAvNalvbee4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three-month period ended July 31, 2023, outstanding vested warrants and stock option grants to purchase 1,541,682 and 344,458 shares of common stock, respectively, and 250 shares of common stock that are issuable pursuant to a stock subscription agreement are not included in the calculation of earnings per share because their effect is anti-dilutive. For the three-month period ended July 31, 2022, 2,850 shares of common stock that are issuable pursuant to stock subscription agreements are included in the calculation of diluted earnings per share. Outstanding warrants to purchase 1,409,732 shares of common stock are not included in the calculation of earnings per share for the three-month period ended July 31, 2022 because their effect is anti-dilutive. Outstanding options to purchase 271,000 shares of common stock are not included in the calculation of earnings per share for the three-month period ended July 31, 2022 because their effect is anti-dilutive.  </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zj67x4oViHte" style="margin: 0 0.2in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z8lxZp80X6me" style="display: none">Schedule of earnings per share</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zfPVthIG3uK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Earnings Per Common Share (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" id="xdx_492_20230501__20230731_zvTaYHGPAEWi" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49D_20220501__20220731_zQxrkKlmeV72" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2022</td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zbVN0ba7oGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Net income (loss) attributable to common stockholders – basic</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(491,655</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">64,477</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--AdjustmentsToNetIncomeLoss_zMc6kcOLN6Mg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Adjustments to net income (loss)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_z2wmSpZd6q8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net income (loss) attributable to common stockholders – diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(491,655</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">64,477</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zh6vpjkv9eU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Weighted average common shares outstanding - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,471,207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,168,547</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DilutiveSecurities_zBzupvCFdYNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Effect of dilutive securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">250</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,850</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_zOR4ukJT67mg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Weighted average common shares outstanding – diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,471,457</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,171,397</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_zHC4mlItSDok" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Earnings (loss) per common share - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_zeASWmzdP8fl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Earnings (loss) per common share - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(.07</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -491655 64477 -491655 64477 7471207 3168547 250 2850 7471457 3171397 -0.07 0.02 -0.07 0.02 <p id="xdx_803_ecustom--PrincipalFinancingArrangementsTextBlock_z8NuYLFsrc78" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_829_z8ugEH50q0kj">Principal Financing Arrangements</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes components debt as of July 31, 2023 and April 30, 2023:</span></p> <p id="xdx_899_eus-gaap--ScheduleOfDebtTableTextBlock_zlsfHwOYO3sk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zkNTEdEWkZLb" style="display: none">Schedule of Debt</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_309_134_zIdateeVwKy5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Principal Financing Arrangements (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">July 31, <br/> 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">April 30, <br/>2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Interest Rate</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify; padding-left: 5.4pt">Secured lender</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember_zatWdn2IVRN5" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0610">—</span>  </td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember_zkIqCHNDjCIc" style="width: 11%; text-align: right">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember_zrt2032GuqB8">12.0</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Notes payable – related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableRelatedPartiesMember_zmOZLqW31sOk" style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableRelatedPartiesMember_zr0G5skBL9c3" style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableRelatedPartiesMember_zI2gHaKpcqq7">0.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">U.S. SBA loan</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanMember_zWJyli7wlvVk" style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanMember_zTZGBM4FVojf" style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanMember_zkLW14GdSQgk">3.75</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">U.S. SBA loan</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanOneMember_zahMHa3yoBRf" style="text-align: right">1,885,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanOneMember_z1JvO8cxNEg2" style="text-align: right">1,885,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanOneMember_z9eBObvEHK66">1.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Loan payable – bank</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanTwoMember_zz8KNQnetljf" style="border-bottom: Black 1pt solid; text-align: right">34,324</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanTwoMember_zMs2soYXjMEh" style="border-bottom: Black 1pt solid; text-align: right">34,324</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanTwoMember_zqgot7U9046c">10.0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">        Total Debt</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--DebtCurrent_iI_c20230731_z6FtTatySno" style="text-align: right">2,435,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtCurrent_iI_c20220430_zahFc0xiATk2" style="text-align: right">2,785,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Less: current portion of long-term debt</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--LongTermDebtCurrent_iI_c20230731_zQlLxLnPWl7k" style="border-bottom: Black 1pt solid; text-align: right">1,935,124</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_c20220430_z0acZZgh4ine" style="border-bottom: Black 1pt solid; text-align: right">2,285,124</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Total long-term debt</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230731_zeLcYlG0JsHj" style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20220430_zOPF9x97AGS5" style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_z5yCC3V4xRz4" style="margin: 0 0 0 22.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span> </p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023 and April 30, 2023, the Company owed its principal lender (“Lender”) $0 and $350,000, respectively, under an amended loan and security agreement dated July 26, 2014, amended several times thereafter and paid in full in May 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023 and April 30, 2023, the Company’s related-party unsecured notes payable totaled $15,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company owes $34,324 as of July 31, 2023 and April 30, 2023 to Chase Bank. For the loan from Chase Bank, the Company pays interest only on a monthly basis, which is calculated at a rate of 10.0% per annum as of July 31, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 6, 2020, the Company borrowed $1,885,800 (the “May Loan”), on June 17, 2020 the Company borrowed $500,000 (the “June Loan”), and on February 2, 2021, the Company borrowed $1,885,800 (the “February Loan”) from a U.S. Small Business Administration (“SBA”) loan program.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The May loan bore interest at a rate of 1% per annum and was forgiven in its entirety in fiscal 2022.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The June Loan required installment payments of $2,437 monthly, beginning on June 17, 2021, over a term of thirty years. However, the SBA postponed the first installment payment for 18 months, and the first payment became due on December 17, 2022. The monthly payments of $2,437 are first applied to accrued interest payable. The monthly payments will not be applied to any of the outstanding principal balance until 2026. Consequently, the entire loan balance of $500,000 is classified as a long term liability. Interest accrues at a rate of 3.75% per annum. The Company agreed to grant a continuing security interest in its assets to secure payment and performance of all debts, liabilities, and obligations to the SBA. The June Loan was personally guaranteed by the Company’s Chief Financial Officer.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The February loan bears interest at a rate of 1% per annum and the due date of the first payment has been postponed by the SBA because the Company has applied for forgiveness of the February Loan.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfDebtTableTextBlock_zlsfHwOYO3sk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zkNTEdEWkZLb" style="display: none">Schedule of Debt</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_309_134_zIdateeVwKy5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Principal Financing Arrangements (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">July 31, <br/> 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">April 30, <br/>2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Interest Rate</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify; padding-left: 5.4pt">Secured lender</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember_zatWdn2IVRN5" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0610">—</span>  </td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember_zkIqCHNDjCIc" style="width: 11%; text-align: right">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember_zrt2032GuqB8">12.0</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Notes payable – related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableRelatedPartiesMember_zmOZLqW31sOk" style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableRelatedPartiesMember_zr0G5skBL9c3" style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableRelatedPartiesMember_zI2gHaKpcqq7">0.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">U.S. SBA loan</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanMember_zWJyli7wlvVk" style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanMember_zTZGBM4FVojf" style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanMember_zkLW14GdSQgk">3.75</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">U.S. SBA loan</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanOneMember_zahMHa3yoBRf" style="text-align: right">1,885,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanOneMember_z1JvO8cxNEg2" style="text-align: right">1,885,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanOneMember_z9eBObvEHK66">1.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Loan payable – bank</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DebtCurrent_iI_c20230731__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanTwoMember_zz8KNQnetljf" style="border-bottom: Black 1pt solid; text-align: right">34,324</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DebtCurrent_iI_c20220430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanTwoMember_zMs2soYXjMEh" style="border-bottom: Black 1pt solid; text-align: right">34,324</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230430__us-gaap--LongtermDebtTypeAxis__custom--USSBALoanTwoMember_zqgot7U9046c">10.0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">        Total Debt</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--DebtCurrent_iI_c20230731_z6FtTatySno" style="text-align: right">2,435,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtCurrent_iI_c20220430_zahFc0xiATk2" style="text-align: right">2,785,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Less: current portion of long-term debt</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--LongTermDebtCurrent_iI_c20230731_zQlLxLnPWl7k" style="border-bottom: Black 1pt solid; text-align: right">1,935,124</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_c20220430_z0acZZgh4ine" style="border-bottom: Black 1pt solid; text-align: right">2,285,124</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Total long-term debt</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230731_zeLcYlG0JsHj" style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--LongTermDebt_iI_c20220430_zOPF9x97AGS5" style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 350000 0.120 15000 15000 0.000 500000 500000 0.0375 1885800 1885800 0.010 34324 34324 0.100 2435124 2785124 1935124 2285124 500000 500000 <p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_z84ynIsDKsW8" style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_822_zdtguq2Jdhfh">Income Taxes</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023, the Company had net operating loss carryforwards for Federal income tax purposes of approximately $267,000, expiring in the years of 2024 through 2042.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three-month periods ended July 31, 2023 and 2022, the Company recorded an income tax benefit of $299,000 and $297,000, respectively.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023 and April 30, 2023, the Company had deferred tax assets calculated at an expected federal rate of 21%, and a state and local rate of 8%, when applicable, or approximately $585,000 and $460,000, respectively. As a result of unrealized book gains on equity securities, the Company also has a deferred tax liability of $1,532,000 and $1,657,000 as of July 31, 2023 and April 30, 2023, respectively. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of July 31, 2023 and April 30, 2023 were as follows:</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zFB3IEY3s6Sl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zMp973XbO8n5" style="display: none">Schedule of Income Taxes </span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_z0LLLTX4tYK8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" id="xdx_499_20230731_zGgYEC5jOAo8"> </td><td> </td> <td colspan="3" id="xdx_497_20230430_zPIZnzuMElW4" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid">July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">April 30, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zojQtyUrQ9te" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Deferred tax assets, net:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_zRJ4zrXwpKai" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: justify; padding-left: 5.4pt">Net operating loss carryforwards</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">77,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">—</span>  </td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BadDebtAllowance_iI_zcwdqx7Fu6S1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Bad debt allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredCompensationShareBasedArrangementsLiabilityCurrent_iI_zfmoT4IYJXvb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">480,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">433,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeTaxAssetsNet_iI_zTZxn2189LC1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">585,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">460,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zLJrwJH1XEXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Deferred tax liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--TaxBasisOfInvestmentsGrossUnrealizedAppreciation_iI_zsSTA2GkOKM7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Unrealized gain</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,117,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,117,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--DeferredTaxLiability_iI_z2iFjzzQBd4g" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Net deferred tax liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,532,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,657,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zNvTJGSOGn31" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zFB3IEY3s6Sl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zMp973XbO8n5" style="display: none">Schedule of Income Taxes </span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_z0LLLTX4tYK8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" id="xdx_499_20230731_zGgYEC5jOAo8"> </td><td> </td> <td colspan="3" id="xdx_497_20230430_zPIZnzuMElW4" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid">July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">April 30, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zojQtyUrQ9te" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Deferred tax assets, net:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_zRJ4zrXwpKai" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: justify; padding-left: 5.4pt">Net operating loss carryforwards</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">77,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">—</span>  </td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BadDebtAllowance_iI_zcwdqx7Fu6S1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Bad debt allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredCompensationShareBasedArrangementsLiabilityCurrent_iI_zfmoT4IYJXvb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">480,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">433,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeTaxAssetsNet_iI_zTZxn2189LC1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">585,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">460,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zLJrwJH1XEXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Deferred tax liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--TaxBasisOfInvestmentsGrossUnrealizedAppreciation_iI_zsSTA2GkOKM7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Unrealized gain</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,117,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,117,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--DeferredTaxLiability_iI_z2iFjzzQBd4g" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Net deferred tax liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,532,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,657,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 77000 28000 27000 480000 433000 585000 460000 2117000 2117000 -1532000 -1657000 <p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zwXIATWthxH4" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_821_zBk04pS8X2Ul">Related Party Transactions</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s largest shareholder, Netcapital Systems LLC (“Systems”), owns 1,711,261 shares of common stock, or 18% of the Company’s 9,434,132 outstanding shares as of July 31, 2023. The company paid Systems $0 and $150,000 in the three-month periods ended July 31, 2023 and 2022, respectively, for use of the software that runs the website www.netcapital.com.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Chief Executive Officer of Netcapital Advisors Inc., (“Advisors”), our wholly owned subsidiary, is a member of the board of directors of KingsCrowd Inc. The Company sold 606,060 shares of KingsCrowd in June 2022 for proceeds of $200,000 and recorded a realized loss on the sale of the investment of $406,060 during the three months ended July 31, 2022. As of July 31, 2023 and April 30, 2023, the Company owned 3,209,685 shares of KingsCrowd Inc., valued at $3,209,685.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Chief Executive Officer of Advisors is a member of the board of directors of Deuce Drone LLC. As of July 31, 2023 and April 30, 2022, the Company owns 2,350,000 membership interest units of Deuce Drone LLC., valued at $2,350,000. The Company has notes receivable aggregating $152,000 from Deuce Drone LLC as of July 31, 2023 and April 30, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation to officers in the three-month periods ended July 31, 2023 and 2022 consisted of stock-based compensation valued at $93,532 and $3,664, respectively, and cash salary of $244,317 and $90,000 respectively.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended July 31, 2022, we paid $12,019 to a related party to retire a note payable of $3,200 and expenses payable of $8,819.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation to a related party consultant in the three-month periods ended July 31, 2023 and 2022 consisted of cash wages of $16,163 and $16,154, respectively. This consultant is also the controlling shareholder of Zelgor Inc. and $16,500 and $11,000 of the Company’s revenues in the three-month periods ended July 31, 2023 and 2022, respectively, were from Zelgor Inc. As of July 31, 2023 and April 30, 2023, the Company owned 1,400,000 shares which are valued at $1,400,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023 and April 30, 2023, the Company has invested $240,080 in an affiliate, 6A Aviation Alaska Consortium, Inc., in conjunction with a land lease in an airport in Alaska. Our Chief Executive Officer is also the Chief Executive Officer of 6A Aviation Alaska Consortium, Inc.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We owe Steven Geary, a director, $31,680 as of July 31, 2023 and April 30, 2023. This obligation is not interest bearing. $16,680 is recorded as a related party trade accounts payable and $15,000 as a related party note payable. We have no signed agreements for the indebtedness to Mr. Geary.</span></p> <p style="margin: 12pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coreen Kraysler, our Chief Financial Officer, has personally guaranteed a $500,000 promissory note from the U.S. Small Business Administration. The note bears interest at an annual rate of 3.75%, has a 30-year term, and monthly payments of $2,437 began on December 17, 2022.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zi1I3DSZpcLk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_826_zoLjwlS6IX5j">Stockholders’ Equity</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue 900,000,000 shares of its common stock, par value $0.001. 9,434,132 and 6,440,527 shares were outstanding as of July 31, 2023 and April 30, 2023, respectively.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the quarter ended July 31, 2022, the Company issued 39,901 shares of common stock with a value of $113,714 to settle a related party payable of $294,054. The Company also issued 93,432 shares of common stock valued at $266,272 to retire $300,000 of convertible promissory notes plus accrued interest of $10,192. The convertible note holders also received warrants to purchase shares of common stock at a per share exercise price of $5.19, that are exercisable immediately, and expire five years from the date of issuance. These equity issuances resulted in a gain from the conversion of debt totaling $224,260, which is recorded as other income in the income statement.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 15, 2022, the Company completed an underwritten public offering of 1,205,000 shares of the Company’s common stock and warrants to purchase 1,205,000 shares of the Company’s common stock at a combined public offering price of $4.15 per share and warrant. The gross proceeds from the offering were $5,000,750 prior to deducting underwriting discounts, commissions, and other offering expenses, which resulted in net proceeds of $3,949,117. The warrants have a per share exercise price of $5.19, are exercisable immediately, and expire five years from the date of issuance.</span></p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company granted the underwriter a 45-day option to purchase up to an additional 180,750 shares of common stock and/or up to 180,750 additional warrants to cover over-allotments, if any. In connection with the closing of the offering, the underwriter partially exercised its over-allotment option and purchased an additional 111,300 warrants, and the Company issued an aggregate of 60,250 warrants to 20 individual representatives of the underwriter.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 16, 2022 the Company completed an underwritten public offering of 1,247,000 shares of the Company’s common stock, at a price to the public of $1.40 per share. Pursuant to the terms of an underwriting agreement, the Company also granted the underwriters a 45-day option to purchase up to an additional 187,000 shares of common stock solely to cover over-allotments, at the same price per share of $1.40, less the underwriting discounts and commissions. In conjunction with this offering, the Company issued the underwriter and its designees warrants to purchase 62,350 shares of our common stock at an exercise price of $1.75. The underwriters exercised their over-allotment option and on January 5, 2023, the Company issued an additional 187,000 shares of its common stock. The Company received net proceeds of $1,621,459 for the issuance of a total of 1,434,000 shares of common stock for both the initial and over-allotment offering. In conjunction with the exercise of the over-allotment, the Company issued the underwriter and its designees warrants to purchase 9,350 shares of our common stock with an exercise price of $1.75.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended April 30, 2023, in addition to the public offerings, the Company issued 75,000 shares of common stock, valued at $732,751, in conjunction with the purchase of a 10% equity stake in Caesar Media Group, Inc., 300,000 shares of common stock, valued at $435,000 to purchase the website and intellectual property of a real-time video conferencing website, 2,600 shares of common stock in conjunction with a stock subscription agreement with accredited investors, valued at $23,400, and 6,250 shares of common stock in conjunction with an acquisition agreement that requires shares to be issued by the Company. As a result of this issuance, the value of the balance sheet account for shares to be issued decreased by $61,063, from $244,250 to $183,187, as of July 31, 2023 and April 30, 2023.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 5, 2023, the Company announced the formation of the Netcapital Inc. 2023 Omnibus Equity Incentive Plan (the “Plan”), which was subsequently approved by a vote of the shareholders. In January 2023, the Company granted stock options to four individuals to purchase an aggregate of 1,600,000 of the Company’s common stock at a price of $1.43 per share and on April 25, 2023 also granted 350,000 stock options under the Plan to employees, consultants, and directors at an exercise price of $1.40 per share. All stock options in the Plan vest monthly on a straight-line basis over a 4-year period and expire in 10 years.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2023, the Company issued 100,000 shares of its common stock, valued at $144,000, in conjunction with a consulting agreement with a business advisor.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 23, 2023, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell to such investors, in a registered direct offering (the “Offering”), 1,100,000 shares of the Company’s common stock, par value $0.001 per share, at a price of $1.55 per Share, for aggregate gross proceeds of $1,705,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Offering closed on May 25, 2023.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also in connection with the Offering, on May 23, 2023, the Company entered into a placement agency agreement with ThinkEquity LLC, pursuant to which, the Company issued warrants to purchase up to 55,000 shares of common stock at an exercise price of $1.94, which were issued on May 25, 2023.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2023, the Company issued 49,855 shares of its common stock in consideration of a release from an unrelated third party in conjunction with the settlement of an outstanding debt between such third party and Netcapital Systems LLC.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 24, 2023 the Company completed an underwritten public offering of 1,725,000 shares of the Company’s common stock, at a price to the public of $0.70 per share for aggregate gross proceeds of $1,207,500, before deducting underwriting discounts and offering expenses payable by the Company. In conjunction with this offering, the Company issued the underwriter, and its designees, warrants to purchase 86,250 shares of the Company’s common stock at an exercise price of $0.875.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 31, 2023, the Company issued 18,750 shares of its common stock in conjunction with the purchase of a 10% interest in Caesar Media Group Inc. The Company did not receive any proceeds for the issuance of these shares.</span></p> <p style="margin: 12pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize information about warrants outstanding as of July 31, 2023 and April 30, 2023:</span></p> <p id="xdx_898_ecustom--ScheduleOfWarrntsRollForwardTableTextBlock_zEguurgjCNDj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BA_ztVwjvKTU8Ed" style="display: none">Schedule of warrants outstanding</span></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_134_z41D4Nap15t9" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details)"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Outstanding </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Exercisable</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prices</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life (Years)</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.875 - $5.19</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztDIttNWCUZ7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,682,932</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3_dtY_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgzJhXmxuY33" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.06</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZcLyXCvzye5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.72</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_z68GGMj2udff" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_zN3NW4ZggFw5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.96</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.75 - $5.19</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zw14vUrgbgR6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIlWta0gE0B8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQiwyPpD3Im5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_zgrogdkssmg5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,469,982</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20220731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_z2AD6qFA2aH6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zweqctLivzZ" style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_ecustom--ScheduleOfWarrantsActivityTableTextBlock_zK6JGdDeOe39" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B4_zlyF4vHdFLbl" style="display: none">Schedule of Warrants activity</span></b></span></p> <p style="margin: 0; color: #027D01"></p> <table cellpadding="0" cellspacing="0" id="xdx_30E_134_zuPoPwvhQcml" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of <br/> Shares</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price <br/> Per Share</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average <br/> Exercise <br/> Price</span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding May 1, 2022</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zV3SHX3SaTZ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ExercisePricePerShare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zUuwpEEo97i3" title="Exercise Price Per Share">1.75</span>-$<span id="xdx_90D_ecustom--ExercisePricePerShare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zvAsFjWMsuj2">5.19</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLYUzpIj2wIa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zq8N09XVk2ve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Outstandingexercisedpricepershare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zW0JFnkVjwbi" title="OutstandingExercisedPricePerShare">1.75</span>-$<span id="xdx_905_ecustom--Outstandingexercisedpricepershare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zUbDzc8l0mfh">5.19</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.53</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjm3IL4goxPj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,250</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_ecustom--ExercisedPriceIssued_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zp5HYddatc" title="Exercised Price Issued">0.875</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-$<span id="xdx_906_ecustom--ExercisedPriceIssued_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zGlvReg4ePu5">1.94</span></span></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.29</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAghVRRZcTKi" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,682,932</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </span></td> <td style="border-bottom: Black 2.5pt double; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_ecustom--WarrantsOutstandingPrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zFwc80OfR0ng" title="Warrants outstanding Price">0.875</span>-$<span id="xdx_909_ecustom--WarrantsOutstandingPrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zHCLBpf5YVt4">5.19</span></span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpAsPZfa3dyg" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.72</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants exercisable, July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ze1R8FWjNz9e" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90E_ecustom--WarrantsExercisablePrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zeMWkwjqlg0b" title="Warrants exercisable Price">1.75</span>-$<span id="xdx_901_ecustom--WarrantsExercisablePrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zOafOTAQ6Kz">5.19</span></span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMjWaGf7wL3k" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.96</span></td> </tr> </table> <p id="xdx_8A5_zKP1yNKSjW2l" style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--ScheduleOfWarrntsRollForwardTableTextBlock_zEguurgjCNDj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BA_ztVwjvKTU8Ed" style="display: none">Schedule of warrants outstanding</span></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_134_z41D4Nap15t9" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details)"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Outstanding </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Exercisable</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prices</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life (Years)</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.875 - $5.19</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztDIttNWCUZ7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,682,932</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3_dtY_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgzJhXmxuY33" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.06</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZcLyXCvzye5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.72</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_z68GGMj2udff" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_zN3NW4ZggFw5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.96</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.75 - $5.19</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zw14vUrgbgR6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIlWta0gE0B8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.25</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQiwyPpD3Im5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_zgrogdkssmg5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,469,982</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20220731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsExercisableMember_z2AD6qFA2aH6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1682932 P4Y21D 4.72 1541682 4.96 1541682 P4Y3M 5.03 1469982 5.19 <p id="xdx_891_ecustom--ScheduleOfWarrantsActivityTableTextBlock_zK6JGdDeOe39" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B4_zlyF4vHdFLbl" style="display: none">Schedule of Warrants activity</span></b></span></p> <p style="margin: 0; color: #027D01"></p> <table cellpadding="0" cellspacing="0" id="xdx_30E_134_zuPoPwvhQcml" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of <br/> Shares</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price <br/> Per Share</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average <br/> Exercise <br/> Price</span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding May 1, 2022</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zV3SHX3SaTZ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ExercisePricePerShare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zUuwpEEo97i3" title="Exercise Price Per Share">1.75</span>-$<span id="xdx_90D_ecustom--ExercisePricePerShare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zvAsFjWMsuj2">5.19</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLYUzpIj2wIa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zq8N09XVk2ve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Outstandingexercisedpricepershare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zW0JFnkVjwbi" title="OutstandingExercisedPricePerShare">1.75</span>-$<span id="xdx_905_ecustom--Outstandingexercisedpricepershare_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zUbDzc8l0mfh">5.19</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.53</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjm3IL4goxPj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,250</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_ecustom--ExercisedPriceIssued_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zp5HYddatc" title="Exercised Price Issued">0.875</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-$<span id="xdx_906_ecustom--ExercisedPriceIssued_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zGlvReg4ePu5">1.94</span></span></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.29</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants outstanding July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAghVRRZcTKi" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,682,932</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </span></td> <td style="border-bottom: Black 2.5pt double; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_ecustom--WarrantsOutstandingPrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zFwc80OfR0ng" title="Warrants outstanding Price">0.875</span>-$<span id="xdx_909_ecustom--WarrantsOutstandingPrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zHCLBpf5YVt4">5.19</span></span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpAsPZfa3dyg" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.72</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants exercisable, July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ze1R8FWjNz9e" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,541,682</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90E_ecustom--WarrantsExercisablePrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MinimumMember_zeMWkwjqlg0b" title="Warrants exercisable Price">1.75</span>-$<span id="xdx_901_ecustom--WarrantsExercisablePrice_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__srt--RangeAxis__srt--MaximumMember_zOafOTAQ6Kz">5.19</span></span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMjWaGf7wL3k" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.96</span></td> </tr> </table> 1541682 1.75 5.19 5.03 1541682 1.75 5.19 141250 0.875 1.94 1682932 0.875 5.19 4.72 1541682 1.75 5.19 4.96 <p id="xdx_804_eus-gaap--FairValueDisclosuresTextBlock_zb1Yb5MhZPu1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 – <span id="xdx_822_zlP25pKNnjWg">Fair Value</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fair Value Measurements Topic of the FASB Accounting Standards Codification establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify; padding-right: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the company has the ability to access at the measurement date.</span></td></tr></table> <p style="margin: 0 0.5in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify; padding-right: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.</span></td></tr></table> <p style="margin: 0 0.5in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify; padding-right: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: inputs are unobservable inputs for the asset or liability.</span></td></tr></table> <p style="margin: 0 0.5in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Fair Value Measurements Topic of the FASB Accounting Standards Codification, we base fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. It is our policy to maximize the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements, in accordance with the fair value hierarchy. Fair value measurements for assets and liabilities where there exists limited or no observable market data and, therefore, are based primarily upon management’s own estimates, are often calculated based on current pricing policy, the economic and competitive environment, the characteristics of the asset or liability and other such factors. Therefore, the results cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability. Additionally, there may be inherent weaknesses in any calculation technique, and changes in the underlying assumptions used.</span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 33%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_809_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zSqSGFe3v9ng" style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Note 10 – <span id="xdx_82D_zWVD4BddVgQ4">Stock-Based Compensation Plans</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to cash payments, the Company enters agreements to issue common stock as payment for services and records the applicable non-cash expense in accordance with the authoritative guidance of the Financial Accounting Standards Board.  </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended July 31, 2023 and 2022, the Company recorded $483,351 and $32,953, respectively, in stock-based compensation expense. As of July 31, 2023 and April 30, 2023, there was $411,178 and $552,329 of prepaid stock-based compensation expense. The prepaid balance is the result of the issuance of 350,000 shares of common stock to a third-party business consultant.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below presents the components of compensation expense for the issuance of shares of common stock and stock options to employees and consultants for the three-month periods ended July 31, 2023 and 2022.</span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"></p> <p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zhdCeSs3hz4" style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z3hec9og4D44" style="display: none">Schedule of stock-based compensation expense</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_z0aIXWeoTsd4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-Based Compensation Plans (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"></td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="3" id="xdx_499_20230501__20230731_zJ9fLANuZBrj" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2023</td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="3" id="xdx_490_20220501__20220731_zhSXn5Zjt1tl" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2022</td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z7YeRxmoYu63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Chief Executive Officer</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">62,494</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">—</span>  </td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zXdnq8nPuXr5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Chief Financial Officer</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,915</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,443</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerOfSubsidiaryMember_zMJLSzu7cdq" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Chief Executive Officer of subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,221</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--FounderMember_z4esHkSbFZS4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Founder</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,915</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--ThirdPartyContractorMember_zjwEgcBmWoac" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Third-party contractor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,829</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0721">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--BusinessConsultantMember_zlJSyVxk6F36" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Business consultant</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">141,151</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--BusinessConsultant1Member_zb4stVNnNan2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Business consultant</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">144,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0727">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--EmployeeStockOptionsMember_z3R4XFDAQDeg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Employee and consultant options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,839</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">29,289</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--ShareBasedCompensationAmount_zat3CRPwoiMb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">483,351</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,953</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zeL1ynob4Da9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize information about stock options outstanding as of July 31, 2023 and April 30, 2023:</span></p> <p id="xdx_89B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zdYtpMWF6mI7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B8_zYpRy6H8wZK4" style="display: none">Schedule of stock options outstanding</span></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_307_134_z5sMErLztljg" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock-Based Compensation Plans (Details 1)"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Outstanding </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Exercisable</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prices</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life (Years)</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.40 - $10.50</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zQ2HoXgHhlh3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230501__20230731__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zKekonKz0vJ9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.35</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zDthwDQ9i30j" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_zlHPUucSGFCe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,458</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_z0pt3zQzbgBc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.78</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.40 - $10.50</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zf9j7ps5xLUg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220501__20230430__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zYkt8OUH2C77" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.63</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_za8sDru3dygc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_zcO9s6Ps5tnl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">294,333</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_zmFY4LTG6Fr9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.69</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zGj9VUiFYRW4" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_890_eus-gaap--ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_zu3CZro608S3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zmpSjezr3Bo" style="display: none">Schedule of stock options activity</span></b></span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_300_134_z2VllYKIpPWb" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock-Based Compensation Plans (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of <br/> Shares</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price <br/> Per Share</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average <br/> Exercise <br/> Price</span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding May 1, 2022</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaK0fLEoFyn8" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWaNXWuimxm3" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10.50</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvMn9NBVXlO5" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zALwBJJjk1pa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,950,000</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--StockOptionExercisePriceIssued_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zCkg3UwVZ379">1.40</span>-</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--StockOptionExercisePriceIssued_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zU0JLDn625Lg">1.43</span></span></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6Hb4TVNMDoh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.42</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zr4ct1cN9718" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,000)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_901_ecustom--StockOptionExercisePriceExercised_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zDndAmt2yNe4">10.50</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zseczXUyH9l1" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2AZNpJgtkcf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_907_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_ziOq9R7TMvCk">1.40</span> - $<span id="xdx_909_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z9UpAmtYiRM8"><span id="xdx_909_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zT2m989CAR12">10.50</span></span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3f6MSdtP7yj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8md39LmDnU5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0763">—</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjmyl2oiNR43" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0764">—</span></span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zCi0BMV03q5i" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0765">—</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAZt2XVVEP97" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0766">—</span></span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options outstanding July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8ofMjKLx9g2" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_ecustom--StockOptionExercisePriceOne_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zIZyCTYfwd18">1.40</span>- <span id="xdx_900_ecustom--StockOptionExercisePriceOne_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zF1nmFqH2uCa">10.50</span></span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPs1oinHuvH4" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options exercisable, July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYybyQAtq2d3" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,458</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_ecustom--ExercisePricePerShareExercisable_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zbZ9S4OGP4Fe">1.40</span>-</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ExercisePricePerShareExercisable_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zlS1vvujZZwb">10.50</span></span></p></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm3l4IQBBbR" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.78</span></td> </tr> </table> <p id="xdx_8AD_zhDxAJn4wq9j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zhdCeSs3hz4" style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z3hec9og4D44" style="display: none">Schedule of stock-based compensation expense</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_z0aIXWeoTsd4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-Based Compensation Plans (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"></td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="3" id="xdx_499_20230501__20230731_zJ9fLANuZBrj" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2023</td><td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="3" id="xdx_490_20220501__20220731_zhSXn5Zjt1tl" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended July 31, 2022</td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z7YeRxmoYu63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt">Chief Executive Officer</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">62,494</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">—</span>  </td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zXdnq8nPuXr5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Chief Financial Officer</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,915</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,443</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerOfSubsidiaryMember_zMJLSzu7cdq" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Chief Executive Officer of subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,221</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--FounderMember_z4esHkSbFZS4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Founder</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,915</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--ThirdPartyContractorMember_zjwEgcBmWoac" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Third-party contractor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,829</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0721">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--BusinessConsultantMember_zlJSyVxk6F36" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Business consultant</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">141,151</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--BusinessConsultant1Member_zb4stVNnNan2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Business consultant</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">144,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0727">—</span>  </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ShareBasedCompensation_hsrt--TitleOfIndividualAxis__custom--EmployeeStockOptionsMember_z3R4XFDAQDeg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Employee and consultant options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,839</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">29,289</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--ShareBasedCompensationAmount_zat3CRPwoiMb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">483,351</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">32,953</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 62494 14915 2443 1208 1221 14915 58829 141151 144000 45839 29289 483351 32953 <p id="xdx_89B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_zdYtpMWF6mI7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B8_zYpRy6H8wZK4" style="display: none">Schedule of stock options outstanding</span></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_307_134_z5sMErLztljg" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock-Based Compensation Plans (Details 1)"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Outstanding </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options Exercisable</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prices</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life (Years)</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.40 - $10.50</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zQ2HoXgHhlh3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230501__20230731__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zKekonKz0vJ9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.35</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zDthwDQ9i30j" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_zlHPUucSGFCe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,458</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230731__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_z0pt3zQzbgBc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.78</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2023</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.40 - $10.50</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zf9j7ps5xLUg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220501__20230430__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_zYkt8OUH2C77" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.63</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__custom--OptionsOutstandingMember_za8sDru3dygc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_zcO9s6Ps5tnl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">294,333</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__custom--OptionsExercisableMember_zmFY4LTG6Fr9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.69</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2202000 P9Y4M6D 2.46 344458 3.78 2202000 P9Y7M17D 2.46 294333 3.69 <p id="xdx_890_eus-gaap--ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_zu3CZro608S3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zmpSjezr3Bo" style="display: none">Schedule of stock options activity</span></b></span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_300_134_z2VllYKIpPWb" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock-Based Compensation Plans (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of <br/> Shares</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price <br/> Per Share</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average <br/> Exercise <br/> Price</span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding May 1, 2022</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaK0fLEoFyn8" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWaNXWuimxm3" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10.50</span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvMn9NBVXlO5" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zALwBJJjk1pa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,950,000</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--StockOptionExercisePriceIssued_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zCkg3UwVZ379">1.40</span>-</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--StockOptionExercisePriceIssued_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zU0JLDn625Lg">1.43</span></span></p></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6Hb4TVNMDoh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.42</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during year ended April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zr4ct1cN9718" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,000)</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_901_ecustom--StockOptionExercisePriceExercised_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zDndAmt2yNe4">10.50</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220501__20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zseczXUyH9l1" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding April 30, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2AZNpJgtkcf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_907_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_ziOq9R7TMvCk">1.40</span> - $<span id="xdx_909_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z9UpAmtYiRM8"><span id="xdx_909_ecustom--StockOptionExercisePrice_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zT2m989CAR12">10.50</span></span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions_iI_c20230430__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3f6MSdtP7yj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8md39LmDnU5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0763">—</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjmyl2oiNR43" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0764">—</span></span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/canceled during quarter ended July 31, 2023</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zCi0BMV03q5i" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0765">—</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAZt2XVVEP97" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0766">—</span></span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options outstanding July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8ofMjKLx9g2" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,202,000</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_ecustom--StockOptionExercisePriceOne_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zIZyCTYfwd18">1.40</span>- <span id="xdx_900_ecustom--StockOptionExercisePriceOne_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zF1nmFqH2uCa">10.50</span></span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPs1oinHuvH4" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46</span></td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options exercisable, July 31, 2023</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYybyQAtq2d3" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,458</span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_ecustom--ExercisePricePerShareExercisable_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zbZ9S4OGP4Fe">1.40</span>-</span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ExercisePricePerShareExercisable_iI_c20230731__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zlS1vvujZZwb">10.50</span></span></p></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm3l4IQBBbR" style="border-bottom: Black 2.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.78</span></td> </tr> </table> 271000 10.50 10.50 1950000 1.40 1.43 1.42 -19000 10.50 10.50 2202000 1.40 10.50 10.50 2.46 2202000 1.40 10.50 2.46 344458 1.40 10.50 3.78 <p id="xdx_802_ecustom--DepositsAndCommitmentsTextBlock_z0jEYADOKxB1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_82E_zm6DYu3MTZFl">Deposits and Commitments</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We utilize a virtual office at 1 Lincoln Street in Boston, Massachusetts. We pay a membership fee of approximately $5,700 a month, which increases to approximately $6,100 a month in October 2023, under a virtual office agreement that expires in March 2025 and includes a deposit of $6,300.</span></p> <p style="margin: 0 0.25in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zNjd7MOhmhF7" style="margin: 0 0.25in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_821_zbb9GpUAumHk">Intangible Assets</span></b></span></p> <p style="margin: 0 0.25in 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets with defined useful lives are generally measured at cost less straight-line amortization. The useful life is determined using the period of the underlying contract or the period of time over which the intangible asset can be expected to be used. Impairments are recognized if the recoverable amount of the asset is lower than the carrying amount. The recoverable amount is the higher of either the fair value less costs to sell or the value in use. The value in use is determined on the basis of future cash inflows and outflows, and the weighted average cost of capital. Intangible assets with indefinite useful lives, such as trade names and trademarks, that have been acquired as part of acquisitions are measured at cost and tested for impairment annually, or if there is an indication that their value has declined.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the major categories of the intangible assets as of July 31, 2023 and April 30, 2023 </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zz1oXDtNFXve" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zH6yctDiOac4" style="display: none">Schedule of intangible assets</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zxAYieU6HDe4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">April 30, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; text-indent: -10pt; padding-left: 10pt">Acquired users</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredUsersMember_zSpOmOD90HJ1" style="width: 12%; text-align: right">14,288,695</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredUsersMember_zfTyTaZ6Q8C5" style="width: 12%; text-align: right">14,288,695</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Acquired brand</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredBrandMember_zUjgDLclZql2" style="text-align: right">583,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredBrandMember_zkbBTvcK9Iw4" style="text-align: right">583,429</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Acquired intellectual property and website</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredIntellectualPropertyAndWebsiteMember_z0ZAcUeBfY9h" style="text-align: right">435,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredIntellectualPropertyAndWebsiteMember_zF7R30qW27Uc" style="text-align: right">435,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Professional practice</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalPracticeMember_zSqNHxd2nVG1" style="text-align: right">556,830</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalPracticeMember_zurSdSQ1HDy1" style="text-align: right">556,830</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Literary works and contracts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LiteraryWorksAndContractsMember_zBUXknsiWbl8" style="border-bottom: Black 1pt solid; text-align: right">107,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LiteraryWorksAndContractsMember_ziCf3h8TIIuj" style="border-bottom: Black 1pt solid; text-align: right">107,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zNTZRvK1isQ5" style="border-bottom: Black 2.5pt double; text-align: right">15,971,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430_zyvRfeaWjaNk" style="border-bottom: Black 2.5pt double; text-align: right">15,971,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zVDpUPdhPcW5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of July 31, 2023, the weighted average remaining useful life for technology, trade names, professional practice, literary works and domains is 14.09 years. Accumulated amortization amounted to $124,738 as of July 31, 2023, resulting in net intangible assets of $15,846,966.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zz1oXDtNFXve" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zH6yctDiOac4" style="display: none">Schedule of intangible assets</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zxAYieU6HDe4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">July 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">April 30, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; text-indent: -10pt; padding-left: 10pt">Acquired users</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredUsersMember_zSpOmOD90HJ1" style="width: 12%; text-align: right">14,288,695</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredUsersMember_zfTyTaZ6Q8C5" style="width: 12%; text-align: right">14,288,695</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Acquired brand</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredBrandMember_zUjgDLclZql2" style="text-align: right">583,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredBrandMember_zkbBTvcK9Iw4" style="text-align: right">583,429</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Acquired intellectual property and website</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredIntellectualPropertyAndWebsiteMember_z0ZAcUeBfY9h" style="text-align: right">435,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredIntellectualPropertyAndWebsiteMember_zF7R30qW27Uc" style="text-align: right">435,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Professional practice</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalPracticeMember_zSqNHxd2nVG1" style="text-align: right">556,830</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalPracticeMember_zurSdSQ1HDy1" style="text-align: right">556,830</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Literary works and contracts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LiteraryWorksAndContractsMember_zBUXknsiWbl8" style="border-bottom: Black 1pt solid; text-align: right">107,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LiteraryWorksAndContractsMember_ziCf3h8TIIuj" style="border-bottom: Black 1pt solid; text-align: right">107,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zNTZRvK1isQ5" style="border-bottom: Black 2.5pt double; text-align: right">15,971,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230430_zyvRfeaWjaNk" style="border-bottom: Black 2.5pt double; text-align: right">15,971,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14288695 14288695 583429 583429 435000 435000 556830 556830 107750 107750 15971704 15971704 <p id="xdx_802_eus-gaap--EquityMethodInvestmentsTextBlock_zHJPWcb2lWPh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13 – <span id="xdx_824_zmUJhL5n3Dwk">Investments</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2023, the Company received 2,853,659 units of RealWorld LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2023, the Company received 2,853,659 units of HeadFarm LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2023, the Company received 2,853,659 units of CupCrew LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2023, the Company received 2,853,659 units of CountSharp LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.41 per unit based on a sales price of $0.41 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,170,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,853,659 units which are valued at $1,170,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023, the Company received 2,100,000 units of Dark LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $1.00 per unit based on a sales price of $1.00 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $2,100,000. As of July 31, 2023 and April 30, 2023, the Company owned 2,100,000 units which are valued at $2,100,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2022, the Company received 1,911,765 units of NetWire LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.68 per unit based on a sales price of $0.68 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,300,000. As of July 31, 2023 and April 30, 2023, the Company owned 1,911,765 units which are valued at $1,300,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company received 1,764,706 units of Reper LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.68 per unit based on a sales price of $0.68 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,200,000. As of July 31, 2023 and April 30, 2023, the Company owned 1,764,706 units which are valued at $1,200,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2022, the Company received 3,000,000 units of Cust Corp. as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.40 per unit based on a sales price of $0.40 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $1,200,000. As of July 31, 2023 and April 30, 2023, the Company owned 3,000,000 units which are valued at $1,200,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2022, the Company received 1,700,000 units of ScanHash LLC as a payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.25 per unit based on a sales price of $0.25 per unit on an online funding portal. The receipt of the units satisfied $425,000 of an accounts receivable balance. As of July 31, 2023 and April 30, 2023, the Company owned 1,700,000 units which are valued at $425,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2022, the Company received 2,850,000 units of Hiveskill LLC as payment for services rendered in conjunction with a crowdfunding offering. The units are valued at $0.25 per unit based on a sales price of $0.25 per unit on an online funding portal. The receipt of the units satisfied an accounts receivable balance of $712,500. As of July 31, 2023 and April 30, 2023, the Company owned 2,850,000 units which are valued at $712,500.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In fiscal 2022, the Company purchased a 10% interest, or 400 shares of common stock, in Caesar Media Group Inc. (“Caesar”) for an initial purchase price of 50,000 shares of the Company’s common stock, valued at $500,000. Caesar is a marketing and technology solutions provider. The purchase agreement includes additional contractual requirements for the Company and Caesar, including the issuance of an additional 150,000 shares of common stock of the Company over a two-year period. The Company issued 37,500 shares of its common stock in April 2022, 25,000 shares of its common stock in September 2022, 12,500 shares of its common stock in October 2022, 18,750 shares of its common stock in January 2023, 18,750 shares of its common stock in April 2023, and 18,750 shares of its common stock in July 2023, as part of its contractual payment obligations. As of July 31, 2023 and April 30, 2023, there have been no observable price changes in the value of Caesar’s common stock and the Company has valued its ownership in Caesar at cost, which amounted to $1,815,939 and $1,632,751 as of July 31, 2023 and April 30, 2023, respectively.</span></p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In August 2020 the Company entered a consulting agreement with C-Reveal Therapeutics LLC (“CRT”). for a $120,000 fee over a 12-month period. $50,000 of the fee was payable in CRT units. As of July 31, 2023 and April 30, 2023, the Company owned 5,000 units, at a value of $50,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2020, the Company entered a consulting contract with MustWatch LLC (“MW”), which allowed the Company to receive 110,000 membership interest units of MW in return for services rendered in conjunction with a crowdfunding offering. The Company earned 97,500 membership interest units in the quarter ended July 31, 2020, valued at $2.14 per unit, or $235,400. As of April 30, 2023, the MW units are valued at $4 per unit based on a sales price of $4 per unit on an online funding portal. As of July 31, 2023 and April 30, 2023, the Company owned 110,000 MW units, which are valued at $440,000.</p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2020, the Company entered into a consulting contract with ChipBrain LLC (“Chip”), which allowed the Company to receive 710,200 membership interest units of Chip in return for services rendered in conjunction with a crowdfunding offering. The Chip units are valued at $4.74 per unit, based on a sales price of $4.74 per unit on an online funding portal. As of July 31, 2023 and April 30, 2023, the units owned by the Company are valued at $3,366,348.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2020, the Company entered a consulting contract with a related party, Zelgor Inc. (“Zelgor”), which allowed the Company to receive 1,400,000 shares of common stock of Zelgor in return for services rendered in conjunction with a crowdfunding offering. The Zelgor shares are valued at $1.00 per share based on a sales price of $1.00 per share on an online funding portal. As of July 31, 2023 and April 30, 2023, the Company owned 1,400,000 shares which are valued at $1,400,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 2, 2020, the Company entered a consulting contract with Deuce Drone LLC (“Drone”), which allowed the Company to receive up to 2,350,000 membership interest units of Drone in return for consulting services. The Drone units are valued at $1.00 per share based on a sales price of $1.00 per share on an online funding portal. As of July 31, 2023 and April 30, 2023, the units owned by the Company are valued at $2,350,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2019, the Company entered a consulting contract with KingsCrowd LLC (“KingsCrowd”), which allowed the Company to receive 300,000 membership interest units of KingsCrowd in return for services rendered in conjunction with a crowdfunding offering. The KingsCrowd units were valued at $1.80 per unit based on a sales price of $1.80 per unit when the units were earned, or $540,000. In December 2020, KingsCrowd converted from a limited liability company to a corporation to facilitate raising capital under Regulation A. KingsCrowd filed a Form 1-A Offering Statement under the Securities Act of 1933 and sold shares at $1.00 per share. In connection with the conversion to a corporation, each membership interest unit converted into 12.71915 shares of common stock, and the Company recorded an unrealized gain of $3,275,745 for the year ended April 30, 2022. The Company sold 606,060 shares of KingsCrowd in June 2022 for proceeds of $200,000 and recorded a realized loss on the sale of the investment of $406,060. KingsCrowd filed a post qualification offering circular amendment on July 21, 2022 and continued to sell shares of stock to the public for $1.00 per share. As of July 31, 2023 and April 30, 2023, the Company owned 3,209,685 shares of KingsCrowd, valued at $3,209,685, respectively.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During fiscal 2019, the Company entered into a consulting contract with Netcapital Systems LLC, a related party, and earned membership interest units. As of July 31, 2023 and April 30, 2023, the Company owned 528 units, at a value of $48,128.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In July 2020 the Company entered into a consulting agreement with Vymedic, Inc. for a $40,000 fee over a 5-month period. Half the fee was payable in stock and half was payable in cash. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 31, 2023 and April 30, 2023 the Company owned 4,000 units, at a value of $11,032.</span></p> <p style="margin: 0; text-align: justify"> </p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the components of investments as of July 31, 2023 and April 30, 2023:</span></p> <p style="margin: 0; text-align: justify"> </p> <p id="xdx_89C_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zJGXoQHZHFfe" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zcLMQ0gubc0g" style="display: none">Schedule of investments</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zgBlOJUe0Rr9" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Investments (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netcapital Systems LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--NetcapitalSystemsLLCMember_z2QI2NzKKNz7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,128</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--NetcapitalSystemsLLCMember_z2UJNhY9qMS9" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,128</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MustWatch LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--MustWatchLLCMember_zIp91pttnlTj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--MustWatchLLCMember_zn5cKHVx80Bj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zelgor Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ZelgorIncMember_zyzvC1jWJkw4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ZelgorIncMember_zslcfk9Z6Puh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ChipBrain LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ChipBrainLLCMember_zOSRHlrkQXFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,366,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ChipBrainLLCMember_zwl7okTXa6V7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,366,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vymedic Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--VymedicIncMember_z7W56vs3wce9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--VymedicIncMember_zzzogI7aqr6h" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-Reveal Therapeutics LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CRevealTherapeuticsLLCMember_z9H0ypcJoHR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CRevealTherapeuticsLLCMember_zIuqqDPpwmBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deuce Drone LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--DeuceDroneLLCMember_z3mEPs2NFeff" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,350,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--DeuceDroneLLCMember_zKTZeHayyfZa" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,350,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hiveskill LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--HiveskillLLCMember_z6zY5SQ2W49" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--HiveskillLLCMember_zCeTMBOWcRnj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ScanHash LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ScanHashLLCMember_zMpuv0zZ2UH6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ScanHashLLCMember_zV2glrcMqQF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caesar Media Group Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CaesarMediaGroupIncMember_zgopwaYKtkna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,815,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CaesarMediaGroupIncMember_zotnjD3pTzd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,632,751</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cust Corp.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CustCorpMember_zmkQ9p50q8nd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CustCorpMember_ze8GoHb8mEd9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kingscrowd Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--KingscrowdIncMember_zFBbcdXHvZEl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,209,685</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--KingscrowdIncMember_zEYa4pwuz2pd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,209,685</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reper LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ReperLLCMember_zdi08ebuNMEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ReperLLCMember_zf90zF0m6zX4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dark LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--DarkLLCMember_zoHlpS5oQVT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--DarkLLCMember_zv7tOVisFeFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netwire LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--NetwireLLCMember_zJHpFktvLJx2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--NetwireLLCMember_zustxrTRMP89" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CountSharp LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CountSharpLLCMember_zGTf8oE6uiJc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CountSharpLLCMember_zN3i5c8y64X2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CupCrew LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CupCrewLLCMember_zWX7fBzeBSn9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CupCrewLLCMember_zq0481o8aX4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HeadFarm LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--HeadFarmLLCMember_zvFVzMt1ylW9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--HeadFarmLLCMember_zqMCatMXe0Lj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RealWorld LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--RealWorldLLCMember_zfQQXoX3Mqpa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--RealWorldLLCMember_z3AD7yYXdoX3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0834">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtCost_iI_c20230731_zO2LXRRYhFU2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,308,632</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230430_zDAZgjvh0tvd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,955,444</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"></p><p id="xdx_8A3_zjioadTVnyX" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above investments in equity securities are within the scope of ASC 321. The Company monitors the investments for any changes in observable prices from orderly transactions. All investments are initially measured at cost and evaluated for changes in estimated fair value.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_zJGXoQHZHFfe" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zcLMQ0gubc0g" style="display: none">Schedule of investments</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zgBlOJUe0Rr9" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Investments (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netcapital Systems LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--NetcapitalSystemsLLCMember_z2QI2NzKKNz7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,128</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--NetcapitalSystemsLLCMember_z2UJNhY9qMS9" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,128</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MustWatch LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--MustWatchLLCMember_zIp91pttnlTj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--MustWatchLLCMember_zn5cKHVx80Bj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zelgor Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ZelgorIncMember_zyzvC1jWJkw4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ZelgorIncMember_zslcfk9Z6Puh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ChipBrain LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ChipBrainLLCMember_zOSRHlrkQXFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,366,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ChipBrainLLCMember_zwl7okTXa6V7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,366,348</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vymedic Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--VymedicIncMember_z7W56vs3wce9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--VymedicIncMember_zzzogI7aqr6h" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-Reveal Therapeutics LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CRevealTherapeuticsLLCMember_z9H0ypcJoHR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CRevealTherapeuticsLLCMember_zIuqqDPpwmBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deuce Drone LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--DeuceDroneLLCMember_z3mEPs2NFeff" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,350,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--DeuceDroneLLCMember_zKTZeHayyfZa" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,350,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hiveskill LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--HiveskillLLCMember_z6zY5SQ2W49" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--HiveskillLLCMember_zCeTMBOWcRnj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ScanHash LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ScanHashLLCMember_zMpuv0zZ2UH6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ScanHashLLCMember_zV2glrcMqQF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caesar Media Group Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CaesarMediaGroupIncMember_zgopwaYKtkna" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,815,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CaesarMediaGroupIncMember_zotnjD3pTzd5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,632,751</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cust Corp.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CustCorpMember_zmkQ9p50q8nd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CustCorpMember_ze8GoHb8mEd9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kingscrowd Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--KingscrowdIncMember_zFBbcdXHvZEl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,209,685</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--KingscrowdIncMember_zEYa4pwuz2pd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,209,685</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reper LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--ReperLLCMember_zdi08ebuNMEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--ReperLLCMember_zf90zF0m6zX4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dark LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--DarkLLCMember_zoHlpS5oQVT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--DarkLLCMember_zv7tOVisFeFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netwire LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--NetwireLLCMember_zJHpFktvLJx2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--NetwireLLCMember_zustxrTRMP89" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CountSharp LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CountSharpLLCMember_zGTf8oE6uiJc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CountSharpLLCMember_zN3i5c8y64X2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CupCrew LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--CupCrewLLCMember_zWX7fBzeBSn9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--CupCrewLLCMember_zq0481o8aX4i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HeadFarm LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--HeadFarmLLCMember_zvFVzMt1ylW9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--HeadFarmLLCMember_zqMCatMXe0Lj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RealWorld LLC</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtCost_iI_c20230731__srt--CounterpartyNameAxis__custom--RealWorldLLCMember_zfQQXoX3Mqpa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,170,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--InvestmentOwnedAtCost_iI_c20230430__srt--CounterpartyNameAxis__custom--RealWorldLLCMember_z3AD7yYXdoX3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0834">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtCost_iI_c20230731_zO2LXRRYhFU2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,308,632</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20230430_zDAZgjvh0tvd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,955,444</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"></p> 48128 48128 440000 440000 1400000 1400000 3366348 3366348 11032 11032 50000 50000 2350000 2350000 712500 712500 425000 425000 1815939 1632751 1200000 1200000 3209685 3209685 1200000 1200000 2100000 2100000 1300000 1300000 1170000 1170000 1170000 1170000 1170000 1170000 1170000 24308632 22955444 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z1eoxXd0CDY3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14 – <span id="xdx_820_zjkWN44Onpvh">Subsequent Events</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated subsequent events through the date these financial statements were available to be issued.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no material subsequent events that required recognition or additional disclosure in these financial statements.</span></p> EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 54 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 168 205 1 false 51 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://ncpl/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://ncpl/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://ncpl/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://ncpl/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Sheet http://ncpl/role/StatementsOfChangesInStockholdersEquity STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - Basis of Presentatio Sheet http://ncpl/role/BasisOfPresentatio Basis of Presentatio Notes 7 false false R8.htm 00000008 - Disclosure - Concentrations Sheet http://ncpl/role/Concentrations Concentrations Notes 8 false false R9.htm 00000009 - Disclosure - Revenue Recognition Sheet http://ncpl/role/RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 00000010 - Disclosure - Earnings Per Common Share Sheet http://ncpl/role/EarningsPerCommonShare Earnings Per Common Share Notes 10 false false R11.htm 00000011 - Disclosure - Principal Financing Arrangements Sheet http://ncpl/role/PrincipalFinancingArrangements Principal Financing Arrangements Notes 11 false false R12.htm 00000012 - Disclosure - Income Taxes Sheet http://ncpl/role/IncomeTaxes Income Taxes Notes 12 false false R13.htm 00000013 - Disclosure - Related Party Transactions Sheet http://ncpl/role/RelatedPartyTransactions Related Party Transactions Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders??? Equity Sheet http://ncpl/role/StockholdersEquity Stockholders??? Equity Notes 14 false false R15.htm 00000015 - Disclosure - Fair Value Sheet http://ncpl/role/FairValue Fair Value Notes 15 false false R16.htm 00000016 - Disclosure - Stock-Based Compensation Plans Sheet http://ncpl/role/Stock-basedCompensationPlans Stock-Based Compensation Plans Notes 16 false false R17.htm 00000017 - Disclosure - Deposits and Commitments Sheet http://ncpl/role/DepositsAndCommitments Deposits and Commitments Notes 17 false false R18.htm 00000018 - Disclosure - Intangible Assets Sheet http://ncpl/role/IntangibleAssets Intangible Assets Notes 18 false false R19.htm 00000019 - Disclosure - Investments Sheet http://ncpl/role/Investments Investments Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://ncpl/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Revenue Recognition (Tables) Sheet http://ncpl/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://ncpl/role/RevenueRecognition 21 false false R22.htm 00000022 - Disclosure - Earnings Per Common Share (Tables) Sheet http://ncpl/role/EarningsPerCommonShareTables Earnings Per Common Share (Tables) Tables http://ncpl/role/EarningsPerCommonShare 22 false false R23.htm 00000023 - Disclosure - Principal Financing Arrangements (Tables) Sheet http://ncpl/role/PrincipalFinancingArrangementsTables Principal Financing Arrangements (Tables) Tables http://ncpl/role/PrincipalFinancingArrangements 23 false false R24.htm 00000024 - Disclosure - Income Taxes (Tables) Sheet http://ncpl/role/IncomeTaxesTables Income Taxes (Tables) Tables http://ncpl/role/IncomeTaxes 24 false false R25.htm 00000025 - Disclosure - Stockholders??? Equity (Tables) Sheet http://ncpl/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://ncpl/role/StockholdersEquity 25 false false R26.htm 00000026 - Disclosure - Stock-Based Compensation Plans (Tables) Sheet http://ncpl/role/Stock-basedCompensationPlansTables Stock-Based Compensation Plans (Tables) Tables http://ncpl/role/Stock-basedCompensationPlans 26 false false R27.htm 00000027 - Disclosure - Intangible Assets (Tables) Sheet http://ncpl/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://ncpl/role/IntangibleAssets 27 false false R28.htm 00000028 - Disclosure - Investments (Tables) Sheet http://ncpl/role/InvestmentsTables Investments (Tables) Tables http://ncpl/role/Investments 28 false false R29.htm 00000029 - Disclosure - Revenue Recognition (Details) Sheet http://ncpl/role/RevenueRecognitionDetails Revenue Recognition (Details) Details http://ncpl/role/RevenueRecognitionTables 29 false false R30.htm 00000030 - Disclosure - Revenue Recognition (Details Narrative) Sheet http://ncpl/role/RevenueRecognitionDetailsNarrative Revenue Recognition (Details Narrative) Details http://ncpl/role/RevenueRecognitionTables 30 false false R31.htm 00000031 - Disclosure - Earnings Per Common Share (Details) Sheet http://ncpl/role/EarningsPerCommonShareDetails Earnings Per Common Share (Details) Details http://ncpl/role/EarningsPerCommonShareTables 31 false false R32.htm 00000032 - Disclosure - Principal Financing Arrangements (Details) Sheet http://ncpl/role/PrincipalFinancingArrangementsDetails Principal Financing Arrangements (Details) Details http://ncpl/role/PrincipalFinancingArrangementsTables 32 false false R33.htm 00000033 - Disclosure - Income Taxes (Details) Sheet http://ncpl/role/IncomeTaxesDetails Income Taxes (Details) Details http://ncpl/role/IncomeTaxesTables 33 false false R34.htm 00000034 - Disclosure - Stockholders Equity (Details) Sheet http://ncpl/role/StockholdersEquityDetails Stockholders Equity (Details) Details 34 false false R35.htm 00000035 - Disclosure - Stockholders Equity (Details 1) Sheet http://ncpl/role/StockholdersEquityDetails1 Stockholders Equity (Details 1) Details 35 false false R36.htm 00000036 - Disclosure - Stock-Based Compensation Plans (Details) Sheet http://ncpl/role/Stock-basedCompensationPlansDetails Stock-Based Compensation Plans (Details) Details http://ncpl/role/Stock-basedCompensationPlansTables 36 false false R37.htm 00000037 - Disclosure - Stock-Based Compensation Plans (Details 1) Sheet http://ncpl/role/Stock-basedCompensationPlansDetails1 Stock-Based Compensation Plans (Details 1) Details http://ncpl/role/Stock-basedCompensationPlansTables 37 false false R38.htm 00000038 - Disclosure - Stock-Based Compensation Plans (Details 2) Sheet http://ncpl/role/Stock-basedCompensationPlansDetails2 Stock-Based Compensation Plans (Details 2) Details http://ncpl/role/Stock-basedCompensationPlansTables 38 false false R39.htm 00000039 - Disclosure - Intangible Assets (Details) Sheet http://ncpl/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://ncpl/role/IntangibleAssetsTables 39 false false R40.htm 00000040 - Disclosure - Investments (Details) Sheet http://ncpl/role/InvestmentsDetails Investments (Details) Details http://ncpl/role/InvestmentsTables 40 false false All Reports Book All Reports ncpl_10q.htm ex31_1.htm ex31_2.htm ex32_1.htm ex32_2.htm ncpl-20230731.xsd ncpl-20230731_cal.xml ncpl-20230731_def.xml ncpl-20230731_lab.xml ncpl-20230731_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 58 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ncpl_10q.htm": { "axisCustom": 0, "axisStandard": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 424, "http://xbrl.sec.gov/dei/2022": 26 }, "contextCount": 168, "dts": { "calculationLink": { "local": [ "ncpl-20230731_cal.xml" ] }, "definitionLink": { "local": [ "ncpl-20230731_def.xml" ] }, "inline": { "local": [ "ncpl_10q.htm" ] }, "labelLink": { "local": [ "ncpl-20230731_lab.xml" ] }, "presentationLink": { "local": [ "ncpl-20230731_pre.xml" ] }, "schema": { "local": [ "ncpl-20230731.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 357, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 58, "http://ncpl/20230731": 32, "http://xbrl.sec.gov/dei/2022": 5, "total": 95 }, "keyCustom": 61, "keyStandard": 144, "memberCustom": 41, "memberStandard": 10, "nsprefix": "ncpl", "nsuri": "http://ncpl/20230731", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ncpl/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Earnings Per Common Share", "menuCat": "Notes", "order": "10", "role": "http://ncpl/role/EarningsPerCommonShare", "shortName": "Earnings Per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:PrincipalFinancingArrangementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Principal Financing Arrangements", "menuCat": "Notes", "order": "11", "role": "http://ncpl/role/PrincipalFinancingArrangements", "shortName": "Principal Financing Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:PrincipalFinancingArrangementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "12", "role": "http://ncpl/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "13", "role": "http://ncpl/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "14", "role": "http://ncpl/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Fair Value", "menuCat": "Notes", "order": "15", "role": "http://ncpl/role/FairValue", "shortName": "Fair Value", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Stock-Based Compensation Plans", "menuCat": "Notes", "order": "16", "role": "http://ncpl/role/Stock-basedCompensationPlans", "shortName": "Stock-Based Compensation Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:DepositsAndCommitmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Deposits and Commitments", "menuCat": "Notes", "order": "17", "role": "http://ncpl/role/DepositsAndCommitments", "shortName": "Deposits and Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:DepositsAndCommitmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Intangible Assets", "menuCat": "Notes", "order": "18", "role": "http://ncpl/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Investments", "menuCat": "Notes", "order": "19", "role": "http://ncpl/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://ncpl/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "20", "role": "http://ncpl/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ncpl:RevenueRecognitionTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Revenue Recognition (Tables)", "menuCat": "Tables", "order": "21", "role": "http://ncpl/role/RevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ncpl:RevenueRecognitionTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Earnings Per Common Share (Tables)", "menuCat": "Tables", "order": "22", "role": "http://ncpl/role/EarningsPerCommonShareTables", "shortName": "Earnings Per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ncpl:PrincipalFinancingArrangementsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Principal Financing Arrangements (Tables)", "menuCat": "Tables", "order": "23", "role": "http://ncpl/role/PrincipalFinancingArrangementsTables", "shortName": "Principal Financing Arrangements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ncpl:PrincipalFinancingArrangementsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "24", "role": "http://ncpl/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:ScheduleOfWarrntsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Stockholders\u2019 Equity (Tables)", "menuCat": "Tables", "order": "25", "role": "http://ncpl/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:ScheduleOfWarrntsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Stock-Based Compensation Plans (Tables)", "menuCat": "Tables", "order": "26", "role": "http://ncpl/role/Stock-basedCompensationPlansTables", "shortName": "Stock-Based Compensation Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Intangible Assets (Tables)", "menuCat": "Tables", "order": "27", "role": "http://ncpl/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "28", "role": "http://ncpl/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Revenue Recognition (Details)", "menuCat": "Details", "order": "29", "role": "http://ncpl/role/RevenueRecognitionDetails", "shortName": "Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ncpl:RevenueRecognitionTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-012023-07-31_custom_ConsultingServicesMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ncpl/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ncpl:RevenueRecognitionTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Revenue Recognition (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://ncpl/role/RevenueRecognitionDetailsNarrative", "shortName": "Revenue Recognition (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ncpl:RevenueRecognitionTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Earnings Per Common Share (Details)", "menuCat": "Details", "order": "31", "role": "http://ncpl/role/EarningsPerCommonShareDetails", "shortName": "Earnings Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ncpl:PrincipalFinancingArrangementsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Principal Financing Arrangements (Details)", "menuCat": "Details", "order": "32", "role": "http://ncpl/role/PrincipalFinancingArrangementsDetails", "shortName": "Principal Financing Arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ncpl:PrincipalFinancingArrangementsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "33", "role": "http://ncpl/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ncpl:ScheduleOfWarrntsRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Stockholders Equity (Details)", "menuCat": "Details", "order": "34", "role": "http://ncpl/role/StockholdersEquityDetails", "shortName": "Stockholders Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ncpl:ScheduleOfWarrntsRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-012023-07-31_us-gaap_WarrantMember", "decimals": null, "lang": "en-US", "name": "ncpl:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ncpl:ScheduleOfWarrantsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-012023-07-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Stockholders Equity (Details 1)", "menuCat": "Details", "order": "35", "role": "http://ncpl/role/StockholdersEquityDetails1", "shortName": "Stockholders Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ncpl:ScheduleOfWarrantsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2022-05-012023-04-30_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "ncpl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Stock-Based Compensation Plans (Details)", "menuCat": "Details", "order": "36", "role": "http://ncpl/role/Stock-basedCompensationPlansDetails", "shortName": "Stock-Based Compensation Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "lang": null, "name": "ncpl:ShareBasedCompensationAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31_custom_OptionsOutstandingMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Stock-Based Compensation Plans (Details 1)", "menuCat": "Details", "order": "37", "role": "http://ncpl/role/Stock-basedCompensationPlansDetails1", "shortName": "Stock-Based Compensation Plans (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31_custom_OptionsOutstandingMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ncpl:ScheduleOfWarrntsRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Stock-Based Compensation Plans (Details 2)", "menuCat": "Details", "order": "38", "role": "http://ncpl/role/Stock-basedCompensationPlansDetails2", "shortName": "Stock-Based Compensation Plans (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2022-05-012023-04-30_us-gaap_StockOptionMember", "decimals": "INF", "lang": null, "name": "ncpl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Intangible Assets (Details)", "menuCat": "Details", "order": "39", "role": "http://ncpl/role/IntangibleAssetsDetails", "shortName": "Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://ncpl/role/CondensedConsolidatedStatementsOfOperations", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:EquityMethodInvestmentsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Investments (Details)", "menuCat": "Details", "order": "40", "role": "http://ncpl/role/InvestmentsDetails", "shortName": "Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:EquityMethodInvestmentsTextBlock", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2022-04-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY", "menuCat": "Statements", "order": "5", "role": "http://ncpl/role/StatementsOfChangesInStockholdersEquity", "shortName": "STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "AsOf2022-04-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": "0", "lang": null, "name": "ncpl:ReceiptOfEquityInLieuOfCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Basis of Presentatio", "menuCat": "Notes", "order": "7", "role": "http://ncpl/role/BasisOfPresentatio", "shortName": "Basis of Presentatio", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Concentrations", "menuCat": "Notes", "order": "8", "role": "http://ncpl/role/Concentrations", "shortName": "Concentrations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:RevenueRecognitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Revenue Recognition", "menuCat": "Notes", "order": "9", "role": "http://ncpl/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ncpl_10q.htm", "contextRef": "From2023-05-01to2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "ncpl:RevenueRecognitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 51, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r365", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ncpl/role/Cover" ], "xbrltype": "booleanItemType" }, "ncpl_AccountsPayableRelatedParties": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Related party" } } }, "localname": "AccountsPayableRelatedParties", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_AccountsReceivablePartiesNoncurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Notes receivable \u2013 related parties" } } }, "localname": "AccountsReceivablePartiesNoncurrent", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_AcquiredBrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Brand [Member]" } } }, "localname": "AcquiredBrandMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ncpl_AcquiredIntellectualPropertyAndWebsiteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Intellectual Property And Website [Member]" } } }, "localname": "AcquiredIntellectualPropertyAndWebsiteMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ncpl_AcquiredUsersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Users [Member]" } } }, "localname": "AcquiredUsersMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ncpl_AdjustmentsToNetIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Adjustments to net income (loss)" } } }, "localname": "AdjustmentsToNetIncomeLoss", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "ncpl_AmortizationOfIntangibleAssets1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets1", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ncpl_BadDebtAllowance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Bad debt allowance" } } }, "localname": "BadDebtAllowance", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ncpl_BusinessConsultant1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Consultant 1 [Member]" } } }, "localname": "BusinessConsultant1Member", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "ncpl_BusinessConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Consultant [Member]" } } }, "localname": "BusinessConsultantMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "ncpl_CRevealTherapeuticsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "C Reveal Therapeutics L L C [Member]" } } }, "localname": "CRevealTherapeuticsLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_CaesarMediaGroupIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Caesar Media Group Inc [Member]" } } }, "localname": "CaesarMediaGroupIncMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_ChangesInDeferredAssets": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangesInDeferredAssets", "negatedLabel": "Changes in deferred taxes" } } }, "localname": "ChangesInDeferredAssets", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_ChiefExecutiveOfficerOfSubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Executive Officer Of Subsidiary [Member]" } } }, "localname": "ChiefExecutiveOfficerOfSubsidiaryMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "ncpl_ChipBrainLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chip Brain L L C [Member]" } } }, "localname": "ChipBrainLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_CommonStockIssuedToPayPromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to pay promissory notes" } } }, "localname": "CommonStockIssuedToPayPromissoryNotes", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_CommonStockIssuedToPayRelatedPartyPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued to pay related party payable" } } }, "localname": "CommonStockIssuedToPayRelatedPartyPayable", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_CommonStockIssuedToPurchase10InterestInCaesarMediaGroupInc.": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock issued to purchase 10% interest in Caesar Media Group Inc." } } }, "localname": "CommonStockIssuedToPurchase10InterestInCaesarMediaGroupInc.", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_CommonStockToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock To Be Issued [Member]" } } }, "localname": "CommonStockToBeIssuedMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "ncpl_ConsultingServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consulting Services [Member]" } } }, "localname": "ConsultingServicesMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "ncpl_ContractRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract revenues not recognized" } } }, "localname": "ContractRevenues", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/RevenueRecognitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ncpl_CountSharpLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Count Sharp L L C [Member]" } } }, "localname": "CountSharpLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_CupCrewLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cup Crew L L C [Member]" } } }, "localname": "CupCrewLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_CurrentPortionOfLongtermSecuredRelatedPartyNote": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Current portion of SBA loans" } } }, "localname": "CurrentPortionOfLongtermSecuredRelatedPartyNote", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_CustCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cust Corp [Member]" } } }, "localname": "CustCorpMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_DarkLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dark L L C [Member]" } } }, "localname": "DarkLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_DeferredTaxLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net deferred tax liability" } } }, "localname": "DeferredTaxLiability", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ncpl_Deposit": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deposits" } } }, "localname": "Deposit", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_DepositsAndCommitmentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deposits and Commitments" } } }, "localname": "DepositsAndCommitmentsTextBlock", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/DepositsAndCommitments" ], "xbrltype": "textBlockItemType" }, "ncpl_DeuceDroneLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deuce Drone L L C [Member]" } } }, "localname": "DeuceDroneLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_DisclosureDepositsAndCommitmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deposits And Commitments" } } }, "localname": "DisclosureDepositsAndCommitmentsAbstract", "nsuri": "http://ncpl/20230731", "xbrltype": "stringItemType" }, "ncpl_DisclosurePrincipalFinancingArrangementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Principal Financing Arrangements" } } }, "localname": "DisclosurePrincipalFinancingArrangementsAbstract", "nsuri": "http://ncpl/20230731", "xbrltype": "stringItemType" }, "ncpl_DisclosureRevenueRecognitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition" } } }, "localname": "DisclosureRevenueRecognitionAbstract", "nsuri": "http://ncpl/20230731", "xbrltype": "stringItemType" }, "ncpl_DueToRelatedPartiesCurrentOne": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Related party debt" } } }, "localname": "DueToRelatedPartiesCurrentOne", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_EmployeeStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Stock Options [Member]" } } }, "localname": "EmployeeStockOptionsMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "ncpl_EquitySecuritiesAtFairValue": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Equity securities at fair value" } } }, "localname": "EquitySecuritiesAtFairValue", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_ExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Per Share" } } }, "localname": "ExercisePricePerShare", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_ExercisePricePerShareExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ExercisePricePerShareExercisable-0]" } } }, "localname": "ExercisePricePerShareExercisable", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "sharesItemType" }, "ncpl_ExercisedPriceIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercised Price Issued" } } }, "localname": "ExercisedPriceIssued", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_FeesFromOnlineServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fees From Online Services [Member]" } } }, "localname": "FeesFromOnlineServicesMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "ncpl_FounderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder [Member]" } } }, "localname": "FounderMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "ncpl_HeadFarmLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Head Farm L L C [Member]" } } }, "localname": "HeadFarmLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_HiveskillLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hiveskill L L C [Member]" } } }, "localname": "HiveskillLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_InvestmentInAffiliate": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Investment in affiliate" } } }, "localname": "InvestmentInAffiliate", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_KingscrowdIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Kingscrowd Inc [Member]" } } }, "localname": "KingscrowdIncMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_LiteraryWorksAndContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Literary Works And Contracts [Member]" } } }, "localname": "LiteraryWorksAndContractsMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ncpl_LoanPayableBankCurrent": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loan payable - bank" } } }, "localname": "LoanPayableBankCurrent", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_MustWatchLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Must Watch L L C [Member]" } } }, "localname": "MustWatchLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_NetcapitalSystemsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netcapital Systems L L C [Member]" } } }, "localname": "NetcapitalSystemsLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_NetwireLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netwire L L C [Member]" } } }, "localname": "NetwireLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_NotesPayableRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable Related Parties [Member]" } } }, "localname": "NotesPayableRelatedPartiesMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "ncpl_OptionsExercisableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Exercisable [Member]" } } }, "localname": "OptionsExercisableMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1" ], "xbrltype": "domainItemType" }, "ncpl_OptionsOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Outstanding [Member]" } } }, "localname": "OptionsOutstandingMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1" ], "xbrltype": "domainItemType" }, "ncpl_OtherOperatingIncomeExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total other income (expense)" } } }, "localname": "OtherOperatingIncomeExpense", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ncpl_Outstandingexercisedpricepershare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OutstandingExercisedPricePerShare" } } }, "localname": "Outstandingexercisedpricepershare", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_PaymentOfRelatedPartyNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Payment of related party note" } } }, "localname": "PaymentOfRelatedPartyNote", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_PrincipalFinancingArrangementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PrincipalFinancingArrangementsTextBlock", "verboseLabel": "Principal Financing Arrangements" } } }, "localname": "PrincipalFinancingArrangementsTextBlock", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangements" ], "xbrltype": "textBlockItemType" }, "ncpl_ProfessionalPracticeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Professional Practice [Member]" } } }, "localname": "ProfessionalPracticeMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ncpl_PurchaseOfIntellectualProperty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase of intellectual property" } } }, "localname": "PurchaseOfIntellectualProperty", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ncpl_PurchaseOfIntellectualPropertyShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase of intellectual property, shares" } } }, "localname": "PurchaseOfIntellectualPropertyShares", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "ncpl_PurchasedTechnologyNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Purchased technology, net" } } }, "localname": "PurchasedTechnologyNet", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_RealWorldLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real World L L C [Member]" } } }, "localname": "RealWorldLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_RealizedInvestmentGainsLosse": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Realized loss on investment" } } }, "localname": "RealizedInvestmentGainsLosse", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_ReceiptOfEquityInLieuOfCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Receipt of equity in lieu of cash" } } }, "localname": "ReceiptOfEquityInLieuOfCash", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ncpl_ReductionInSharesToBeIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Reduction in shares to be issued" } } }, "localname": "ReductionInSharesToBeIssued", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ncpl_ReductionInSharesToBeIssuedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reduction in shares to be issued, Shares" } } }, "localname": "ReductionInSharesToBeIssuedShares", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "ncpl_Rent": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Rent" } } }, "localname": "Rent", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ncpl_ReperLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reper L L C [Member]" } } }, "localname": "ReperLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_RevenueRecognitionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RevenueRecognitionTextBlock", "verboseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionTextBlock", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "ncpl_ScanHashLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Scan Hash L L C [Member]" } } }, "localname": "ScanHashLLCMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_ScheduleOfWarrantsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Warrants activity" } } }, "localname": "ScheduleOfWarrantsActivityTableTextBlock", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "ncpl_ScheduleOfWarrntsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrants outstanding" } } }, "localname": "ScheduleOfWarrntsRollForwardTableTextBlock", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "ncpl_SecuredNotedPayableToRelatedParty": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Secured note payable" } } }, "localname": "SecuredNotedPayableToRelatedParty", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_ShareBasedCompensationAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total stock-based compensation expense" } } }, "localname": "ShareBasedCompensationAmount", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers-0]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodOne", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "sharesItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod1", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "sharesItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions-0]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOptions", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "sharesItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1-0]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions-0]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOptions", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3]" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "ncpl_SharesIssuedForDebtConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for debt conversion" } } }, "localname": "SharesIssuedForDebtConversion", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ncpl_SharesIssuedForDebtConversionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued for debt conversion, Shares" } } }, "localname": "SharesIssuedForDebtConversionShares", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "ncpl_SmallBusinessAdministrationLoansPayable": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long-term SBA loans, less current portion" } } }, "localname": "SmallBusinessAdministrationLoansPayable", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_StockOptionExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:StockOptionExercisePrice-0]" } } }, "localname": "StockOptionExercisePrice", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_StockOptionExercisePriceExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:StockOptionExercisePriceExercised]" } } }, "localname": "StockOptionExercisePriceExercised", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_StockOptionExercisePriceIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:StockOptionExercisePriceIssued]" } } }, "localname": "StockOptionExercisePriceIssued", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_StockOptionExercisePriceOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:StockOptionExercisePriceOne-0]" } } }, "localname": "StockOptionExercisePriceOne", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "ncpl_StockSubscriptionPayable": { "auth_ref": [], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock subscription payable" } } }, "localname": "StockSubscriptionPayable", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ncpl_StockbasedSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock-based settlement" } } }, "localname": "StockbasedSettlement", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ncpl_StockbasedSettlementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-based settlement, shares" } } }, "localname": "StockbasedSettlementShares", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "ncpl_ThirdPartyContractorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party Contractor [Member]" } } }, "localname": "ThirdPartyContractorMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "ncpl_USSBALoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "U S S B A Loan [Member]" } } }, "localname": "USSBALoanMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "ncpl_USSBALoanOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "U S S B A Loan One [Member]" } } }, "localname": "USSBALoanOneMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "ncpl_USSBALoanTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "U S S B A Loan Two [Member]" } } }, "localname": "USSBALoanTwoMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "ncpl_VestingOfStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Vesting of stock options" } } }, "localname": "VestingOfStockOptions", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "ncpl_VymedicIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vymedic Inc [Member]" } } }, "localname": "VymedicIncMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "ncpl_WarrantsExercisableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Exercisable [Member]" } } }, "localname": "WarrantsExercisableMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "ncpl_WarrantsExercisablePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercisable Price" } } }, "localname": "WarrantsExercisablePrice", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "ncpl_WarrantsOutstandingPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants outstanding Price" } } }, "localname": "WarrantsOutstandingPrice", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "ncpl_ZelgorIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Zelgor Inc [Member]" } } }, "localname": "ZelgorIncMember", "nsuri": "http://ncpl/20230731", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r128", "r129", "r206", "r223", "r334", "r336" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r190", "r191", "r192", "r193", "r238", "r316", "r324", "r331", "r332", "r346", "r348", "r353", "r393", "r403", "r404", "r405", "r406", "r407", "r408" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r190", "r191", "r192", "r193", "r238", "r316", "r324", "r331", "r332", "r346", "r348", "r353", "r393", "r403", "r404", "r405", "r406", "r407", "r408" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r176", "r317", "r347", "r352", "r389", "r390", "r394", "r409" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r176", "r317", "r347", "r352", "r389", "r390", "r394", "r409" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r190", "r191", "r192", "r193", "r237", "r238", "r263", "r264", "r265", "r315", "r316", "r324", "r331", "r332", "r346", "r348", "r353", "r388", "r393", "r404", "r405", "r406", "r407", "r408" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r190", "r191", "r192", "r193", "r237", "r238", "r263", "r264", "r265", "r315", "r316", "r324", "r331", "r332", "r346", "r348", "r353", "r388", "r393", "r404", "r405", "r406", "r407", "r408" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r128", "r129", "r206", "r223", "r335", "r336" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r386", "r400" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r11", "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r1", "r11" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r179", "r180" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r115", "r116", "r299", "r300", "r301", "r302", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "AdditionalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r6", "r351" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r267", "r268", "r269", "r382", "r383", "r384", "r398" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r34", "r46", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r83", "r93", "r109", "r124", "r167", "r170", "r174", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r287", "r291", "r298", "r351", "r391", "r392", "r401" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r107", "r112", "r124", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r287", "r291", "r298", "r351", "r391", "r392", "r401" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1", "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r41", "r43" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentatio" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/BasisOfPresentatio" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r30", "r36", "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of the period", "periodStartLabel": "Cash and cash equivalents, beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r30", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Net increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r374" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Non-Cash Investing and Financing Information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r18", "r86", "r97" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r382", "r383", "r398" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r53" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r5", "r351" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $.001 par value; 900,000,000 shares authorized,\u00a0\u00a0\u00a0\u00a09,434,132 and 6,440,527 shares issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r62", "r63", "r69", "r74" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Stock-Based Compensation Plans" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r25", "r124", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r298", "r391" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Costs of services" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r23" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r38", "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "negatedLabel": "Gain on debt conversion" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r110" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r16", "r80", "r221", "r306" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r17", "r54", "r55", "r56", "r57", "r79", "r80", "r82", "r92", "r130", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r306", "r341", "r342", "r343", "r344", "r345", "r380" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Gain on debt conversion" } } }, "localname": "DebtSecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationShareBasedArrangementsLiabilityCurrent": { "auth_ref": [ "r14" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements payable within one year (or the operating cycle, if longer).", "label": "Deferred Compensation Share-Based Arrangements, Liability, Current", "verboseLabel": "Stock-based compensation" } } }, "localname": "DeferredCompensationShareBasedArrangementsLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r270", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r375" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets, net:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r75", "r396" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred tax liability, net" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax liability" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_DilutiveSecurities": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.", "label": "Effect of dilutive securities" } } }, "localname": "DilutiveSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r120", "r136", "r137", "r138", "r139", "r140", "r144", "r147", "r154", "r155", "r156", "r160", "r295", "r296", "r320", "r322", "r338" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic earnings (loss) per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r120", "r136", "r137", "r138", "r139", "r140", "r147", "r154", "r155", "r156", "r160", "r295", "r296", "r320", "r322", "r338" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted earnings (loss) per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r157", "r158", "r159", "r161" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r53", "r105", "r115", "r116", "r117", "r131", "r132", "r133", "r135", "r141", "r143", "r162", "r182", "r235", "r267", "r268", "r269", "r276", "r277", "r294", "r299", "r300", "r301", "r302", "r303", "r304", "r307", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity", "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Investments" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/FairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r185", "r186", "r187", "r188", "r318", "r319" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r47", "r48" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r49", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r24", "r124", "r167", "r169", "r173", "r175", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r298", "r340", "r391" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r125", "r280" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Net income (loss) before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r20", "r87", "r89", "r98", "r120", "r134", "r136", "r137", "r138", "r139", "r147", "r154", "r155", "r296", "r320" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings (loss) per common share - basic" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r20", "r98", "r100", "r120", "r134", "r136", "r137", "r138", "r139", "r147", "r154", "r155", "r156", "r296", "r320", "r322" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings (loss) per common share - diluted" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r126", "r273", "r274", "r275", "r278", "r281", "r283", "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r142", "r143", "r166", "r272", "r279", "r282", "r323" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r31", "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r33" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r33" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Accounts payable \u2013 related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r33" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r337" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxes": { "auth_ref": [ "r378" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.", "label": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r33" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Accrued interest payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in non-cash working capital balances:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r33" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r81", "r91", "r118", "r165", "r305" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r379" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Cash paid for interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Schedule of investments" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r377" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Payroll and payroll related expenses" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r124", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r288", "r291", "r292", "r298", "r339", "r391", "r401", "r402" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r10", "r85", "r96", "r351", "r381", "r387", "r399" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r15", "r108", "r124", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r288", "r291", "r292", "r298", "r351", "r391", "r401", "r402" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r3", "r84", "r94", "r210", "r220", "r342", "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term liabilities:" } } }, "localname": "LongTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r17", "r51" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketingExpense": { "auth_ref": [ "r26" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.", "label": "Marketing" } } }, "localname": "MarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r30", "r32", "r35" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r21", "r35", "r90", "r99", "r106", "r113", "r114", "r117", "r124", "r134", "r136", "r137", "r138", "r139", "r142", "r143", "r152", "r167", "r169", "r173", "r175", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r296", "r298", "r340", "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows", "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r136", "r137", "r138", "r139", "r144", "r145", "r153", "r156", "r167", "r169", "r173", "r175", "r340" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net income (loss) attributable to common stockholders \u2013 basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r146", "r148", "r149", "r150", "r151", "r153", "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net income (loss) attributable to common stockholders \u2013 diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r167", "r169", "r173", "r175", "r340" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r111", "r183", "r184", "r333" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.", "label": "Weighted average common shares outstanding \u2013 diluted" } } }, "localname": "ProFormaWeightedAverageSharesOutstandingDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfInvestmentProjects": { "auth_ref": [ "r27" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.", "label": "Proceeds from sale of investment" } } }, "localname": "ProceedsFromSaleOfInvestmentProjects", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r103", "r104" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Consulting expense" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r106", "r113", "r114", "r121", "r124", "r134", "r142", "r143", "r167", "r169", "r173", "r175", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r286", "r289", "r290", "r296", "r298", "r321", "r340", "r349", "r350", "r376", "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss July 31, 2023 quarter" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForOtherLosses": { "auth_ref": [ "r22", "r33", "r88" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to other loss.", "label": "Provision for bad debts" } } }, "localname": "ProvisionForOtherLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized loss on sale of investment" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r308", "r309", "r310", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedLabel": "Payments to secured lender" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r7", "r58", "r95", "r328", "r329", "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r105", "r131", "r132", "r133", "r135", "r141", "r143", "r182", "r267", "r268", "r269", "r276", "r277", "r294", "r325", "r327" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r236" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Remaining Performance Obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/RevenueRecognitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r119", "r124", "r163", "r164", "r168", "r171", "r172", "r176", "r177", "r178", "r181", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r298", "r321", "r391" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations", "http://ncpl/role/RevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Income Taxes" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r64", "r65", "r66", "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/EarningsPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r47", "r48", "r318" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r47", "r48" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.", "label": "Schedule of stock options activity" } } }, "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of employee stock purchase plan activity.", "label": "Schedule of stock-based compensation expense" } } }, "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of stock options outstanding" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/PrincipalFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r26" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "General and administrative costs" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r33" ], "calculation": { "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Employee and consultant options", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfCashFlows", "http://ncpl/role/Stock-basedCompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1", "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1", "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1", "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1", "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails1", "http://ncpl/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Beginning balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r19", "r53", "r105", "r115", "r116", "r117", "r131", "r132", "r133", "r135", "r141", "r143", "r162", "r182", "r235", "r267", "r268", "r269", "r276", "r277", "r294", "r299", "r300", "r301", "r302", "r303", "r304", "r307", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity", "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/RevenueRecognitionDetails", "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r131", "r132", "r133", "r162", "r317" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/RevenueRecognitionDetails", "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r4", "r5", "r53", "r58", "r73" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock-based Compensation, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Sale of common stock shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r4", "r5", "r53", "r58", "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Sale of common stock" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r4", "r5", "r53", "r58" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Purchase of equity interest shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r4", "r5", "r53", "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Purchase of equity interest" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r5", "r8", "r9", "r44", "r351", "r381", "r387", "r399" ], "calculation": { "http://ncpl/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets", "http://ncpl/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r59", "r123", "r222", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate gross unrealized appreciation for all Investments in which there is an excess of value over tax cost.", "label": "Unrealized gain" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedAppreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income taxes notes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital": { "auth_ref": [ "r2", "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Shares to be issued" } } }, "localname": "TemporaryEquityValueExcludingAdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/Stock-basedCompensationPlansDetails2", "http://ncpl/role/StockholdersEquityDetails", "http://ncpl/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r146", "r156" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r144", "r156" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic", "verboseLabel": "Weighted average common shares outstanding - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ncpl/role/CondensedConsolidatedStatementsOfOperations", "http://ncpl/role/EarningsPerCommonShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r354": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r355": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r356": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r357": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r358": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r359": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r361": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r362": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r363": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r364": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r365": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r366": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r367": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r368": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r369": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r371": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r372": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r373": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(14))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 59 0001903596-23-000722-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001903596-23-000722-xbrl.zip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�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end